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ZERO-INFLATED LONGITUDINAL MIXTURE MODEL FOR STOCHASTIC RADIO-
GRAPHIC LUNG COMPOSITIONAL CHANGE FOLLOWING RADIOTHERAPY OF
LUNG CANCER
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A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy in Biostatistics at Virginia Commonwealth University.
Virginia Commonwealth University, 2020.
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Compositional data (CD) is mostly analyzed as relative data, using ratios of components,
and log-ratio transformations to be able to use known multivariable statistical methods.
Therefore, CD where some components equal zero represent a problem. Furthermore, when
the data is measured longitudinally, observations are spatially related and appear to come
from a mixture population, the analysis becomes highly complex. For this matter, a two-
part model was proposed to deal with structural zeros in longitudinal CD using a mixed-
effects model. Furthermore, the model has been extended to the case where the non-zero
components of the vector might a two component mixture population. Maximum likelihood
estimates for fixed effects and variance components are calculated by an approximate Fisher
scoring procedure base on sixth-order Laplace approximation. The EM algorithm is used to
estimate the probability of the mixture model.
The proposed model was used to analyze the radiation therapy effect on tissue change in
one patient with non-small cell lung cancer (NSCLC). Five CT-scans were obtained during
24 months following RT. Instead of using voxel-level data, voxels were grouped into larger
subvolumes called patches. Data in each patch can be represented by a vector in the form
of CD with the proportions of tissue classified as dense, hazy, or normal. A statistical
model of radiation-induced lung damage (RILD) over time for each patch as a function of
time and dose was implemented. The predicted longitudinal compositions were classified to
describe tissue change using cluster analysis. Finally, proposed method and cluster analysis
were applied to two groups of patients with and without radiation pneumonitis (RP) to
characterize tissue changes in RP.
1. Introduction
1.1 Background knowledge
Compositional data are vectors of non-negative real numbers that represent parts of some
whole. Therefore, a composition x = [x1, x2, . . . , xD] is subject to the constraint
∑D
i=1 xi = k,
with xi > 0. Usually, the parts of a composition are presented as proportions or percentages,
then k=1 or 100.1 Common examples include the proportion of different cell types in a
patient’s blood, proportion of nutrients in a patient’s diet, portions of the chemical elements
in the air, the proportion of working time spent on different activities, etc. In all previous
examples, there is a total amount, but our interest is on how this total is split among the
different components. The sum over the amounts of all parts must add up to the total.
Then, the proportion with respect to the total for each component can be calculated and
used for analysis.
Compositional data have been commonly analyzed using multivariate data analysis with-
out any transformation. Nonetheless, this approach can lead to paradoxes and misinterpre-
tations of the results. Karl Pearson was the first person to comment about the issues when
analyzing proportions using standard statistical methods. Unfortunately, his observations
were ignored until Felix Chayes2 pointed out the spurious correlation when using multivariate
analysis that leads to a negative bias induced by the constant-sum constraint.3,4
In the 1980s, Aitchison proposed the first methodology with a new geometry framework
to analyze compositional data as relative data, using ratios of components and log-ratio
transformations to be able to use known multivariable statistical methods. Currently, new
approaches using orthonormal coordinates have been implemented to be able to use the real
1
Euclidean space when analyzing compositional data.3,4
The composition x = [x1, x2, . . . , xD] is a D-part composition, but it is completely spec-
ified by its first D − 1 parts, since xD = k − x1 − . . . − xD−1. Consequently, a D-part
composition is a D − 1 dimensional vector. Therefore, in the analysis of compositional
data, the sample space is restricted to the simplex by the constant-sum constraint.1,3,4 This
singularity invalidates the use of the Euclidian space, which is the reason why statistical
measurements such as mean, standard deviation, correlation, and even hypothesis testing
may lead to erroneous interpretations when used in compositional data analysis.1,4
Scale invariance, permutation invariance, and subcompositional coherence are the main
principles of compositional data analysis. The scale invariance property states that two
compositions x and y must produce the same results if their parts represent the same
percentages. For instance, x = [10, 40, 50] and y = [50, 200, 250] might be expressed as the
composition [0.1, 0.4, 0.5], so that x and y are compositional equivalent and should lead to
the same results. This principle reinforces the idea that a composition holds only relative
information. The permutation invariance implies that the results do not depend on the
order that the parts appear in the composition. Finally, subcompositional coherence states
that the inferences obtained when analyzing a subcomposition should be the same as the
inferences using the whole composition when analyzing the common parts.1,4
The simplex space, and the principles of compositional data, stated above, prompts
the definition of new basic operations to handle this type of data. Aitchison proposed the
perturbation and the powering operations.1 Then, the simplex with these two operations
establishes a vector space.4












for working with compositional data.1 As mentioned above, the analysis of compositional
2
data is based on the relative information, which justifies the use of ratios. Since log-ratios
are easier to manipulate than the ratios, and have some advantages in interpretability and
power when compared with other transformations,5 it justifies the use of logarithms.
In Equation (1.1), the last part of the composition is used as the denominator for the
ratio, although any part could have been used. Consequently, different alr transformations
can be obtained from the same composition. Therefore, the alr transformation is not sym-
metric, which have implications in the analysis such as inner products or distances cannot be
computed.6,7 Despite this limitation, when analyzing compositional data as dependent vari-
able using linear statistical methods, the alr transformation is very useful since the additive
logistic normal distribution can be used.1,4,8












where g(x) = (x1 × x2 × . . . × xD) is the geometric mean.1 The clr transformation is
symmetric, but the sum of its parts adds to zero. Hence, the covariance matrix of the
transformation is singular. Furthermore, the clr transformation is not subcompositional
coherent, since the geometric mean of composition might not be the same as the geometric
mean in a subcomposition.4,7 The clr transformation, however, preserves distances allowing
us to use statistical methods that require this measurement as an analysis input.9
Finally, the isometric log-ratio transformation (ilr) was defined to create an orthogonal
coordinate system in the simplex.6 This transformation allows the use of geometric elements
in the simplex, permitting the use of most complex statistical approaches. The main idea
behind this transformation is to split the composition into two different subsets and use
them to construct the orthogonal coordinates for the composition.6 In addition of this,
there are many different ways to divide the composition into two distinct subsets. Despite
the mathematical advantages, this approach leads to some difficulties in choosing the best
3
subset, as well as in the interpretation of the results.7,10
Since the proposed transformations all use ratios and the logarithmic transformation,
compositional data where some component equals zero, run into problem. Some methods
for handling this problem have been proposed.1,11–16 The modified Aitchison replacement
is one of the most frequently implemented method in the analysis of compositional data.
This replacement method first substitutes the parts of the composition equal zero by a small
quantity, and afterwards, each non-zero component is reduced by a factor to preserve the
share ratios.11 The above method works properly in the presence of rounding zeros or gen-
erated by detection limits in the measurement. Nonetheless, in the presence of structural
zeros (true zeros), the idea of substituting them for a small amount does not seem entirely
adequate. For this matter, in this research, a two stages modeling approach has been pro-
posed to deal with structural zeros. The first step determines if the composition contains
parts equal zero and the second stage models the proportions among the non-zero parts of
the composition.12,13
Compositional data as response variable has been analyzed using the transformed com-
position as the regressor in multivariate analysis of variance (MANOVA) and multivari-
ate regression assuming multivariate normal distributions, logistic-normal distributions or
additive-logistic skew-normal distributions;1,4,8 but also some non-parametric and Bayesian
approaches have been implemented to particular cases.17–20 Some applications of mixed effect
models and polynomial smoothing splines have been used to study the longitudinal behavior
of compositional data.16,21–23 Also, several applications implementing dimension reduction
and clustering of compositional data have been performed, and several publications have
talked about the interpretation of these results.1,7,9,10 Further, approximations to clustering
compositional data trajectories over time have been proposed.21
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1.2 Motivating example
Lung cancer (LC) is the second most common cancer in both men and women, and even
though the incidence of LC has declined, it still represents almost 14% of all new cases of
cancer.24,25 Although there has been an improvement on early diagnosis and treatment for
these patients,26 LC is the leading cause of cancer death, representing about 25% of the
cancer deaths in both genders, and overall it has a low 5-year survival (18%).24,27 There
are three main types of LC, non-small cell (NSCLC), small cell (SCLC), and lung carcinoid
tumor (LCT); while SCLC is the most deadly type of LC, NSCLC is the most frequent type,
accounting for 80 to 90% of LC cases.25 NSCLC covers squamous cell carcinoma, large cell
carcinoma, adenocarcinoma, among other less common types of LC. Even though smoking
is the main risk factor for NSCLC, other factors such as exposure to asbestos, air pollution
and family history of LC have also shown an association with an increase in LC risk.25
Radiation therapy (RT) is the standard treatment for medically inoperable patients in the
early stages of NSCLC.28 The idea behind RT is to break the DNA inside cells, keeping cancer
cells from growing and causing them to die.29 Stereotactic body radiotherapy (SBRT), one
type of external RT, works with a specially designed coordinate-system to accurately target
the tumor while limiting the toxic exposure to normal tissue.30,31 As Figure 1.1 shows, SBRT
delivers treatment dose over several fractions using beams from different angles, which allows
performing treatment in fewer fractions with a higher dose per fraction as compared with the
conventional RT. Usually, conventional RT is conducted in 20 to 40 fractions (2Gy/fraction),
while SBRT schedules between three and five fractions with doses of 6 to 20 Gy/fraction.30–33
These key features, tumor targeting and fewer fractions with a higher dose, enhance the
treatment in dose conformity, tumor coverage, therapeutic ratio, and also allows for delivering
the treatment in a shorter time.28
Despite the precision of the SBRT and the fact that the total dose of RT to be delivered
is limited by the volume of the normal tissue in the lung, healthy tissue near the tumor is
exposed to clinically relevant doses of RT causing radiation-induced lung damage (RILD)
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Figure 1.1: Stereotactic body radiation therapy (SBRT) treatment planning images
in the vicinity of the tumor.34 The RILD patterns and severity can vary widely among
patients and although some damage is observed in almost all patients undergoing RT, it
is expected that under a low radiation exposure, healthy tissue’s cells do not suffer any
permanent damage that may lead to late toxicities.28,30 Nonetheless, about 10 to 20% of
patients undergoing RT develop clinical symptoms of radiation pneumonitis (RP), a lung
inflammation considered one of the significant toxicities following RT,31,33 and therefore is
one of the main limitations of the dose to be delivered in the treatment.28
Symptoms of RP and radiologic changes in the lung are usually developed between six
weeks to six months after RT.28,30 Although most patients are asymptomatic or with mod-
erate symptoms, RP has been associated with adverse effects on lung functionality, quality
of life, and even mortality.28,31,35
Following RT, computed tomography (CT) scans are obtained at regular time points to
assess RP, observe tumor regression, and detect potential tumor recurrence. The CT scan
combines numerous x-ray taken from different angles to create multiple 2D transverse slices
of the body parts in a gray scale (Figure 1.2a). CT scan data is saved as a three-dimensional
array of voxels, where each voxel stores the data (gray scale value) corresponding to a tiny
cube of tissue on the CT scan (Figure 1.2b). On the three-dimensional array, each voxel
is denoted by ijk, where i = 1, . . . , I and j = 1, . . . , J represents the position of the voxel
along the transverse plane; and k = 1, . . . , K being the number of the transverse slices. In
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(a) Multiple 2D transverse slices (b) 3D matrix
Figure 1.2: Multiple 2D transverse slices saved as a 3D matrix
the context of lung CT, the voxel dimensions are approximately 2-3 mm in superior-inferior
direction, and less than 1 mm in the other two directions.
Several grading systems that combine clinical, functional and radiographic changes have
been implemented for the diagnosis of RP.28 However, each scale uses a different weighting for
the above factors, making the comparison between scales particularly challenging.36 Also, the
grading systems depend mostly on physicians’ interpretations of the CT scan and clinical
findings, which might be very subjective and non-reproducible.37 For example, dyspnea,
one of the common symptoms, is non-specific and can be caused by other pathologies; or
improvement in lung function can be caused by a shrinkage of the tumor, hiding the presence
of RP.36
Even though RILD pattern and the recovery process after conventional RT have been
widely studied, the hypofractionation feature of the SBRT might result in different injury
patterns. Some studies have reported that RILD after SBRT is visible a little later and with
different appearance compared to conventional RT.30,32 Some approximations to use the CT
scan to build normal tissue complication probability (NTCP) models have been developed,
most of them looking in the dose/volume relationship to plan the treatment.28,36 However,
the results have not been entirely satisfactory. Among several reasons, these models use a
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single value to summarize all the dose effects, ignoring the local distribution of the dose-
response as well as the local variability in composition and functionality of the lung.36,38–40
A second approach, based on voxel data, has been proposed to deal with the underlying
dose distribution in the lung.39,41 Even though this approach offers a good perspective for
analyzing CT images, this represents some issues regarding the analysis over time since the
lung tissue deforms after RT (fibrotic distortions), e.g., tumor shrinkage, which allows the
expansion of the normal tissue into the vacant space.42 Thus, it is not possible to assume
that a voxel in the three-months CT scan represents the same tissue as the corresponding
voxel at the six-months CT scan (Figure 1.3). Image registration would improve the tem-
poral integrity of the patches by taking care of systemic sources such as patient motion,
breathing pattern, etc. However, traditional registration algorithms, including deformable
registrations, do not account for fibrotic distortion. Therefore, even with state-of-the-art im-
age registration, integrity of the voxel tissue across time cannot be assured in clinical image
pairs without extensive, labor-intensive effort to manually annotate images to a sufficient
degree. As a result, following the RILD pattern for each voxel is not meaningful from a
medical point of view.
Figure 1.3: CT scan follow-up with lung shrinkage after radiation therapy
All things considered, there is a clear need for objective image interpretation that pro-
vides better characterization of RILD, its correlation with RP, and that allows a better
differentiation of RP from other lung pathologies after RT. With a much lower level of noise
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compared to earlier medical images, statistical models have much to offer in reaching this
goal by using minute changes in tissue texture. Hence, it is necessary to develop statistical
models for smaller segments of tissue as observed in the current day high-resolution images
rather than an aggregate model. The new approach should also be flexible enough to ac-
commodate the spatial dependence between neighboring voxels, and other risk factors when
modeling the changes over time of RILD using comprehensive CT scan data.
Our preliminary data consists of five CT scans of one NSCLC female patient (reference
patient) obtained at 3, 6, 12, 18 and 24 months following SBRT with 57 Gy dose. The
patient’s tumor was located on the right upper lobe, and the planning target volume (PTV)
was 23.2 mL. Data of the reference patient has been used to build and test all methodologies
in the present work. Additionally, data of 18 NSCLC patients with follow-up CT scans
at 3,6 and 12 months post-treatment has been used to assess the reproducibility of the
proposed methodologies. Patients were treated from 2007 - 2016 at the Massey Cancer
Center at Virginia Commonwealth University. Treatment dose varied between 46 and 70 Gy
delivered in several fractions every other day. Nine patients in this group have a positive
diagnosis of RP. Frequency matching was used to assure the same distributions by treatment
technique and primary tumor volume between patients with and without RP. Table 1.1 shows
a description of the patient characteristics, overall and by RP diagnosis
Characteristics Overall No RP (n=9) RN (n=9)
Age, mean (sd) 68.2 (10.1) 64.5 (3.8) 72 (2.6)
Male 9 (50.0%) 3 (33.3%) 6 (66.7%)
African American race 10 (55.6) 5 (55.6%) 5 (55.6)
Current smoker 9 (50.0%) 6 (66.7%) 3 (33.3%)
Diabetes 3 (16.7%) 1 (11.1%) 2 (22.2%)
Tumor located in the upper lobe 14 (77.8%) 6 (66.7%) 7 (77.8%)
Baseline lung density (HU), mean (sd) -724 (67.0) -721 (21.6) -727 (24.2)
Planning target volume, mean (sd) 49 (38.2) 48 (12.4) 50 (13.8)
Prescription dose (Gy), mean (sd) 59 (1.2) 59 (2.1) 60 (1.2)
Table 1.1: Characteristics of 18 NSCLC patients
For this study, one physician manually contoured the area with RILD on the CT scans
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using commercial contouring software (MIM Maestro v6.6, MIM Software, Cleveland, OH).
Even though, in the CT scan, the extent of radiographic injury is observed in a continuous
manner with the RT dose, voxels were classified according to their radiographic findings
into three-threshold based ordinal categories of radiographic injury, namely, dense (repre-
senting areas of consolidation and fibrosis), hazy (representing ground-glass changes) and
normal.30,32
After RILD contouring, deformable image registration was performed using a multi-pass
b-spline to account for major changes in lung architecture after RT. Follow-up CT scans were
registered to the baseline treatment planning scan using a commercial registration package
(Velocity - Varian Medial Systems).
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2. Approximation to assemble subvolumes as a combination of voxels
A lot of information regarding disease progression/regression, radiation response, tumor
growth is captured in the CT scans of the patients. Statistical analysis of these CT scans
using a single measure to summarize the whole RT dose-response effect in the lung is clearly
loosing a lot of information contained in the entire image. The other extreme, using each
voxel level data is impractical, as the spatial integrity of the voxel over time is very difficult to
ascertain even after a very modern image registration technique. Both such approach would
lead to misspecified model in the longitudinal analysis of RILD. Thus, a more meaningful
approach would be to consider combination of the voxels into larger subvolumes (patches),
small enough that the treatment dose to the voxels within a patch is approximately homo-
geneous, but large enough to be trackable over time. Several definitions of such patches, as
well as an evaluation of their performance is presented in the sequel for 18 NSCLC patients
scanned between 3 to 5 times following their RT.
2.1 Cubic patch definition
The first approach, called cubic patch, consists of p voxels along each direction in the CT
scan (i, j, and k). Figure 2.1 (a) shows an example of the cubic patch composition grouping
eight voxels along each direction (p=8). Each small cube represents a voxel, and each colored
group of voxels represents a patch. In this case, each patch consists of 512 voxels. In the
following, different definitions of these patches combining p voxels along each direction with
p = 4, . . . , 10 are explored to define their suitability through some notion of optimality.
Once a patch has been defined, voxel-level data must be combined to obtain data at
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(a) Patch definition (b) RILD in cubic patch size 8
Figure 2.1: Cubic patch
the patch-level. Patch-level dose was obtained through the minimum RT dose, maximum,
median, mean, and standard deviation of voxel dose. To obtain a measure of the RILD
for each patch, the proportions of voxels falling into the category of ’dense’ or ’hazy’ was
calculated. The Figure 2.1 (b) is a zoom-in of one of the patches of size 8. The voxels
in dark purple represent voxels classified as dense regions, light purple are hazy regions,
and white voxels represent normal tissue. In this example, there are 27 dense voxels, 98
hazy voxels, and 387 normal tissue voxels. Then, the RILD measure for this patch is 5.3%
dense, 19.1% hazy, and 75.6% normal. This calculation was done for all the follow-up
CT scans. Therefore, each patch is summarized into a vector pit = (dit, hit, cit), where
i = 1, . . . , total number of patches, t = 3, 6, 12, . . . , Ti; dit and hit represent the proportion
of dense and hazy voxels in the patch i on time t, 0 ≤ dit ≤ 1 and 0 ≤ hit ≤ 1 and
cit = 1− dit− hit. This vector is in the form of compositional data where components of the
vector are positive and sum to 1. In this case, two vectors pit and pi′t with the proportions
for two different patches i and i′, are correlated if they are close neighbors. Thus, we
have correlated compositional data measured over time, where the unit of observation is a
composition within each patch.
The cubic-patch approach was implemented in the CT scans of our reference patient.
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Patch size
Total number Patches without RILD Patches for Patches with
of patches and max dose = 0 analysis RILD
n % n % n %
4× 4× 4 425,984 311,403 73.10 114,581 26.90 295 0.26
5× 5× 5 222,789 162,515 72.95 60,274 27.05 201 0.33
6× 6× 6 133,128 98,443 73.95 34,685 26.05 115 0.33
7× 7× 7 82,140 59,304 72.20 22,836 27.80 86 0.38
8× 8× 8 53,248 37,753 70.90 15,495 29.10 77 0.50
9× 9× 9 38,988 27,823 71.36 11,169 28.64 56 0.50
10× 10× 10 29,744 21,285 71.56 8,459 28.44 59 0.70
Table 2.1: Total number of patches in the cubic-patch definition for the reference patient
The total number of patches by patch size is presented in Table 2.1. The total number of
patches range from 425,984 to 29,744 depending on the size of the patch. However, for all
patch sizes, more than 70% of the patches did not receive any radiation (max dose equals
zero) and did not show any RILD, then these patches are excluded from further analysis.
Out of the patches used for analysis purposes, less than 1% present RILD at some point
during the 2-years follow-up for the reference patient.
Since RILD is a direct adverse event of the received radiation dose, our statistical model
would use patch dose as a covariate to model the change in tissue damage. Hence, the
dose distribution within patch should be homogeneous enough to make any of our summary
dose definition to be a good representative measure of patch dose. Figure 2.2 shows the
distribution of the maximum, minimum, and standard deviation of the received dose by
presence/absence of RILD for the reference patient. For the maximum amount of radiation,
it is expected that patches without RILD received a small amount of RT while patches with
RILD received a larger amount of RT. The max dose for more than 80% of the patches
without RILD was lower than 2 Gy, while it was more than 10 Gy for all patches with
RILD. As expected, the minimum dose in patches without RILD was lower than 2 GY for
more than 90% of the patches for all patch sizes. On the other hand, in patches with RILD,
more than 50% have a minimum dose larger than 5 Gy. Finally, patches without RILD have
a low within patch dose variability (Figure 2.2 (e)), thus indicating a good homogeneity in
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the amount of radiation received within those patches. Nevertheless, there is more within
patch variability in patches with RILD (Figure 2.2 (f)). For patch sizes 4 to 8, at least 50%
of the patches have an SD lower than 5 Gy. However, in patch sizes 9 and 10, almost all the
patches have an SD larger than 5 Gy, indicating larger heterogeneity in those patch sizes.
Since the distributions of the minimum and maximum dose for both RILD groups, as well
as the distribution of the SD in the group without RILD, meet the expected, a deeper analysis
of the heterogeneity of the dose received in the patches with RILD was performed using the
Calinski-Harabasz (CH) index.43 The CH index is a method for clustering evaluation, which
measures how distinct a patch is from other patches. This index calculates the ratio between
the average sum of squares between patches and the average sum of squares within patches,
for each patch size. Higher values of the CH index are indicators of better separation between
patches. In comparison with other clustering validation methods, the use of the average sum
of squares instead of the sum of squares allows for a more fair assessment when comparing
clustering setups with different numbers of clusters, in this case, different number of patches.
Figure 2.3 (a) shows the CH index for the different patch sizes. Although patch size 10 has
the highest value of CH index, the mean SD at size 10 is larger than 10 Gy (Figure 2.3 (b)).
Now, the patch size 8 shows the second-largest CH index, 51.0% of the patches in that size
have an SD lower than 5 Gy, and the mean SD is 7.5 Gy. Therefore, the cubic-patch of size
8 seems the most appropriate for analysis purposes.
As validation of the obtained results, the same statistics presented in Table 2.1, and
Figures 2.2 and 2.3 were calculated for the 18 NSCLC patients. The distribution of the
maximum, minimum and SD of the RT dose for patches without RILD is presented on
Figures 2.4, 2.6, and 2.8, respectively. As observed, the distribution across patch sizes
is very similar within patients, which does not give indications of any issues that should
concern us with any of the patch sizes. In addition, the distribution of the maximum dose
in patches with RILD gives similar results (Figure 2.5). Summarizing the results of the
standard deviation within patches and the CH index (Figures 2.10 and 2.11, respectively),
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(a) Max in non-RILD (b) Max in RILD
(c) Min in non-RILD (d) Min in RILD
(e) SD in non-RILD (f) SD in RILD
Figure 2.2: Dose distribution by patch size and RILD presence in the cubic-patch definition
for the reference patient
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(a) Calinski-Harabasz (CH) index (b) Mean SD
Figure 2.3: Calinski-Harabasz (CH) index and mean standard deviation (SD) for patches
with RILD by patch size in the cubic-patch definition for the reference patient
patch size 8 seems a reasonable option for almost all patients but patients 14 and 18 where
sizes 10 and 9 seem more suitable. Then, trying to consolidate all patient’s data, overall
mean SD and CH index were calculated (Figure 2.12 (a)). Even though sizes 9 and 10 have a
larger CH index, they also have a larger mean SD, implying larger variability within patches.
Therefore, with the idea of maintaining the lowest heterogeneity in the received dose inside
each patch, patch size 8 is selected as the best option for further analysis.
The cubic patch size 8 has 15, 495 patches on the reference patient, and 77 of them
presented RILD at some point during the first 24 months after RT. Then, less than 1.0% of
the patches present some level of RILD over time after RT (Figure 2.13 (a)). The median
dose in patches with RILD is at least 10 Gy (Figure 2.13 (b)), while the median dose in
patches without RILD range from 0 Gy to 50 Gy. Figure 2.13 (c) shows the distribution of
composition pit = (dit, hit, cit) after alr transformation. As observed, both dense and hazy
transformed data show a bimodal distribution.
The ternary plots of the RILD composition overtime for the reference patient are dis-
played in Figure 2.14. Change from 3 months to 6 months is marked by an increase in dense
proportions. Following that, at 12 months, the plot shows a reduction in both dense and
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(a) patient 1 (b) patient 2 (c) patient 3
(d) patient 4 (e) patient 5 (f) patient 6
(g) patient 7 (h) patient 8 (i) patient 9
(j) patient 10 (k) patient 11 (l) patient 12
(m) patient 13 (n) patient 14 (o) patient 15
(p) patient 16 (q) patient 17 (r) patient 18
Figure 2.4: Distribution of maximum dose for patches without RILD by patch size in the
cubic-patch definition
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(a) patient 1 (b) patient 2 (c) patient 3
(d) patient 4 (e) patient 5 (f) patient 6
(g) patient 7 (h) patient 8 (i) patient 9
(j) patient 10 (k) patient 11 (l) patient 12
(m) patient 13 (n) patient 14 (o) patient 15
(p) patient 16 (q) patient 17 (r) patient 18
Figure 2.5: Distribution of maximum dose for patches with RILD by patch size in the cubic-
patch definition
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(a) patient 1 (b) patient 2 (c) patient 3
(d) patient 4 (e) patient 5 (f) patient 6
(g) patient 7 (h) patient 8 (i) patient 9
(j) patient 10 (k) patient 11 (l) patient 12
(m) patient 13 (n) patient 14 (o) patient 15
(p) patient 16 (q) patient 17 (r) patient 18
Figure 2.6: Distribution of minimum dose for patches without RILD by patch size in the
cubic-patch definition
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(a) patient 1 (b) patient 2 (c) patient 3
(d) patient 4 (e) patient 5 (f) patient 6
(g) patient 7 (h) patient 8 (i) patient 9
(j) patient 10 (k) patient 11 (l) patient 12
(m) patient 13 (n) patient 14 (o) patient 15
(p) patient 16 (q) patient 17 (r) patient 18
Figure 2.7: Distribution of minimum dose for patches with RILD by patch size in the cubic-
patch definition
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(a) patient 1 (b) patient 2 (c) patient 3
(d) patient 4 (e) patient 5 (f) patient 6
(g) patient 7 (h) patient 8 (i) patient 9
(j) patient 10 (k) patient 11 (l) patient 12
(m) patient 13 (n) patient 14 (o) patient 15
(p) patient 16 (q) patient 17 (r) patient 18
Figure 2.8: Distribution of standard deviation of dose for patches without RILD by patch
size in the cubic-patch definition
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(a) patient 1 (b) patient 2 (c) patient 3
(d) patient 4 (e) patient 5 (f) patient 6
(g) patient 7 (h) patient 8 (i) patient 9
(j) patient 10 (k) patient 11 (l) patient 12
(m) patient 13 (n) patient 14 (o) patient 15
(p) patient 16 (q) patient 17 (r) patient 18
Figure 2.9: Distribution of standard deviation of dose for patches with RILD by patch size
in the cubic-patch definition
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(a) patient 1 (b) patient 2 (c) patient 3
(d) patient 4 (e) patient 5 (f) patient 6
(g) patient 7 (h) patient 8 (i) patient 9
(j) patient 10 (k) patient 11 (l) patient 12
(m) patient 13 (n) patient 14 (o) patient 15
(p) patient 16 (q) patient 17 (r) patient 18
Figure 2.10: Mean standard deviation of dose for patches with RILD by patch size in the
cubic-patch definition
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(a) patient 1 (b) patient 2 (c) patient 3
(d) patient 4 (e) patient 5 (f) patient 6
(g) patient 7 (h) patient 8 (i) patient 9
(j) patient 10 (k) patient 11 (l) patient 12
(m) patient 13 (n) patient 14 (o) patient 15
(p) patient 16 (q) patient 17 (r) patient 18
Figure 2.11: Calinski-Harabasz (CH) index for patches with RILD by patch size in the
cubic-patch definition
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(a) CH index and Mean SD (b) SD distribution
Figure 2.12: Calinski-Harabasz (CH) index, mean SD and distribution of standard deviation
for patches with RILD combining data of 18 NSCLC patients by patch size in cubic-patch
definition
(a) Percentage of RILD
(b) Median dose
(c) Density Plot of alr Transforma-
tion in Dense and Hazy
Figure 2.13: Percentage of RILD presence, median dose by patch, and density plot of alr
transformation in dense and hazy RILD by time after RT in the cubic-patch size 8 for the
reference patient
hazy portions. However, at 24 months, the percentages of hazy and dense increase. Finally,
Figure 2.15 shows the values of alr(dense) and alr(hazy) vs. the median dose of RT for the
reference patient. As observed, at low doses of RT, the percentage of dense and hazy are
zero, and even though some damage is observed after a dose of 16 Gy, many of the patches
preset zero or very low values of dense and hazy with large doses of RT.
Table 2.2 presents the number of patches for each of the 18 NSCLC for the cubic-patch
size 8. The total number of patches goes from 40 thousand to 73 thousand for the different
patients. However, between 50% to more than 80%, in some cases, of the patches did not
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(a) 3 Months (b) 6 Months (c) 12 Months
(d) 18 Months (e) 24 Months
Figure 2.14: Ternary plots of dense and hazy composition by time after RT in the cubic-patch
size 8 for the reference patient
(a) alr(Dense) vs. Dose (b) alr(Hazy) vs. Dose
Figure 2.15: Scatter plot of alr-transformed dense and hazy vs. median dose per patch in
the cubic-patch size 8 for the reference patient
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Patient
Total number Patches without RILD Patches for Patches with
of patches and max dose = 0 analysis RILD
n % n % n %
1 61440 45755 74.47 15685 25.53 65 0.41
2 57344 36245 63.21 21099 36.79 247 1.17
3 60632 42049 69.35 18583 30.65 69 0.37
4 61440 45335 73.79 16105 26.21 32 0.20
5 61440 47856 77.89 13584 22.11 83 0.61
6 61440 46785 76.15 14655 23.85 206 1.41
7 57344 39880 69.55 17464 30.45 390 2.23
8 65536 45096 68.81 20440 31.19 109 0.53
9 69632 47444 68.14 22188 31.86 13 0.06
10 69632 52294 75.10 17338 24.90 12 0.07
11 69632 56884 81.69 12748 18.31 133 1.04
12 49152 38614 78.56 10538 21.44 335 3.18
13 40960 26100 63.72 14860 36.28 33 0.22
14 49152 25355 51.58 23797 48.42 409 1.72
15 65536 56779 86.64 8757 13.36 42 0.48
16 65536 52298 79.80 13238 20.20 144 1.09
17 73728 47520 64.45 26208 35.55 326 1.24
18 73728 48976 66.43 24752 33.57 72 0.29
Table 2.2: Total number of patches in the cubic-patch definition size 8 for the 18 NSCLC
patients
received any radiation neither present some RILD; therefore, those patches are not considered
for further analysis. As observed on the reference patient, the percentage of patches with
RILD is small on the 18 NSCLC patients (0.06% to 3.18%).
2.2 Spherical patch definition
A second patch definition approach was defined as the combination of the voxels at the same
distance of the voxel with the highest received dose (Reference). Using Figure 2.16 (a) as
an example, the Reference is identified on the CT scan (red dot), and the Euclidian distant
from the Reference is calculated for all other voxels. Then, the first patch consists of the
Reference voxel and the voxels within a voxel distance from it. The second patch consists
of those voxels with a Euclidean distance greater than 1 voxel but less or equal to 2 voxels.
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The third patch has the voxels with at Euclidian distance between 2 and 3, and so on. Even
though the main idea of this patch approach is to build spheres, given the cuboid shape
of the voxels, the operationalization of the spherical patch looks more like Figure 2.16 (b),
where each color represents a different patch.
(a) Patch definition (b) Transverse slice of patch op-
erationalization
Figure 2.16: Spherical patch
The spherical patch approach on the reference patient has 297 patches, one of them
composed of voxels that did not receive any dose and did not present RILD. Then, 296
patches are useful for analysis purposes. Given the way the patches are constructed in this
approach, each patch has a different size. In the reference patient, the patch’s size varies from
27 voxels for the first patch to 114,640 voxels in the largest patch. Out of the 296 patches,
50 (16.89%) presented RILD at some point during the first 24 months after RT (Figure 2.17
(a)). The median dose in patches with RILD range from 0.27 Gy to 57.08, while the median
dose in patches without RILD range from 0 Gy to 0.26 Gy (Figure 2.17 (b)). Figure 2.17
(c) shows the distribution of the composition pit = (dit, hit, cit) after alr transformation. As
observed, both dense and hazy transformed data show a bimodal distribution.
The ternary plots of the RILD composition overtime for the reference patient are dis-
played in Figure 2.18. At 3 months, some patches present a high percentage of dense and
hazy. Change from 3 months to 6 months is marked by a decrease in dense and hazy propor-
tions. Following that, at 12 months, almost no hazy, either dense, compositions are observed.
Finally, Figure 2.19 shows the values of alr(dense) and alr(hazy) vs. the median dose of
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(a) Percentage of RILD
(b) Median dose
(c) Density Plot of alr Transforma-
tion in Dense and Hazy
Figure 2.17: Percentage of RILD presence, median dose by patch, and density plot of alr
transformation in dense and hazy RILD by time after RT in the spherical-patch for the
reference patient
RT for the reference patient. As observed, at doses lower than 40 Gy, very small values of
dense and hazy are observed. However, in the highest doses, the percentages of both dense
and hazy increase.
When analyzing the data of 18 NSCLC patients, the number of patches ranges from 185
to 398 and the percentage of patches with RILD ranges from 2.52% to 45.54% (Figure 2.20).
Additionally, the distribution of the transformed data presented also a bimodal shape, as
observed for the reference patient.
2.3 Isodose patch definition
Lastly, a third patch approach was defined using the isodose lines, combining voxels that
received somewhat a uniform dose (Figure 2.21 (a)). The lines are drawn at regular intervals
of length t, and voxels with a received treatment dose within the interval are combined on the
same patch. In that way, voxels that received a dose on the interval (0, t] were combined in
one patch, and voxels with a received dose on the interval (t, 2t], were combined on a different
patch. Voxels that did not receive any radiation therapy (dose equals zero) were combined on
the same patch. For the isodose lines approach, intervals of length t = 0.05, 0.1, 0.2, 0.5, 1 Gy
have been attempted. Figure 2.21 (b) shows a transverse slice of the isodose-patch approach
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(a) 3 Months (b) 6 Months (c) 12 Months
(d) 18 Months (e) 24 Months
Figure 2.18: Ternary plots of dense and hazy composition by time after RT in the spherical-
patch for the reference patient
(a) alr(Dense) vs. Dose (b) alr(Hazy) vs. Dose
Figure 2.19: Scatter plot of alr-transformed dense and hazy vs. median dose per patch in
the spherical-patch for the reference patient
30
(a) patient 1 (b) patient 2 (c) patient 3
(d) patient 4 (e) patient 5 (f) patient 6
(g) patient 7 (h) patient 8 (i) patient 9
(j) patient 10 (k) patient 11 (l) patient 12
(m) patient 13 (n) patient 14 (o) patient 15
(p) patient 16 (q) patient 17 (r) patient 18
Figure 2.20: Percentage of RILD presence by time after RT in the spherical-patch for the 18
NSCLC patients
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applied to the reference patient. The ocean-green region corresponds to voxels that did not
receive any RT dose, and the center of the image, where the smallest region is located (dark
blue), is the region with the highest received dose.
(a) Patch definition (b) Transverse slice of patch op-
erationalization
Figure 2.21: Isodose patch
The total number of patches by threshold t is presented in Table 2.3. In the reference
patient, the total number of patches goes from 1151 on the interval of length t = 0.05 Gy, to
59 patches when t = 1 Gy, but there is always one patch completely formed with zero-dose
voxels that it is not useful for analysis purposes. As the spherical patch, in the isodose-patch,
the number of voxels per patch varies from patch to patch. The patch’s size varies from 5
voxels for the first patch to 5,856,399 voxels depending on the patch interval length. In the
isodose-patch definition, 50 to 60% of the patches present RILD after the RT.
Interval Total number Voxels Patches with RILD
length of patches x patch n %
0.05 1151 5 - 2,185,368 627 54.47
0.10 576 16 – 3,512,097 326 56.60
0.20 289 16 – 4,698,252 169 58.48
0.50 116 156 – 5,534,109 69 59.48
1.00 59 156 – 5,856,399 36 61.02
Table 2.3: Total number of patches in the isodose-patch definition for the reference patient
Figure 2.22 shows the CH index for the isodose-patch approach. Since the isodose patches
are built based on the dose, the CH index monotone decreases as the interval increases, and
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its value shows a high homogeneity in the dose within patches. Therefore, all interval-length
thresholds would represent a good option to guarantee dose homogeneity. Then, for further
analysis, the interval length of 0.2 Gy has been used since it increases the likelihood of
tracking the same region over time.
Figure 2.22: Calinski-Harabasz (CH) index for patches with RILD by interval length thresh-
old in the isodose-patch definition for the reference patient
The isodose-patch of interval length of 0.2 Gy has 288 patches for analysis, and the rate of
patches with RILD is 58.48% (Figure 2.23 (a)). The median dose in patches with RILD is at
least 22 Gy (Figure 2.23 (b)), while the median dose in patches without RILD range from 0
Gy to 24 Gy. Figure 2.23 (c) shows the distribution of the composition pit = (dit, hit, cit) after
alr transformation. As observed, both dense and hazy transformed data show a bimodal
distribution.
The ternary plots of the RILD composition overtime for the reference patient are dis-
played in Figure 2.24. At 3 months, some patches present a high percentage of dense and
hazy. Change from 3 months to 6 months is marked by a steep decrease in dense and hazy
proportions. Following that, at 12 months, low percentages of hazy and dense are observed.
Similar patterns are observed at 18 and 24 months after RT. Figure 2.25 shows the values of
alr(dense) and alr(hazy) vs. the median dose of RT for the reference patient. As observed,
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(a) Percentage of RILD
(b) Median dose
(c) Density Plot of alr Transforma-
tion in Dense and Hazy
Figure 2.23: Percentage of RILD presence, median dose by patch, and density plot of alr
transformation in dense and hazy RILD by time after RT in the isodose-patch of 0.2 Gy for
the reference patient
at doses lower than 20 Gy, almost not dense neither hazy are observed. However, in the
highest doses, the percentages of both dense and hazy increase.
For the 18 NSCLC patients, the number of patches ranges from 234 to 353, and the
percentage of patches with RILD goes from 21.59% to 99.34%. Additionally, the distribution
of the transformed data presented also a bimodal shape, as observed for the reference patient.
2.4 Conclusion
Cancer patients are usually followed via non-invasive imaging at frequent intervals. From the
practitioner point of view, the use of medical imaging has become quite sophisticated and
continues to evolve into a very accurate tool for medical diagnosis. Present levels of techno-
logical sophistication render very high resolution for almost all medical images of different
modalities. As newer modalities and better resolution of existing modalities continue to
improve, a much better level of prediction accuracy, automation, and early diagnosis of dis-
ease is expected. Therefore, development of image-based analysis that characterize imaging
changes and predict the clinical outcomes is currently the focus of medical research.
Nevertheless, the analysis of medical images has been under-developed as the technology
of medical imaging progressed exponentially over the past few decades. It is rarely used
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(a) 3 Months (b) 6 Months (c) 12 Months
(d) 18 Months (e) 24 Months
Figure 2.24: Ternary plots of dense and hazy composition by time after RT in the isodose-
patch of 0.2 Gy for the reference patient
(a) alr(Dense) vs. Dose (b) alr(Hazy) vs. Dose
Figure 2.25: Scatter plot of alr-transformed dense and hazy vs. median dose per patch in
the isodose-patch of 0.2 Gy for the reference patient
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for predicting or determining the future course of action. Generally, two approaches us-
ing the CT scan for the study of RILD following RT have been implemented. Still, both
methodologies present important limitations to characterize the local changes after radiation
therapy.
Consequently, we proposed three different approaches to create small groups of voxels and
study the changes in RILD at the patch level. The cubic-patch combines adjacent voxels
along each direction in cuboid shape. The spherical-patch finds the voxel with the highest
dose and combine equidistant voxels into the same patch. Finally, the isodose-patch merges
voxels that received a very similar amount RT.
In the cubic-patch approach, patch size eight was selected for carrying further analysis
given a combination between its size and the dose homogeneity within patches. There is only
one proposal for the spherical-patch approach. For the isodose-patch approach, five different
interval lengths were assessed, all of them with high dose homogeneity. The interval length
of 0.2 Gy was selected for further analysis.
In addition to the shape, the three approaches to patch definition present several differ-
ences. First, the number of patches per patient. While the cubic-patch results on thousands
of patches for analysis, the spherical-patch and the isodose-patch approaches result in 200 to
400 patches. A small number of patches when analyzing the CT scans of one patient might
result in a more efficient and faster way to analysis RILD over time. However, the reduction
in the number of patches came from an increase in the number of voxels within patches.
In the cubic-patch size 8, most of the patches combine 512 voxels, but border patches are
composed of fewer voxels. However, this does not represent a problem because the patches
located on the border usually receive none or a minimal RT dose and do not present any
RILD. On the other hand, the number of voxels within a patch for the two other patch
definitions varies from as few as five voxels to as many as millions. The number of voxels
within a patch might become an essential issue in the analysis of these two patch definitions
since we are going to use the percentage of dense and hazy regions as primary outcomes.
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Therefore, patches with a large number of voxels can result in tiny proportions of dense and
hazy damage.
Although the cubic-patch approach shows an interesting property giving the consistency
on the number of voxels within a patch, giving a large number of patches for analysis in
that approach, the percentage of patches with RILD is less than 3.00% for all the analyzed
subjects. Even though in the other two patch definition, the rate of RILD is larger as
compared with the observed in the cubic-patch, the distribution of RILD still heavily biased
towards the no presence of RILD. Therefore, when analyzing data from different approaches,
it is crucial to have a statistical model that can handle the heavily-biased distribution of
RILD.
The distribution of the proportion of dense and hazy, for all patch definitions, showed a
bimodal distribution. This might be suggesting two different types of patches, response to
RT dose, or different locations on the lung. Whatever the reason for this finding, the present
pattern must be taken into account in the analysis to produce an adequate study of RILD
over time.
Finally, it is important to highlight that for all the presented patch approaches, the
patches present spatial correlation with each other. For example, in the cubic-patch, neigh-
bors patches are correlated and this correlation should decrease as the distance between the
patches increases. Then, this characteristic of the data structure will play an important role
when analyzing the CT scan over time.
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3. Two-part mixed effects mixture model for zero-inflated longitudinal
compositional data
Let Y ij a semicontinuous bivarite vector for the i-th (i = 1, ..., N) patch at time tij (j =
1, ..., ni). Then, this outcome vector can be represented by two processes, an occurrence
variable Uij and an intensity vector V ij. Then,
Uij =

1 if Y ij 6= 0
0 otherwise
and the intensity variable V ij = log(Y ij), when Yij 6= 0. The log transformation has
been used to make V ij approximately normal with a patch-time-specific mean, and at the
same time, handle compositional data.
Now the focus is on the distribution for the occurrence variable Uij, and the conditional
distribution of V ij. Let us assume that Uij follows a random effects logistic regression model:
logit{Pr(Uij = 1|ci)} = logit{πij|ci}
= ηij
= Xijβ + Zijci
(3.3)
where Xij is a 1×p covariate vector for the fixed effects, β is a p×1 fixed effects regression
coefficient vector, Zij is a 1 × q covariate vector for the random effects, and ci is a q × 1
patch-level vector of random intercept and random effects.
Further, the vector V ij|Y ij 6= 0 follows a bivariate linear mixed model:
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V ij|(di,Y ij 6= 0) = X∗ijγ + Z∗ijdi + εij (3.4)
where X∗ij and Z
∗
ij might have the same variables as Xij and Zij in (3.3), but this is not
required; γ is the regression coefficient matrix (p∗ × 2) for the fixed effects; and di is the
subject-level matrix with the random effects (q∗ × 2). Additionally, the error term
εij ∼ N
0,Σ =
 σ2Y 1 ρσY 1σY 2





The random effects vector (ci, d̃i), where d̃i = vec(di), is distributed by a mixture of 2
multivariate normal distributions. Correlation between random effects in (3.3) and (3.4) is
allowed since the presence or absence of tissue damage at one time point is related with the

















r=1mr = 1 and
∑2
r=1mrµr = 0.
Now, we define ∆i = 1 if bi is sampled from the first component in the mixture, and 0
otherwise. Then,
ci ∼ N(0,Ψcc) (3.7)
and
d̃i|ci ∼ [m1N(µ1 + ΨdcΨ−1cc ci,H)]∆i [(1−m1)N(µ2 + ΨdcΨ−1cc ci,H)]1−∆i (3.8)
where H = Ψdd −ΨdcΨ−1cc Ψcd, and µ2 = − m11−m1µ1.
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3.1 The likelihood
The estimation of the parameters in the model defined by (3.3) - (3.8) is based on the








f(yi|β,γ, ci, d̃i,Σ)f(ci, d̃i|m1,µ1,Ψ)dcid̃i (3.9)










f(yij|β,γ, ci, d̃i,Σ)f(ci, d̃i|m1,µ1,Ψ)dcid̃i




























[f(V ij|γ, d̃i,Σ)]Uijf(ci|Ψcc)f(d̃i|m1,µ1, ci,Ψdd)dcidd̃i























































V ij − (X∗ijγ + Z∗ijdi)
)T])
× f(ci|Ψcc)f(d̃i|m1,µ1, ci,Ψdd)dcidd̃i























































































































































































































d̃i − (µ2 + ΨdcΨ−1cc ci)
)))
dd̃i





















































d̃i − (µ2 + ΨdcΨ−1cc ci)
)))
dd̃i
where Ṽ i∗ = vec(V i∗), γ̃ = vec(γ), X̃
∗
i∗ = I2×2 ⊗ X∗i∗ , Z̃
∗
i∗ = I2×2 ⊗ Z∗i∗ , and Σ̃−1 =
Σ−1 ⊗ Ini∗×ni∗
Let Ai∗ = Ṽ i∗ − X̃
∗
i∗γ̃; f i1 = µ1 + ΨdcΨ
−1






































































































































































































































































































































































































































































































































































−1Ai∗ + ∆i(1−∆i)fTi2H−1B−1i H−1f i1









































































































































































































































− (∆iµT1 + (1−∆i)µT2 )H−1ΨdcΨ−1cc ci
+ (∆2iµ
T


























































−1 −H−1B−1i H−1)µ1 −
1
2


















−1 −H−1B−1i H−1)ΨdcΨ−1cc ci
)




















1 + (1−∆i)µT2 ,























































































































































































































































































































































































































































The integral in (3.12) is intractable, but it is similar to the likelihood in a mixed ef-
fects logistic regression where the random effects follow a normal distribution with different
location and scale parameters. As discussed for different authors, several strategies have
been implemented to evaluate this integral. Using Olsen and Schafer44 approach with a











































































• c̃i = (Ψ−1cc +Di +ZTi W̃iZi)−1(ZTi W̃i(U ∗i −X iβ) + Gi)
• U ∗i = W̃−1i (U i − π̃i) + η̃i
• W i is a diagonal matrix with elements πij(1− πij)
• W̃i, W̃−1, π̃i, and η̃i are evaluated at ci = c̃i
• −f (2)(c̃i) = ZTi W̃iZi + Ψ−1cc +Di = Gi
• m̃(k)ij is the (k − 1)th derivative of πij with respect to ηij evaluated at c̃i
Even though more terms can be added to the Laplace approximation for greater accuracy,
the omitted terms on the sixth-order approximation are Op(n
−5/2
i ) or smaller.
44
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−1Gi + f(c̃i) +
1
2




























































































































































































First, the expectation–maximization (EM) algorithm is implemented. In the E-step, the
conditional expectation of the likelihood is obtained, and only the posterior probability to




























































−1Gir + f(c̃ir) +
1
2



















































In the M-step, the conditional expectation is maximized with respect of m1, the prob-













However, the other parameters in the model cannot be updated analytically. Then, an
51
approximate Fisher scoring numerical maximization procedure is implemented. Score vectors
were derived using the proposed score vectors by Olsen and Schafer44, but φcc, φH , and φΣ
represent the vectorized upper triangles of Ψcc, H, and Σ. Additionally, score vectors were
extended to accommodate multivariate data. Expressions for the components of the score































−1Ṽi − X̃∗Ti Σ̃−1Z̃∗i B−1i Z̃∗Ti Σ̃−1Ṽi − X̃∗Ti Σ̃−1X̃∗i γ̃ + X̃∗Ti Σ̃−1Z̃∗i B−1i Z̃∗Ti Σ̃−1X̃∗i γ̃







































− Z̃∗i B−1i Z̃∗Ti − AiATi + 2AiATi Σ̃−1Z̃∗i B−1i Z̃∗Ti




























− Z̃∗i B−1i H−1µ2µT2 Z̃∗Ti Σ̃−1Z̃∗i B−1i Z̃∗Ti
)








































































































































= −(Ip ⊗H∗i )
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vec[H −B−1i −B−1i Z̃∗Ti Σ̃−1AiATi Σ̃−1Z̃∗i B−1i +m1B−1i Z̃∗Ti Σ̃−1Z̃∗i µ1µT1H−1B−1i
−m1B−1i Z̃∗Ti Σ̃−1Z̃∗i µ1µT1 + (1−m1)B−1i Z̃∗Ti Σ̃−1Z̃∗i µ2µT2H−1B−1i


















































P ∗i = (∂c̃i)/(∂vec










i ⊗G−1i (ΨdcΨ−1cc )TH−1B−1i Z̃∗Ti )
− (Y ∗Ti G−1i (ΨdcΨ−1cc )T Z̃∗Ti ⊗G−1i (ΨdcΨ−1cc )TH−1B−1i Z̃∗Ti )
− (ATi Σ̃−1Z̃∗i B−1i Z̃∗Ti ⊗G−1i (ΨdcΨ−1cc )TH−1B−1i Z̃∗Ti )
+ (ATi ⊗G−1i (ΨdcΨ−1cc )TH−1B−1i Z̃∗Ti ) (3.27)
M∗i = −(Y ∗Ti G−1i (ΨdcΨ−1cc )T Z̃∗Ti Σ̃−1Z̃∗i B−1i ⊗G−1i (ΨdcΨ−1cc )T ) + (ATi Σ̃−1Z̃∗i B−1i ⊗G−1i (ΨdcΨ−1cc )T )
− (ATi Σ̃−1Z̃∗i B−1i ⊗G−1i (ΨdcΨ−1cc )TH−1B−1i )








i ⊗G−1i (ΨdcΨ−1cc )TH−1B−1i ) (3.28)
D∗i = −(Y ∗Ti G−1i ⊗G−1i ) (3.29)
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− (G−1i ⊗ Y ∗Ti G−1i H∗Ti )− (Y ∗Ti G−1i ⊗G−1i H∗Ti ) (3.31)























































































































































































At each iteration, the values of the new estimates for the variance and correlation pa-
rameters are validated to assess whether the estimations are outside the parameter space.
When needed, a step-halving procedure is applied to return the estimates within the pa-
rameter space. Also, a second step-halving procedure was implemented for all parameters
in the model to guarantee that the deviance of the new set of estimates is lower than in the
previous iteration.
Initial values for β, γ, Ψcc, and the diagonal in Ψdd are generated by logistic regression
for the occurrence variable and independent linear mixed model for each variable in the
intensity vector. Starting values for the out of diagonal in Ψdd are set using the diagonal
values and a correlation of 0.1. Initial values for Σ are set as the variances and correlations
of the variables in the intensity vector. For simplicity, the starting values for m1 and µ1 are
set as 0.6 and (−0.1, 0.1), respectively.
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Approximate empirical Bayes estimates by importance sampling for unnormalized densi-
ties are implemented for the random effects. A thousand samples (c
(1)
i , . . . , c
(1000)
i ) were taken
from a multivariate t distribution with 4 degrees of freedom, centered at the mode c̃i with
covariance matrix proportional to G−1i , as proposed by Gelman et al.,
45 and implemented
by Olsen and Shafer.44 Unadjusted importance sampling, as well as truncated46 and Pareto
smoothed importance sampling47 are implemented. Using the drawn sample for ci, estimated




Performance of the proposed method was evaluated using a simulation study. However, spe-
cial care was taken to keep the simulation set up to be very similar to real data. Dose-response
data were simulated based on the motivating example of RILD in lung cancer patients using
the spherical-patch definition, presented in Chapter 2. The composition (%Dense, %Hazy,
%Normal) was the outcome of interest (Y ij), for the i-th (i = 1, ..., N) patch at time tij
(j = 1, ..., ni). Then, as mentioned in Chapter 3, this outcome vector can be represented by
two processes. First, an occurrence variable Uij which equals one if some RILD is present
(Normal 6= 1), or zero otherwise. The second process is the bivariate intensity vector V ij,
which is the alr transformation of the composition, when Y ij 6= 0.
Three different number of patches (N = 300, 500, 1000) were used. Also, three different
numbers of follow-up measurements after RT were considered (ni = 3, 4, 5). The received
dose was simulated following a logarithmic distribution. For both parts of the model (oc-
currence and intensity), intercept, dose-effect, and time after radiotherapy in years (linear
and quadratic) were considered as fixed effects to build the data. As a random effects, only
a random intercept was used in both model parts (ci and di for occurrence and intensity
models respectively).
The following are the population parameters used in the simulation:
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logit{Pr(Uij = 1|ci)} = −10 + 1.5 Dosei − 2 timeij − 3 time2ij + ci
alr(Dense)ij|(di,Y ij 6= 0) = −7 + 1 Dosei + 0.5 timeij − 1 time2ij + d1i + ε1ij

































A total of 1000 data sets were generated with the above parameters and within each
combination of sample size and follow-up time points. Subsequently, the scoring procedure
for the estimation of the two-part mixed-effects mixture model for zero-inflated longitudinal
compositional data, presented in Chapter 3, was applied to each data set. Estimates for
all parameters, regression coefficients and nuisance parameters, were obtained. The perfor-
mance of the algorithm in the estimation of the regression coefficients was assessed by two
statistics, which were computed for each parameter estimate: the standardized bias (SB)
(difference between the average estimate and the true value as a percentage of the SD esti-
mate), and the coverage rate of the nominal 95% confidence interval (estimate ± 1.96SE).
As suggested by Collins et al.,49 SB larger than 40% was considered as an indicator of poor
performance. Although the nominal coverage percentage is 95%, coverage rate lower than
90% was considered troublesome.49 Additionally, the square of the correlation between the
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observed and predicted data, as well as the mean absolute scaled error (MASE), were calcu-
lated for each simulation. As a comparison method, the square of the correlation and MASE
were calculated for the ”naive” model, using the initial values obtained by a mixed-effects
logistic regression for the occurrence variable and independent linear mixed model for each
variable in the intensity vector without correlation between the models.
Additionally, to assess the model’s false positive rate of the fixed effects, the same sim-
ulation scenario described above was performed but with the coefficients of dose, time, and
time squared set equal to zero. Parameter estimates and respective standard errors were
calculated using the proposed model, and 95% confidence intervals were obtained. Type I
error was calculated as the proportion of intervals that did not contain zero.
4.1 Results
For all the simulation scenarios, the procedure failed to converge in less than 5 samples
(Figure 4.1 (a)) and for those that the procedure converged, the average number of iterations
for convergence was between 11 to 14 steps (Figure 4.1 (b)). The average time estimating
fixed effects was less than 10 min with 300 patches (N = 300), between 10 and 20 min with
N = 500, and between 35 min and 50 min with N = 1000 (Figure 4.1 (c)). The estimation of
the random effects took longer, around 45 min with N = 300, 1 to 1.5 hours with N = 500,
and more than 2.5 hours with N = 1000 (Figure 4.1 (d)).
4.1.1 Performance of estimated fixed effects
The results of the simulation for the fixed effects are shown in Table 4.1, and a set of plots
showing these results are presented in Figure 4.2. For each scenario, Table 4.1 list the average
and the standard deviation (SD) of the point estimates, the average standard error (SE),
the standardized bias (SB), and the coverage rate. In the occurrence model, it seems that
the coefficients for the intercept and dose are underestimated, particularly with N = 300. In
the intensity model, for both alr(Dense) and alr(Hazy), the estimation of the parameters
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(a) Convergence (b) Steps
(c) Time coefficient estimation (d) Time RE estimation
Figure 4.1: Simulation Results: Percentage of convergence, average number of iteration
before convergence, average time for estimation of fixed effects (min), and average time for
estimation of random effects (RE)
is quite good, even in small sample sizes. The number of time points seems to have a
substantial effect on the performance of the estimates in occurrence model, with estimation
bias decreasing as the number of time points increases.
Summary of the standardized bias (SB) demonstrates that it is consistently lower than
40% for all parameters, therefore bias impact on the efficiency, coverage and error rate with
the proposed model is minimal. However, in some scenarios, the SB is larger than 20%,
particularly for the estimation of the intercepts and the dose effect. In most of the cases,
the average SE is close to the SD of the estimate; however, with N = 300, the average SE
and the SD differ substantially. This might indicate that the estimation of the standard
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Occurrence alr(Dense) alr(Hazy)
Int. Dose Time Time2 Int. Dose Time Time2 Int. Dose Time Time2
Population -10 1.5 -2 -3 -7 1 0.5 -1 -3 2 0.5 -1
N=1000, t=5
Average estimate -10.38 1.46 -1.93 -3.19 -6.98 1.00 0.49 -0.99 -2.96 1.99 0.48 -0.99
SD estimate 1.32 0.27 1.73 1.34 0.23 0.02 0.52 0.26 0.19 0.02 0.33 0.17
Average SE 1.01 0.07 1.93 0.96 0.22 0.01 0.50 0.30 0.19 0.01 0.33 0.19
Standardized bias (%) -29.12 -15.86 4.28 -14.50 7.56 -16.86 -2.50 2.24 21.26 -27.98 -6.45 6.20
Coverage (%) 87.26 54.26 97.79 95.69 89.77 61.99 88.97 87.96 91.07 63.89 88.26 87.96
N=1000, t=4
Average estimate -10.29 1.44 -2.09 -3.04 -7.00 0.99 0.50 -1.00 -2.97 1.99 0.50 -1.00
SD estimate 1.17 0.24 1.79 1.14 0.26 0.05 0.69 0.42 0.20 0.02 0.46 0.28
Average SE 1.34 0.13 2.65 1.57 0.21 0.01 0.57 0.35 0.18 0.01 0.39 0.24
Standardized bias (%) -24.29 -25.28 -5.05 -3.59 0.66 -11.38 -0.02 1.14 17.41 -28.00 -0.71 1.27
Coverage (%) 93.76 72.13 98.69 98.09 85.71 63.08 88.13 87.73 89.03 63.58 86.72 86.02
N=1000, t=3
Average estimate -10.36 1.44 -1.96 -3.17 -6.97 1.00 0.43 -0.94 -2.95 1.99 0.47 -0.98
SD estimate 1.49 0.26 3.40 2.79 0.37 0.02 1.37 1.08 0.29 0.02 0.96 0.76
Average SE 2.32 0.17 6.10 4.65 0.30 0.01 1.10 0.87 0.23 0.01 0.73 0.58
Standardized bias (%) -24.01 -23.08 1.10 -6.01 8.00 -13.21 -5.14 5.12 18.28 -21.25 -2.87 3.21
Coverage (%) 99.70 80.06 99.70 99.90 85.77 60.42 87.07 86.37 84.67 60.92 84.27 83.67
N=500, t=5
Average estimate -10.52 1.50 -2.12 -3.15 -6.99 1.00 0.49 -1.00 -2.97 1.99 0.52 -1.01
SD estimate 1.69 0.31 1.98 1.10 0.23 0.03 0.56 0.27 0.21 0.03 0.42 0.21
Average SE 1.27 0.08 2.45 1.27 0.25 0.01 0.57 0.31 0.23 0.01 0.39 0.21
Standardized bias (%) -31.08 -1.12 -6.19 -13.63 3.07 -5.79 -1.34 0.96 12.73 -21.99 3.58 -3.26
Coverage (%) 86.45 51.71 98.19 95.28 91.47 68.17 90.56 92.17 90.56 68.98 86.04 87.65
N=500, t=4
Average estimate -10.58 1.50 -2.01 -3.24 -6.98 1.00 0.48 -0.99 -2.96 2.00 0.48 -0.98
SD estimate 1.85 0.30 2.42 1.65 0.29 0.02 0.82 0.49 0.24 0.02 0.58 0.34
Average SE 2.02 0.18 4.13 2.62 0.28 0.01 0.80 0.50 0.24 0.01 0.53 0.34
Standardized bias (%) -31.51 1.63 -0.34 -14.86 6.89 -13.57 -2.55 2.17 16.12 -17.04 -3.11 4.48
Coverage (%) 94.98 74.22 99.30 98.29 88.67 65.60 90.67 91.37 91.37 69.01 88.37 88.16
N=500, t=3
Average estimate -10.70 1.51 -2.13 -3.18 -7.00 1.00 0.48 -0.98 -2.99 2.00 0.53 -1.02
SD estimate 2.82 0.46 4.78 3.69 0.42 0.02 1.58 1.24 0.35 0.02 1.23 0.97
Average SE 3.35 0.26 8.47 6.43 0.39 0.01 1.47 1.17 0.31 0.01 1.01 0.79
Standardized bias (%) -24.72 2.67 -2.63 -4.96 -0.06 -7.74 -0.97 1.61 3.79 -20.72 2.39 -2.44
Coverage (%) 99.60 86.83 99.30 99.30 90.55 65.03 91.06 91.16 89.75 68.44 87.04 87.04
Table 4.1: Simulation results for estimated fixed effects
errors generated by the proposed method may not adequately represent the variation of the
estimator in small sample sizes. Coverage percentages were close to 90% or larger for all
parameters but the dose coefficient. Contrary to our common experience, relatively higher
coverage rates were observed with the smallest sample size (N = 300). This is due to large
standard errors resulting from small sample size, not better estimation performance.
The false positive rate of the fixed effects model is presented in Table 4.2. The type I
error rate for the coefficient associated with dose was equal or less than 0.05 for both model
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Occurrence alr(Dense) alr(Hazy)
Int. Dose Time Time2 Int. Dose Time Time2 Int. Dose Time Time2
Population -10 1.5 -2 -3 -7 1 0.5 -1 -3 2 0.5 -1
N=300, t=5
Average estimate -11.23 1.14 -2.30 -3.70 -6.99 1.00 0.52 -1.01 -2.99 2.00 0.53 -1.01
SD estimate 7.97 9.19 6.74 8.47 0.28 0.03 0.62 0.30 0.24 0.03 0.43 0.20
Average SE 1.61 0.09 3.06 1.49 0.30 0.01 0.69 0.37 0.27 0.02 0.47 0.25
Standardized bias (%) -15.47 -3.90 -4.51 -8.28 3.22 -1.78 3.21 -3.31 4.65 -9.14 6.66 -6.91
Coverage (%) 88.14 49.05 97.99 95.98 91.56 64.82 92.76 92.96 93.87 70.05 92.56 92.56
N=300, t=4
Average estimate -11.41 0.97 -2.74 -3.69 -6.99 1.00 0.50 -1.00 -2.96 2.00 0.51 -1.01
SD estimate 14.11 12.18 12.04 10.56 0.31 0.02 0.88 0.53 0.26 0.02 0.63 0.38
Average SE 2.26 0.20 4.15 2.47 0.33 0.01 0.92 0.57 0.27 0.01 0.62 0.39
Standardized bias (%) -9.97 -4.32 -6.14 -6.50 4.36 -5.79 -0.31 0.21 15.94 -15.68 2.10 -1.62
Coverage (%) 95.18 74.17 98.99 98.69 93.57 68.54 93.87 93.87 90.85 71.66 89.45 90.65
N=300, t=3
Average estimate -13.22 0.34 -3.38 -4.12 -7.01 1.00 0.60 -1.08 -2.97 2.00 0.46 -0.96
SD estimate 25.30 19.33 17.48 11.20 0.51 0.03 1.88 1.48 0.38 0.03 1.38 1.08
Average SE 4.81 0.35 12.08 9.11 0.50 0.02 1.89 1.50 0.38 0.02 1.26 1.00
Standardized bias (%) -12.71 -6.02 -7.88 -9.97 -2.43 -11.28 5.19 -5.22 8.91 -17.41 -2.99 3.70
Coverage (%) 98.09 90.24 98.09 97.79 92.25 67.10 92.45 92.45 91.95 69.11 89.84 90.74
Table 4.1: Simulation results for estimated fixed effects (cont.)
parts for all sample sizes (N) and the number of follow-up time points (t). The coefficient for
time showed the highest type I error among the model coefficients, particularly for the first
part of the model (occurrence model). This issue is a result of the underestimation of that
coefficient, which gets worse as the sample size (N) increases. For the coefficient associated
with Time2, the type I error rate is larger than 0.05 for most of the scenarios. Additionally,
an increase in the error is observed with larger sample sizes and number of time points;
this given to the increase in the precision of the estimates as the number of observations
increases.
The average squared correlation between observed and predicted values was at least 0.70
for the proposed two-part model, and it was less than 0.40 in the naive approach (Figure
4.5). Similarly, the Two-part model also showed better performance than the naive model
when comparing the MASE, with an average MASE lower than 0.71 and 0.58 for dense and





Figure 4.2: Simulation Results for estimated fixed effects: average estimate of fixed effects
in the occurrence model ± 1.96 average standard error
N t
Dose Time Time2
Occurrence Dense Hazy Occurrence Dense Hazy Occurrence Dense Hazy
1000 5 0.03 0.04 0.05 0.62 0.08 0.11 0.22 0.11 0.12
1000 4 0.02 0.05 0.03 0.42 0.08 0.11 0.03 0.09 0.13
1000 3 0.02 0.05 0.04 0.02 0.11 0.14 0.01 0.11 0.14
500 5 0.02 0.04 0.05 0.87 0.06 0.07 0.13 0.06 0.10
500 4 0.03 0.05 0.04 0.50 0.06 0.11 0.03 0.08 0.11
500 3 0.01 0.03 0.04 0.03 0.08 0.12 0.01 0.09 0.11
300 5 0.02 0.05 0.04 0.84 0.04 0.06 0.09 0.06 0.09
300 4 0.03 0.05 0.05 0.27 0.06 0.06 0.03 0.07 0.09
300 3 0.02 0.04 0.04 0.01 0.06 0.08 0.02 0.08 0.09




Figure 4.3: Simulation Results for estimated fixed effects: average estimate of fixed effects
in the intensity model for alr(Dense) ± 1.96 average standard error
4.1.2 Performance for estimation of nuisance parameters
In addition to the estimates of the fixed effects, the proposed model also performs the
estimation of the variance components (Σ and Ψ) and the components associated with the
mixture model (m and µ). The results obtained in the simulation for these parameters are
observed in the Table 4.3. This table lists the average and the SD of the point estimates.
All the variance components but Ψ12 are underestimated and strongly biased. This bias is
basically caused by the inclusion of the step-halving procedure that forces a lower deviance




Figure 4.4: Simulation Results for estimated fixed effects: average estimate of fixed effects
in the intensity model for alr(Hazy) ± 1.96 average standard error
the step-halving procedure is necessary and widely used to deal with common convergence
problems when using non-standard link functions, such as the log link binomial model used
in the occurrence model.
The model performance on the estimation of the parameters of the mixture model was
also not satisfactory. The average percentage of membership to the most frequent part of
the mixture (m) has been shrunk towards 0.50, and the mean towards zero, indicating a
no mixture model. This has then an effect on the estimation of the mean (µ), that being
consistent with m = 0.5 has to take values very close to zero.
Now, even though the nuisance parameters are usually not the main interest in research,
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(a) Dense in Two-part model (b) Dense by naive model
(c) Hazy by Two-part model (d) Hazy by naive model
Figure 4.5: Simulation Results: Average correlation2 between simulated and predicted data
± 1.96 standard deviation
Two-part model predictions correspond to the proposed method. Naive predictions use predictions from
independent mixed-effects models)
they are used on the estimation of the random effects, and therefore will affect the model’s
predictions, and are also used on the hypothesis testing involving these parameters to find a
more parsimonious model.
4.2 Conclusion
Since the scoring procedure proposed in the two-part mixed-effects mixture model for zero-
inflated longitudinal compositional data is only a maximization to an approximate log-
likelihood, it was important to analyze the performance of the model in estimating the
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(a) Dense in Two-part model (b) Dense by naive model
(c) Hazy by Two-part model (d) Hazy by naive model
Figure 4.6: Simulation Results: Average mean absolute scaled error (MASE) between sim-
ulated and predicted data ± 1.96 standard deviation
Two-part model predictions correspond to the proposed method. Naive predictions use predictions from
independent mixed-effects models)
parameters. With this objective, a simulation was performed to assess some of the per-
formance aspects of the model. The results showed mixed performance, with reasonable
estimates of the model’s fixed effects, but with highly biased estimates of other parameters.
Although the method seems to have good convergence in different sample sizes, in future
studies, it is important to assess whether the implemented step-halving procedure is causing
false convergence. The implemented procedure is similar to the implemented “loop3” in the
R function glm,50 which invokes the step-halving until convergence, until the difference in
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Σ11 Σ22 Cor12 Ψ11 Ψ12 Ψ13 Ψ22 Ψ33 Ψ23 m µ1 µ2
Population 1 0.5 0.2 1 0.07 0.2 0.5 1 0.07 0.6 -0.1 0.1
N=1000, t=5
Average estimate 0.74 0.35 0.59 0.75 0.07 0.11 0.29 0.55 -0.07 0.51 0.00 0.00
SD estimate 0.19 0.14 0.30 0.72 0.05 0.06 0.12 0.13 0.09 0.01 0.01 0.02
N=1000, t=4
Average estimate 0.74 0.35 0.62 0.71 0.07 0.11 0.27 0.55 -0.06 0.51 0.00 0.00
SD estimate 0.19 0.13 0.30 0.64 0.04 0.06 0.11 0.12 0.09 0.01 0.01 0.01
N=1000, t=3
Average estimate 0.74 0.33 0.69 0.75 0.07 0.11 0.27 0.53 -0.05 0.51 0.00 0.00
SD estimate 0.19 0.12 0.27 0.81 0.04 0.06 0.11 0.11 0.08 0.01 0.01 0.01
N=500, t=5
Average estimate 0.81 0.38 0.57 0.86 0.07 0.11 0.27 0.54 -0.05 0.51 -0.01 0.00
SD estimate 0.19 0.14 0.28 1.62 0.05 0.07 0.12 0.16 0.09 0.01 0.01 0.01
N=500, t=4
Average estimate 0.80 0.37 0.58 0.83 0.07 0.11 0.27 0.53 -0.04 0.51 -0.01 0.00
SD estimate 0.20 0.14 0.28 1.03 0.06 0.08 0.13 0.14 0.09 0.01 0.01 0.01
N=500, t=3
Average estimate 0.81 0.37 0.62 0.92 0.07 0.12 0.27 0.53 -0.04 0.51 -0.01 0.00
SD estimate 0.20 0.14 0.26 1.47 0.10 0.10 0.14 0.15 0.09 0.01 0.01 0.01
N=300, t=5
Average estimate 0.86 0.40 0.61 1.27 0.08 0.11 0.27 0.53 -0.03 0.51 -0.01 0.01
SD estimate 0.20 0.14 0.24 7.02 0.14 0.19 0.13 0.15 0.09 0.01 0.01 0.01
N=300, t=4
Average estimate 0.86 0.39 0.61 1.49 0.08 0.12 0.27 0.53 -0.03 0.51 -0.01 0.01
SD estimate 0.20 0.13 0.24 9.93 0.27 0.21 0.15 0.15 0.08 0.01 0.01 0.01
N=300, t=3
Average estimate 0.88 0.40 0.64 2.91 0.08 0.14 0.27 0.53 -0.03 0.51 -0.01 0.01
SD estimate 0.21 0.14 0.24 21.3 0.18 0.32 0.16 0.17 0.08 0.01 0.01 0.01
Table 4.3: Simulation results for estimated nuisance parameters
the relative deviance goes from one side of the convergence region to the other, or until this
process has been repeated a fixed number of times. In this last situation, the new estimates
can be very close to the previous ones and fall inside the convergence region, which could
be causing a false convergence.50 In this study, this step-halving procedure has repeated a
maximum of 50 times. The effects in the model performance on those cases when convergence
is attained after reaching the maximum number of repetitions need to be assessed.
The average time that the procedure takes for the estimation of the fixed effects seems
to be in the feasible range for statistical analysis. Even for N = 1000, the procedure took on
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average almost an hour to converge. The estimation of the random effects required a longer
time, and large differences in the average time were observed between sample sizes, with
less than one hour for N = 300 and more than 2.5 hours for N = 1000. The long times for
the random effects estimations are a consequence of the empirical Bayes procedure involving
the importance sampling method. In our approach, three different sets of random effects
were produced (normal, truncated, and Pareto), then some optimization of the program
might be done by providing only the Pareto estimates. However, it will only have a small
reduction in the estimation time. Therefore, for estimation of the fixed the proposed method
seems equally suited even for large sample size. Nevertheless, if the objective is focused on
predictions, the estimation of the random effects will be necessary, and the method might
be impractical for very large sample sizes.
The method proposed in the present dissertation seems to be making an adequate esti-
mate of the variability of the estimates through the SE. However, for N = 300 performance
of the estimated SEs was inadequate. Since it is very common to find studies with sample
sizes smaller than 300, it is advisable to use the method with caution in such cases. In future
research on this method, it is recommended to test the model performance on smaller sample
sizes.
Estimation of nuisance parameters was somewhat unsatisfactory. As mentioned above,
“loop 3” is the most likely cause of poor model performance in estimating variance com-
ponents. By performing the step-halving procedure in each iteration, the change of each
parameter is reduced more and more with each time this loop runs. Therefore, the changes
in the estimates between iterations can be tiny for some parameters. Improvements to the
step-halving procedure, perhaps limiting it only to fixed effects, could be implemented to
mend this lack of performance.
The estimation of the parameters in the mixture model was also unsatisfactory. In this
case, the percentage of membership in the most frequent distribution was reduced to 0.5.
This could be an effect of the implemented estimation process, in which all patches, with or
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without RILD, were used to update the m in each iteration. However, the proposed model
only assumes a mixture of distributions for the random effects of the intensity vector (di).
Perhaps, limiting the update of m to observations with non-zero intensity could improve the
estimation of m, and therefore the estimation of µ.
In conclusion, the two-part mixed-effects mixture model for zero-inflated longitudinal
compositional data has shown reasonable performance in estimating fixed effects. However,
the model would benefit from improvements in the estimation of the nuisance parameters.
Additionally, future research should study the impact of the inclusion of other random effects
that represent clustering, or random slopes, as well as the effect of missing data.
71
5. Probabilistic model for longitudinal lung tissue changes following RT
The two-part mixed-effects mixture model for zero-inflated longitudinal compositional data
presented in Chapter 3 was applied separately to each of the patch definitions in Chapter
2 for the data of the reference patient. As mentioned, the RILD intensity on each patch
was consolidated in the compositional vector pit = (%Dense,%Hazy,%Normal). Then,
each patch was classified as without RILD presence (%Normal=100), or with RILD presence
(%Normal 6= 100).
For applying the proposed model, the outcome variable (Y ij; i = 1, . . . , number of patches;
j = 1, . . . , 5) was the ratio of the vector pit, using the last component (Normal) as denomina-
tor (Y ij=(%Dense/%Normal, %Hazy/%Normal)). When the whole patch presented RILD
(%Normal=0), or when only one of the damage components, dense or hazy, equals zero,
the zero replacement method proposed by Fry et al.11 whit δ = 0.003 was applied before
calculating the alr transformation. Therefore, Y ij = 0 represents no observed tissue damage
after radiation in the patch i at the time point j (%Dense=0,%Hazy=0,%Normal=100).
The percentage of patches without RILD varies across patch definitions, as observed in
Chapter 2. This percentage ranges between 50% to 99% (Figures 2.13 (a), 2.17 (a), 2.23
(a)). Regardless of the patch definition, there is a large proportion of zeros on these data
sets. Hence, the occurrence variable is defined as
Uij =

1 If RILD is observed in the patch i at the time point j
0 otherwise
and the intensity variable V ij = log(Y ij), when Y ij 6= 0. Then, V ij is the alr trans-
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formation of the compositional vector (%Dense,%Hazy,%Normal). Median patch dose,
time in years, and time squared were used as explanatory variables for modeling the fixed
effects for both outcomes (occurrence and intensity). To account for the interdependence
over time, a random intercept was used in both models. No other factors were considered
as random effects. Iterative estimation was performed until convergence was attained (tol-
erance = 1e-8). Table 5.1 shows the estimates of the fixed effects in the models for all three
patch definitions.
In the cubic-patch definition of dimension 8 × 8 × 8, the reference patient has 15,495
patches for analysis, and only 0.50% of them present RILD at some point. For this scenario,
the scoring procedure converged in 6 iterations, which took 8.3 hours for maximum relative
parameter change of 4.9E-14. Calculation of starting values took 15.5 minutes, and the
estimation of the random effects took 41.1 hours. Looking at the parameter estimates, an
increment in one Gy showed a 14% increment in the odds of RILD for a particular patch
(OR: 1.14; 95%CI:1.11, 1.18) (Table 5.1). On the other hand, the odds of RILD increase
during the first 14 months, then decrease over time. The estimated baseline composition,
when the patch received zero dose, was (%Dense=0, %Hazy=0.02, %Normal=0.98). Table
5.2 shows the shift in the composition from the baseline by a unit change in each covariate
when the other covariates are unchanged. Values close to 0.33 imply that changes in the
covariate do not have an effect on that particular part of the composition. In the same
way, values larger than 0.33 suggest a positive correlation between the covariate and the
composition part, and values smaller than 0.33 indicate negative correlations. Therefore,

















































































































































































































































































































































































































































































































































































































































































































Patch definition Dense Hazy Normal Disturbance
Cubic
Baseline 0.00 0.02 0.98
Median dose 0.35 0.33 0.32 0.05
Years 0.89 0.02 0.09 2.72
Years2 0.11 0.59 0.30 1.17
Spherical
Baseline 0.00 0.00 1.00
Median dose 0.35 0.36 0.29 0.15
Years 0.33 0.17 0.50 0.76
Years2 0.32 0.43 0.25 0.39
Isodose
Baseline 0.00 0.00 1.00
Median dose 0.35 0.35 0.30 0.13
Years 0.85 0.09 0.06 2.05
Years2 0.17 0.38 0.45 0.75
Table 5.2: Additive logistic transform estimates of the model applied to the composition
given that there is some RILD presence
The reference patient has 296 patches of the spherical type, and less than 20% of them
present RILD. In this patch approach, the scoring procedure took 6 iterations to converge,
which took 7 minutes to a maximum relative parameter change of 1.3E-13. Additionally, the
estimation of the random effects took 33 minutes. The odds of RILD, for a particular patch,
increased 58% by each Gy increase in the dose (OR:1.58, 95%CI:1.14, 2.19) (Table 5.1). On
the other hand, the odds of RILD decrease over time. Given that there is RILD presence in
the patch, the estimated baseline composition was (Dense=0, Hazy=0, Normal=1) (Table
5.2). An increase of 1 Gy in the dose shifts the baseline composition by (0.35, 0.36, 0.29).
Therefore, in this scenario, the dose is positively correlated with the percentage of dense and
hazy, while it is negatively correlated with the percentage of normal tissue. Moreover, over
time a big shift on the composition would be expected as an increment on the normal tissue
by month.
For the isodose definition, the reference patient has 288 patches, of which 58.48% present
RILD at some point after RT. The model converged after 6 iterations, which took 8.1 minutes
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to a maximum relative parameter change of 1.2E-13. Also, the estimation of the random
effects took 30 minutes. In this patch approach, the odds of RILD, for a particular patch,
increased 26% for each Gy increase in the dose (Table 5.1). Likewise, the odds of RILD
increase until 17 months after RT, then the odds decrease over time. In the results for the
intensity vector, the estimated baseline composition was (Dense= 0, Hazy= 0, Normal= 1)
(Table 5.2). An increase of 1 Gy in the dose shifts the baseline composition by (0.35, 0.35,
0.30). Consequently, the dose is positively correlated with both dense and hazy. Furthermore,
over time the changes in the compositions are characterized by an increment in the proportion
of dense.
5.1 Assessing model adequacy
Assumptions and goodness of fit of the model were assessed for all patch definitions. First,
the normality assumption of the random effects was assessed. In this cases, the random effects
come from two different sources, the random effects for the occurrence model (ci), and the
random effects from the intensity model (di). In the occurrence model, the random effects
are distributed N(0,Ψcc). The qq-plots of this random effect for all patch definitions are
presented on Figure 5.1. Apparent deviations of the normality assumption are observed for
almost all patch definitions. In the cubic definition, the tail of the distribution corresponds
to patches without RILD, while in the spherical and isodose definitions, the tails correspond
to patches with RILD.
The bivariate vector of random effects in the intensity model is distributed by a mixture
of normal distributions. A goodness-of-fit test of a mixture of normal distributions using the
Cramér-von Mises51 can be implemented for this objective. However, these results are not
presented in the current work. The lack of agreement with the normality assumption can
be a given by the exclusion or misspecification of the variables in the model. However, as
shown in Verbeke and Lesaffre52, and in Butler and Louis53, the inference of the fixed effects









Figure 5.2 shows the q-q plots for the errors of the intensity model. There is also evidence
of a lack of normality in the residuals, and mainly, in all patch definitions, patches that move
further from the straight line correspond to patches without RILD, which is expected given
that the intensity model is conditional on the presence of RILD. However, the number of
patches in all the patch definitions is larger than 250. Therefore, Central Limit Theorem
should assure some robustness, provided the model is asymptotically unbiased.
Nevertheless, violation of the homoscedasticity assumption of the residuals might have
a negative impact on the variance estimates of the parameters in the model. Figures 5.3
and 5.4 shows the scatter plot of the standardized residuals versus dose and time. The
subresiduals come from the comparison between the predicted values in the intensity model
and the observed values. The predicted values from the intensity model were multiplied
for the estimated probability of RILD, and these values where used on the calculation of
the residuals. Also, in these plots, patches with no observed RILD at any occasion cluster
along lines, and since the estimates of the random effects (di) are set at the population-level
predictions, large standard errors for the random effects in these patches are expected.
For the cubic patch, residuals for both dense and hazy seem to have zero variability in
low doses (< 10 Gy), since these patches did not present any RILD at any time point (Figure
5.3 (a)-(d)). In doses larger than 10 Gy, there is not evidence of heteroscedasticity in the
cubic-patch approach. In the spherical patch, for both transformed dense and hazy, the
residuals seem to have larger variability on the lower and higher ends of dose range (Figure
5.3 (e)-(h)). There is no evidence of a relationship between median dose and the subresiduals
(Figure 5.3 (e) and (g)), which contributes some evidence in favor of the linearity assumption.
In the isodose patch, residuals in doses less than 20 Gy have zero variability because
those patches did not present RILD at any time point. After 20 Gy, the residuals seem to
have larger variability at larger doses of RT (Figure 5.3 (i)-(l)). Additionally, these scatter

























(i) Subresiduals Dense (j) Residuals Dense (k) Subresiduals Hazy (l) Residuals Hazy
Figure 5.3: Standardized residuals vs. dose for the reference patient by patch definition
Subresiduals are calculated from the intensity model, residuals are calculated from the two-part model
(integration between occurrence and intensity models)
which might imply that further transformation of the median dose could improve the model
goodness-of-fit in the isodose patch. When looking at the plots between the residuals and
time, no particular systematic pattern indicating violations of assumptions are observed
(Figure 5.4).
For assessing the assumption that the two models, occurrence and intensity, are corre-
lated, Figure 5.5 shows the estimated log odds for each patch and the expected alr(Dense)
and alr(Hazy). As mentioned, the points cluster along lines representing the patches that
did not have RILD at any time point after RT. Based on the plots for the cubic patch, patches
with low propensities to present RILD also tend to have lower RILD intensity (Figure 5.5



















(i) Subresiduals Dense (j) Residuals Dense (k) Subresiduals Hazy (l) Residuals Hazy
Figure 5.4: Standardized residuals vs. time using median dose as predictor, for the reference
patient by patch definition
Subresiduals are calculated from the intensity model, residuals are calculated from the two-part model
(integration between occurrence and intensity models)
(f)). However, in the spherical patch, the plots indicate that patches with low propensities
to present RILD also tend to have large RILD intensity (Figure 5.5 (c) and (d)).
Figure 5.6 shows the observed number of times that each patch presented RILD, and the
sum of the predicted probabilities at each time point (
∑ni
j=1 Ûij). As observed, in all patch
definitions, the prediction in patches of normal tissue during the whole follow-up (Observed
= 0) is very good. However, in the cubic and spherical-patch approaches, the predictions
of the occurrence for patches with RILD is either underestimated or overestimated, with
large variability. Out of all patch definitions, the isodose patch seems to have the smaller



















(e) Dense (f) Hazy
Figure 5.5: Estimated mean alr(Dense) and alr(Hazy) vs. logit-probability of RILD for




Ûi.(ni − Ûi.)/ni were calculated, and outliers were identified as scaled residuals
with magnitude larger than 2.5. In the cubic patch, 0.20 % of the patches were classified
as outliers, in the spherical patch this proportion was 5.0%, and it was 1.0% in the isodose
patch definition.
Figure 5.7 shows the scatter plots of predicted vs. observed transformed dense and hazy
proportions. The predicted values from the intensity model are labeled as “subpredicted” and
are in the first column of this set of plots. In the second column are presented the predictions
form the first model multiplied by the estimated probability of RILD for each patch. There
is an effect of the underestimated probabilities of RILD from the occurrence model on the
predicted values from the intensity model adversely resulting in inferior predictions. The
model using the isodose patch demonstrates the least deviation even with adjustment with
the prediction of the occurrence model (Figure 5.7 (j) and (l)).
5.2 Clinical implications
In patients with lung cancer, medical images of different modalities are easy to access and
a non-invasive tool to monitor radiographic changes following radiotherapy. Although the
process of lung tissue changes following radiation is clearly visible, predictive models of such
changes are not available. Part of the reason why statistical models for longitudinal image
sets are underdeveloped is the complexity of the data. Prior to the models presented in this
research, simple and direct longitudinal models for dense and hazy compositions of patches
were tested. However, predictions out of those models were unsatisfactory, with strong
violations of model assumptions. The two-part model for zero-inflated longitudinal compo-
sitional data appears to be a big improvement to address these issues. Additionally, after
a descriptive analysis of the patch data, the bimodality of the dense and hazy distribution
was observed and the model was adjusted accordingly.
The two-part mixed-effects mixture model for zero-inflated longitudinal compositional





Figure 5.6: Observed number of times with RILD vs. expected probability of RILD for the






(a) Subpredicted Dense (b) Predicted Dense







(e) Subpredicted Dense (f) Predicted Dense
(g) Subpredicted Hazy (h) Predicted Hazy








(i) Subpredicted Dense (j) Predicted Dense
(k) Subpredicted Hazy (l) Predicted Hazy
Figure 5.7: Observed vs. predicted alr(Dense) and alr(Hazy) for the reference patient by
patch definition (cont.)
Subpredicted values are the predictions of the intensity model, the predicted values are the prediction of the
two-part model (integration between occurrence and intensity models)
the most consistent results, with the best goodness-of-fit were obtained in the the isodose
patch approach. Based on this model, increments in the RT dose were associated with an
increase in the odds of RILD for a particular patch (OR: 1.26, 95%CI:1.21, 1.31) (Table 5.1).
Also, the dose was positively associated with both the percentage of dense and hazy (Table
5.2).
The predictions of the two-part model for the isodose patch were transformed back to
the composition form. Figure 5.8 shows the predicted composition for the patches of the
reference patient. The predictions show a large increment in dense and a small increment
in hazy during the first 18 months after RT, and those percentages start decreasing after
that time point. When comparing the predictions with the observed data (Figure 2.24), the
predictions underestimate the high percentages of dense and hazy at 3 months after RT.
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(a) 3 Months (b) 6 Months (c) 12 Months
(d) 18 Months (e) 24 Months
Figure 5.8: Predicted ternary plots of dense and hazy composition by time after RT in the
isodose-patch using median dose as predictor for the reference patient
Also, even though the predictions show a decrease in dense and hazy after some time, it is
not as substantial and fast as in the observed data. Figure 5.9 show predicted values for doses
between 0 to 60 Gy by month. As mentioned before, increments in dose were related with
increments in both dense and hazy percentages, and over time, dense percentage increases.
Also, similar to the observed data for this patient, only patches with high doses present
dense or hazy damage in the predictions.
The violation of the assumptions was mainly related to patches without RILD presence.
In these cases, the estimates of the random effects revert to the population-level regres-
sion predictors, resulting in very variable estimates, affecting predictions at the patch level.
However when comparing the predicted compositions (Figure 5.8) with the observed com-
positions (Figure 2.24), these prediction problems do not seem to strongly affect the patches
without RILD (%Dense=0, %Hazy=0, %Normal=1). Nevertheless, this departures form the
assumptions might explain the differences between observed and predicted compositions in
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(a) 3 Months (b) 6 Months (c) 12 Months
(d) 18 Months (e) 24 Months
Figure 5.9: Predicted ternary plots of dense and hazy composition by time after RT in the
spherical-patch using log of median dose as predictor
patches with RILD.
5.3 Conclusion
The two-part mixed-effects mixture model for zero-inflated longitudinal compositional data
was applied to the three different patch definitions (cubic, spherical, and isodose), and mixed
results were observed. The isodose patch approach showed the best performing model with
respect to goodness-of-fit, by better predictions of both occurrence and intensity, as well as
fewer violations to the model assumptions. Based on this model, increments in the RT dose
were associated with an increase in the odds of RILD for a particular patch. Also, the dose
was positively associated with both the percentage of dense and hazy.
Results suggest a correlation between the random effects of both models (occurrence
and intensity). The methodology proposed in this study considers this correlation in the
estimation process. Ignoring this relationship, by fitting the logit and the linear models
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separately, would introduce substantial bias in the estimates of coefficients, particularly in
the coefficients of the intensity model.
It is important to consider that the estimated coefficients in the occurrence model rep-
resent the effect of changes in the variables on a particular patch, not a population-average
effect. That is, the model responds to the probability of RILD for each patch, not to the
percentage of patches with RILD. Population-average estimates tend to maintain the same
direction as the mixed model estimates but with smaller magnitude, as well as smaller stan-
dard errors. Some approaches to estimate the population-averaged effects based on mixed
model estimates have been discussed in the literature,54 but were not implemented here since
the main interest was the effect of the variables in each patch and not the overall effect.
The lack of agreement with the normality assumption was observed, for both the ran-
dom effects and the error term in the intensity model. Exclusion or misspecification of the
variables in the model might be one of the explanations of this finding. In this particu-
lar example, the number of patches in all the patch definitions is larger than 250; Central
Limit Theorem should allow asymptotic approximation to a reasonable level. Therefore, the
inference of the fixed effects might be robust to the non-normality of random effects,52,53
but the predictions at the patch level might be affected. Nevertheless, violation of the ho-
moscedasticity assumption of the residuals might have a negative impact on the variance
estimates of the parameters in the model. Notably, the patches with no RILD at all time
points represent an issue for both parts of the model. First, in the occurrence model, these
patches might have an actual logit of probabilities of RILD of −∞.44 Also, even though
the intensity model can provide predictions on these patches, these predictions have large
standard errors.44 Therefore, these patches have a substantial impact on the model assump-
tions. Furthermore, most of the procedures for diagnosing lack of adequacy in this model are
based on the independent results or residuals of each of the parts (occurrence and intensity);
however, future research should involve formal and informal methods for model adequacy
assessment using the residuals from the two-part model.
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Additionally, the model presented in this section is a simplified version of the radiographic
lung change following radiotherapy of lung cancer, being able to predict an average trajectory
overtime for all patches, which moves higher as the received dose increases, and starts at
different points for each patch due to the random intercept. However, this model does not
allow us to identify different trajectories over time. Therefore, future applications in this
data should include more complex models than better adjust the behavior of different patches
over time, e.g. adding interactions between time and received dose.
The current analysis is assuming that the patches are independent; however, the spatial
correlation between patches has been ignored. Failing to consider the spatial correlation
between patches might result in biased estimates and smaller standard errors.55 Adjustments
to the proposed model to account for spatial correlation is an important topic for future
research. For example, an iterative estimation process can be implemented by estimating the
two-part model parameters first, and later, the residuals of that model are used to estimate
the spatial correlation. Then, these two steps are repeated until convergence indicated by
non-significant changes in the estimated likelihood over consecutive iterations.
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6. Identification of different patterns of tissue deformation
In this section, the results from previous sections were used to address a clinical question.
The two-part mixed-effects mixture model for zero-inflated longitudinal compositional data
from the isodose patch definition provided a predicted time trajectory for the vector Yij
for each patch (Chapter 5). It is expected that patches in distinct anatomic positions or
at different distances from the tumor have different patterns of tissue changes. Then, the
predicted composition was used to classify the obtained trajectories in different clusters
to identify patch groups with similar patterns of tissue changes. The cluster analysis for
longitudinal compositional data proposed by Bruno et al.21 was implemented to cluster the
predicted trajectories of the composition. Since the interest was in mean levels of RILD,
the vectors with the predicted trajectories (Ŷij = [Ŷi3, Ŷi6, . . . , Ŷi24]
T ) were the data under
analysis for this section. Clustering by mean levels groups trajectories with similar predicted
means over time even though they have different shapes.
The distance between two compositional trajectories for two different patches i and i′
were calculated at each time point using Aitchison distance,56 which is an extension of the
Euclidean distance for composition data. This distance method has shown to preserve the
requirements for compositional data (scale invariance, permutation invariance, perturbation
invariance, and subcompositional dominance).9 Partitioning around medoids (PAM) algo-
rithm was used for clustering the trajectories. In this method, a representative trajectory
for each cluster is selected, and other trajectories are grouped in the cluster with the closest
distance to the reference trajectory.
The separation distance between the resulting clusters was assessed using silhouette anal-
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ysis.57 For each patch, the average distance with patches in the same cluster a(i) is calculated,
as well as the average distance of patch i to all patches in the nearest cluster b(i). Then, the
silhouette coefficient was calculated for each patch as s(i) = b(i)−a(i)
max{a(i),b(i)} . This coefficient
ranges from -1 to 1, with 1 being the value that indicates that the patch is far away from the
neighboring clusters. Values close to 0 are indicative that the sample is close to the bound-
ary between two neighboring clusters, and negative values are indicators than that particular
patch might have been assigned to the wrong cluster. The average silhouette coefficient is
presented for the resulting clusters. Additionally, descriptive statistics for the clusters was
performed to summarize the different observed patterns.
The idea of creating tissue deformation patterns have important clinical relevance in
patient management. Hence the selection of the appropriate number of clusters was guided
mainly by the clinical relevance. Final number of clusters was chosen based on which setup
provided more interpretable and biologically feasible results.
6.1 Results
The Aitchison distance was calculated for each pair of patches i and i′ at each time point,
and the average distance across time was used as the distance metric for the clustering
analysis. Figure 6.1 shows the average silhouette coefficient against the number of clusters
by clustering using PAM algorithm for the reference patient. As observed, two clusters is the
clustering configuration with the largest silhouette score, indicating that this configuration
showed the best separation between clusters, compared with other configurations. However,
when analyzing the characteristics of the patches within these two clusters, cluster 1 has
all the patches that did not present RILD at any time point, while cluster 2 has 98.22% of
the patches with RILD (Table 6.1). Therefore, this configuration will not give us enough
information about the different patterns of tissue change beyond the percentage of lung
damage.
The other studied clustering configurations (three to seven clusters) showed similar av-
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Number of No RILD RILD Average silhouette
clusters N=119 N=169 coefficient
Two 0.75
Cluster 1 119 (100%) 3 (1.78%) 0.67
Cluster 2 0 (0.00%) 166 (98.22%) 0.81
Three 0.58
Cluster 1 119 (100%) 3 (1.78%) 0.61
Cluster 2 0 (0.00%) 87 (51.48%) 0.46
Cluster 3 0 (0.00%) 79 (46.75%) 0.65
Four 0.52
Cluster 1 56 (47.06%) 3 (1.78%) 0.18
Cluster 2 63(52.94%) 0 (0.00%) 0.75
Cluster 3 0 (0.00%) 87 (51.48%) 0.46
Cluster 4 0 (0.00%) 79 (46.75%) 0.65
Five 0.57
Cluster 1 56 (47.06%) 0 (0.00%) 0.61
Cluster 2 63(52.94%) 0 (0.00%) 0.63
Cluster 3 0 (0.00%) 87 (51.48%) 0.46
Cluster 4 0 (0.00%) 79 (46.75%) 0.65
Cluster 5 0 (0.00%) 3 (1.78%) 0.11
Six 0.52
Cluster 1 33 (27.73%) 2 (1.18%) 0.20
Cluster 2 40 (33.61%) 0 (0.00%) 0.60
Cluster 3 46 (38.66%) 0 (0.00%) 0.62
Cluster 4 0 (0.00%) 87 (51.48%) 0.46
Cluster 5 0 (0.00%) 79 (46.75%) 0.65
Cluster 6 0 (0.00%) 1 (0.60%) 0.00
Seven 0.51
Cluster 1 33 (27.73%) 2 (1.18%) 0.20
Cluster 2 40 (33.61%) 0 (0.00%) 0.60
Cluster 3 46 (38.66%) 0 (0.00%) 0.62
Cluster 4 0 (0.00%) 43 (25.44%) 0.45
Cluster 5 0 (0.00%) 59 (34.91%) 0.49
Cluster 6 0 (0.00%) 64 (37.87%) 0.61
Cluster 7 0 (0.00%) 1 (0.60%) 0.00
Table 6.1: Results of clustering with partition around medoids algorithm by RILD presence
for the reference patient
erage silhouette coefficient (Figure 6.1). As observed in Figure 6.2, all these clustering con-
figurations have a strong and positive relationship with the received median dose. Basically
the different clusters are generated by different cutoffs of the received median dose with little
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Figure 6.1: Average silhouette coefficient by number of clusters using partition around
medoids algorithm for the reference patient
dose overlap between clusters. An important observation here is that in all configurations,
except for five clusters, the three patches with the highest dose are classified in the first
cluster. These three patches presented very high percentages of dense at 3 months, but this
percentage was zero for all observations after 6 months. When looking at the predictions for
these three patches, those are close to zero in all time points. Since these patches received
the highest dose, they are highly likely to correspond to the tumor. For this reason, the
identification of these clusters is important since large tissue changes are expected over time.
Additionally, given the construction of the patches with the isodose lines, these patches
combine the least number of voxels when compared to other patches.
Figure 6.3 shows the boxplots for the predicted parts of the composition (Dense, Hazy,
Normal) by clustering configuration, while Figure 6.4 shows similar plots for the observed
compositions. It is observed how all clustering configurations show a pattern to separate
patches with and without RILD. The use of 3 and 4 clusters shows a good performance in
identifying the magnitude of the composition and dose effect. Even though the clustering
algorithm was performed using the predicted compositions, analysis of the distribution of
the observed composition within the predicted clusters demonstrates the robustness of the
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(a) Two clusters (b) Three clusters (c) Four clusters
(d) Five clusters (e) Six clusters (f) Seven clusters
Figure 6.2: Boxplot of the median dose by the number of resulting clusters using partition
around medoids algorithm for the reference patient
clustering method to the errors in the prediction. When analyzing the boxplots for the
observed compositions (Figure 6.4), even though three clusters present a good separation of
the intensity of the damage, the five clustering configuration identifies the patches with very
extensive damage at the beginning of the follow-up that show a faster decrease over time, as
mentioned before.
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(a) Two clusters - Dense (b) Two clusters - Hazy (c) Two clusters - Normal
(d) Three clusters - Dense (e) Three clusters - Hazy (f) Three clusters - Normal
(g) Four clusters - Dense (h) Four clusters - Hazy (i) Four clusters - Normal
Figure 6.3: Boxplot of predicted composition (Dense,Hazy,Normal) by the number of result-
ing clusters using partition around medoids algorithm for the reference patient
6.2 Conclusion
This section shows an application of the cluster analysis to compositional data trajectories
with a strong presence of zeros on them. Although the clustering was performed using
the predicted trajectories, which do not have zeros, they have very small, close to zero,
values. Even under this situation, the clustering analysis showed good internal validity
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(j) Five clusters - Dense (k) Five clusters - Hazy (l) Five clusters - Normal
(m) Six clusters - Dense (n) Six clusters - Hazy (o) Six clusters - Normal
(p) Seven clusters - Dense (q) Seven clusters - Hazy (r) Seven clusters - Normal
Figure 6.3: Boxplot of predicted composition (Dense,Hazy,Normal) by the number of result-
ing clusters using partition around medoids algorithm for the reference patient (cont.)
(high silhouette scores), and also showed good separation between cluster with and without
RILD, by RILD intensity, and a strong association with radiation dose.
In this application, cluster configurations with two, three, and five clusters showed
promise for identifying patch groups with similar trends in radiographic lung change fol-
lowing radiotherapy of lung cancer. However, these results are based on only one patient;
therefore, the external validity of these findings is not clear, which implies that it is not
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(a) Two clusters - Dense (b) Two clusters - Hazy (c) Two clusters - Normal
(d) Three clusters - Dense (e) Three clusters - Hazy (f) Three clusters - Normal
(g) Four clusters - Dense (h) Four clusters - Hazy (i) Four clusters - Normal
Figure 6.4: Boxplot of observed composition (Dense,Hazy,Normal) by the number of resulting
clusters using partition around medoids algorithm for the reference patient
known if similar results will be obtained in other patients. For this reason, and taking into
account that the selection of the clustering configuration was proposed to be performed by
clinical relevance, it is necessary to study in greater depth the external validity, particularly
with cluster settings of two, three, and five clusters.
The results presented in this section were obtained using the predicted values, which
groups patches with similar predicted means over time, even though they have different
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(j) Five clusters - Dense (k) Five clusters - Hazy (l) Five clusters - Normal
(m) Six clusters - Dense (n) Six clusters - Hazy (o) Six clusters - Normal
(p) Seven clusters - Dense (q) Seven clusters - Hazy (r) Seven clusters - Normal
Figure 6.4: Boxplot of observed composition (Dense,Hazy,Normal) by the number of resulting
clusters using partition around medoids algorithm for the reference patient (cont.)
shapes. It would also be interesting to perform cluster analysis using the predicted first
derivatives, which would allow grouping patches with a similar rate of change over time.
This analysis was not performed here since the model presented in Chapter 5 was simple
and gave the same rate of change over time for all patches. Therefore, more complex models
that better adjust the behavior of different patches over time, adding interactions between
time and received dose, might yield better performance.
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7. Association of tissue change with radiation pneumonitis in NSCLS patients
Radiation therapy (RT) is the standard treatment for medically inoperable patients in the
early stages of NSCLC,28 however, exposure of healthy tissue near the tumor to high doses
of RT cause radiation-induced lung damage (RILD) in the vicinity of the tumor.34 An as-
sociation between RILD, radiation pneumonitis (RP), demographic and clinical factors has
been suggested in other studies. However, the presence of differences in tissue changes over
time after RT between patients with and without RP is still questionable. Using findings of
previous chapters, a characterization of tissue changes in NSCLC patients by RP is studied
in this chapter.
Data of two groups of patients, one with RP and another without RP have been collected.
Each patient had three follow-up CT scans and otherwise similar tumor and treatment
characteristics (Table 1.1). Each CT scan was manually contoured classifying the voxels in
dense, hazy, or normal looking tissue based on intensity threshold. Afterward, deformable
image registration was performed to ensure temporal correspondence.
Isodose patches were built for each set of CT scans, and patch-specific longitudinal com-
positional vectors for each patient were calculated. Predicted longitudinal compositions for
each patch within patients were obtained using the two-part mixed-effects mixture model for
zero-inflated longitudinal compositional data. Next, predicted compositions were classified
using the patterns found in Chapter 6 for the reference patient, using two to five clusters.
For each patient, the proportion of patches following each type of pattern was calculated.
Finally, for each cluster configuration, a logistic regression model with RP diagnosis as out-
come was performed with the percentage of patches in each cluster as predictors. Since
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the distribution of patches among clusters is a compositional vector, ilr transformation was
performed before running the model. For each cluster configuration, accuracy, sensitivity,
specificity, and area under the curve (AUC) were calculated.
7.1 Results
Out of the 18 patients available for this analysis (Table 1.1), only 16 had more than two
follow-up CT Scans, eight patients have RP, and eight did not have such a diagnosis. Table
7.1 shows the estimates of the fixed effects in the models for each patient. Large variability
is observed in the estimates of the intercepts in the model of occurrence, as well as in the two
outcomes of the intensity model. The estimation of the dose-effect has less variability, with
similar direction and magnitude in most of the patients. There is also considerable variability
in the estimates of time (Years, Years2). This could be indicating that the trend over time is
different for each subject. Histograms of these parameter estimates by RP diagnosis did not
show a trend toward differences between groups (Figure 7.1). The squared correlation and
MASE between predicted and observed values are shown in Table 7.2. As demonstrated,
the prediction performance is different for different patients and might be indicative of the



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































(g) Dose (h) Time (i) Time2
Figure 7.1: Histograms of parameter estimates of the fixed effects for modeling RILD using
isodose lines patch definition by radiation pneumonitis (RP) diagnosis
The estimated baseline composition, when the patch received zero dose for each patient is
presented in Table 7.3. Also, the shift in the composition from the baseline by a unit change
in each covariate, when the other covariates are unchanged, is presented. It is observed
how despite the differences in the magnitude and direction of dose estimates in Table 7.1,
when transforming the estimates to the impact in the compositional vector, the effect across




Correlation2 MASE Correlation2 MASE
1 0.24 0.98 0.21 0.92
2 0.34 0.90 0.34 1.01
3 0.31 0.90 0.41 0.76
4 0.37 0.99 0.39 0.99
5 0.66 0.33 0.54 0.34
6 0.65 0.58 0.38 0.84
7 0.52 0.35 0.44 0.40
8 0.67 0.37 0.14 0.40
10 0.47 0.94 2.1E-05 0.99
11 0.72 0.51 0.71 0.37
12 0.02 0.96 0.03 0.77
13 0.76 0.69 0.71 0.65
14 0.56 0.82 0.78 0.54
15 0.31 0.94 0.32 0.98
17 0.82 0.33 0.81 0.51
18 2.2E-04 1.00 0.18 0.95
Table 7.2: Correlation and mean absolute scaled error (MASE) between observed and pre-
dicted data using isodose lines patch definition
Id
Baseline Dose Years Years2
Dense Hazy Normal Dense Hazy Normal Dense Hazy Normal Dense Hazy Normal
1 0.00 0.00 1.00 0.39 0.35 0.26 0.15 0.01 0.85 0.04 0.95 0.01
2 0.00 0.01 0.99 0.34 0.34 0.32 0.97 0.01 0.02 0.04 0.49 0.47
3 0.00 0.00 1.00 0.34 0.34 0.32 0.00 0.01 0.99 0.89 0.11 0.00
4 0.00 0.00 1.00 0.34 0.35 0.31 0.17 0.76 0.07 0.39 0.11 0.51
5 0.00 0.00 1.00 0.34 0.35 0.31 0.06 0.29 0.64 0.75 0.22 0.02
6 0.00 0.00 1.00 0.34 0.35 0.30 0.45 0.55 0.00 0.00 0.00 1.00
7 0.04 0.10 0.86 0.34 0.34 0.32 0.02 0.00 0.98 0.01 0.99 0.00
8 0.00 0.00 1.00 0.35 0.34 0.31 0.05 0.02 0.93 0.68 0.32 0.00
10 0.00 0.00 1.00 0.35 0.35 0.31 0.00 1.00 0.00 0.01 0.00 0.99
11 0.00 0.00 1.00 0.36 0.34 0.30 0.00 0.49 0.51 0.99 0.01 0.00
12 0.00 0.01 0.99 0.34 0.34 0.32 0.54 0.07 0.39 0.31 0.34 0.36
13 0.00 0.00 1.00 0.39 0.30 0.31 0.08 0.38 0.54 0.71 0.20 0.09
14 0.00 0.00 1.00 0.35 0.34 0.31 0.00 0.72 0.28 0.97 0.01 0.03
15 0.00 0.00 1.00 0.36 0.34 0.30 0.23 0.22 0.55 0.68 0.17 0.15
17 0.00 0.00 1.00 0.34 0.35 0.31 1.00 0.00 0.00 0.00 0.27 0.73
18 0.00 0.00 1.00 0.35 0.34 0.31 1.00 0.00 0.00 0.01 0.03 0.96
Table 7.3: Additive logistic transform estimates of the model applied to the composition
given that there is some RILD presence using isodose lines patch definition
Predicted compositions were classified using the patterns found in Chapter 6 for the refer-
ence patient, using two to five clusters. Table 7.4 shows the average silhouette coefficient for
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each patient data set by number of clusters. Similar to the results with the reference patient
(Figure 6.1), two clusters was the clustering configuration with the largest silhouette score
for almost all patients, indicating that this configuration has the best separation between
clusters. The other clustering configurations (three to five clusters) showed a similar average
silhouette score.
The proportion of patches following each type of pattern is presented in Table 7.5. Dif-
ferences between the distribution of cluster membership is observed between patients. These
percentages were transformed using the ilr transformation and were used as predictors of
RP. A summary of performance of the clustering configurations to classify patients with and
without RP is shown in Table 7.6. Even though the configuration with two clusters has the
highest average silhouette coefficient, this is the configuration with the most inferior perfor-
mance. Among the other options, four and five clusters seem to have better performance
identifying patients with RP.
Id
Number of Clusters
Two Three Four Five
1 0.53 0.41 0.38 0.39
2 0.75 0.53 0.57 0.56
3 0.54 0.28 0.39 0.39
4 0.66 0.49 0.49 0.48
5 0.27 0.18 0.34 0.65
6 0.67 0.5 0.53 0.51
7 0.88 0.72 0.68 0.71
8 0.61 0.43 0.4 0.39
10 0.59 0.52 0.54 0.54
11 0.81 0.52 0.52 0.53
12 0.86 0.44 0.44 0.43
13 0.3 0.24 0.23 0.32
14 0.79 0.46 0.49 0.49
15 0.41 0.33 0.47 0.41
17 0.71 0.62 0.61 0.6
18 0.73 0.42 0.41 0.46
Average 0.63 0.44 0.47 0.49
Table 7.4: Average silhouette coefficient by number of clusters using partition around
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Number of Clusters Accuracy Sensitivity Specificity AUC
Two 0.50 0.50 0.50 0.63 (0.31, 0.94)
Three 0.69 0.63 0.75 0.64 (0.33, 0.95)
Four 0.69 0.75 0.63 0.66 (0.34, 0.97)
Five 0.69 0.63 0.75 0.66 (0.34, 0.97)
Table 7.6: Model discrimination of radiation pneumonitis by number of clusters using par-
tition around medoids algorithm with the isodose lines patch definition
7.2 Conclusion
This section shows an application of the isodose-patch definition, the two-part mixed-effects
mixture model for zero-inflated longitudinal compositional data, and the cluster analysis to
compositional data trajectories in a data set of 16 NSCLC patients. For these patients, the
number of patches ranges from 234 to 353, and the percentage of patches with RILD goes
from 21.59% to 99.34%.
The coefficients for some parameters vary considerably (intercept and time), therefore in
future analysis of this data set, it is suggested to consider random effects for these parameters
in the subject level to accommodate such variability. It is important to highlight that
estimations on the intensity model (second part) seem more stable among patients than in
the occurrence model. This result is consistent with what was observed in Chapter 4.
The method for estimating the parameters ignores the spatial correlation between patches.
Augmenting this method by spatial correlation might result in more consistent estimates.
Moreover, as shown in Chapters 4 and 5, the two-part model has some other limitations in
small samples (around 300 patches) with few follow-ups. All the patients in this data set
present this situation and thus suffering from the same limitations. Despite these limita-
tions, dose estimates appear consistent when transforming the data to the original units in
the compositional data.
In this application, cluster configurations with four and five clusters showed promise for
identifying patients with RP. However, these results are based on a small sample of patients,
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and it was not adjusted by other covariates. A larger data set and inclusion of other covariates
should benefit the study of the association between tissue change and RP. As a first attempt




Longitudinal compositional data, with a peak at zero, occur in many applications in health
sciences. Different sources of correlation in the data are observed between subjects over time
and between parts of the compositional vector. Additionally, the presence of singular zero
represents a particular challenge in the analysis of such data.
Several approximations have been proposed to analyze zero-inflated longitudinal data,
from Aitchison’s proposal in 1955,58 going through various applications of likelihood-based
models,59 to proposals using Bayesian methods that do not require making asymptotic ap-
proximations.60 However, only a few approaches have been applied to analyzing zero-inflated
longitudinal compositional data.16,61
A new approach for the analysis of zero-inflated longitudinal compositional data, which
additionally shows bimodal distributions of the components, is proposed in this work. Here a
two-part mixed-effects mixture model was proposed. This model is fully parametric and uses
asymptotic approximations to estimate the parameters. The likelihood was approximated
using a sixth-order multivariate Laplace method, and even though a higher-order could have
been used, empirical evidence shows that it would not improve the accuracy.62 The EM
algorithm was used to estimate the probability of the mixture model, and the approximate
Fisher scoring procedure was implemented to estimate other parameters in the model. Three
different sets of empirical Bayes estimates of the random effects were implemented, standard,
truncated, and Pareto. No big differences were observed in the estimations between the three
methods, however, the predictions with the Pareto estimates were slightly better than with
the other methods.
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A simulation study showed that the proposed method performs reasonably for estimation
of the fixed effects, and their variability. Also, the average time that the procedure takes for
the estimation seems feasible for statistical analysis. However, the model produced biased
estimates of the nuisance parameters in the model. As discussed in Chapter 4, these results
might be caused by the implementation of the step-halving procedure that forces a decrease in
the deviance at each iteration. This procedure can be limiting the changes in the estimates
and causing false convergence. Changes in this procedure, like using it only on the fixed
effects or other approximations to improve convergence, should be studied to improve model
performance.
Currently, the implemented code for running the proposed method considers random
intercepts for both parts of the model. Nevertheless, future expansion of the model should
accommodate random slopes for important factors, as well as other random effects that
can handle cluster or multilevel data. Also, the estimated coefficients in this method do
not represent the population-average effect. Therefore, future extensions of this work can
attempt the estimation of such effects based on the current estimates.
The proposed model was used to address a clinical question. The aim was to build
a statistical model for stochastic radiographic lung change following radiotherapy of lung
cancer, and to explore how the results could be used to characterize patients with radiation
pneumonitis. From the practitioner’s point of view, the use of medical imaging has become
quite sophisticated and continues to evolve into a very accurate, non-invasive tool for medical
diagnosis. In patients with lung cancer, medical images of different modalities are easy
to access and a non-invasive tool to monitor radiographic changes following radiotherapy.
RT of the lung shows a clear footprint of the dose distribution in post-treatment scans.
Although the process of lung tissue changes following radiation is clearly visible, predictive
models of such changes are not available. Part of the reason why statistical models for
longitudinal image sets are underdeveloped is the complexity of the data and difficulty of
accurate image registration. First, image data are often extremely large data sets that
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require extensive computational resources to analyze. Additionally, in the case of following
LC patients after RT, the temporal integrity of the data is questionable, given the tissue
changes in the lung after RT. For this reason, the approaches presented in this study, grouping
voxels into larger subvolumes called patches, represents an improvement over aggregative
approach that combines the entire image into few summary measures or voxel-wise model.
The two-part mixed-effects mixture model for zero-inflated longitudinal compositional
data was applied to the data of one NSCLC patient for the purpose of modeling the intensity
of RILD overtime after RT. The proposed method performed well in simulation and was
applied successfully to the clinical data, and when analyzing the results in the compositional
data framework, estimates seemed to be robust to the model limitations. However, the
presented model did not adjust by the spatial correlation between patches, neither included
random slopes for time effects, both important features for future studies in these data.
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Appendix
A Clustering results for the reference patient
(a) Two clusters (b) Three clusters (c) Four clusters
(d) Five clusters (e) Six clusters (f) Seven clusters
Figure A.1: Silhouette analysis by the number of resulting clusters using partition around
medoids algorithm for the reference patient
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B Relevant Code
B.1 Chapter 2: Patch definitions
Also available at: https://github.com/vivifj03/TumorModel/blob/master/Code%20chapter2%
20-%20patch%20definition.R
#First , export CT scan data from Slicer to Matlab , and from Matlab
#to R using Kingston Kang ’s code.




# Read data -------------------------------------------------------------
files <-list.files(pattern = "*.rda")
dta <- new.env()
lapply(files ,load ,dta)
















"c7_11_0.rda", envir = dta)
# There is overlap in the images. Hazy has dense data , so next lines
# remove dense from hazy
dta$c7_011. rda$dvf <-ifelse(dta$c7_011. rda$dvf==dta$c7_101. rda$dvf ,
0,dta$c7_011. rda$dvf)
dta$c7_012. rda$dvf <-ifelse(dta$c7_012. rda$dvf==dta$c7_102. rda$dvf ,
0,dta$c7_012. rda$dvf)
dta$c7_013. rda$dvf <-ifelse(dta$c7_013. rda$dvf==dta$c7_103. rda$dvf ,
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0,dta$c7_013. rda$dvf)
dta$c7_014. rda$dvf <-ifelse(dta$c7_014. rda$dvf==dta$c7_104. rda$dvf ,
0,dta$c7_014. rda$dvf)
dta$c7_015. rda$dvf <-ifelse(dta$c7_015. rda$dvf==dta$c7_105. rda$dvf ,
0,dta$c7_015. rda$dvf)
#I have to fix dose to be positive. because there are some negative
#values
#The min dose value in the original data (small size) is 0.0035
dta$c7_111. rda$dvf <-ifelse(dta$c7_111. rda$dvf <0,0,dta$c7_111. rda$dvf)
#Make sure all images have the same size
# c7_111 id the dose file
#If there are more files in dat than the images we need , then delete
remove(c7_000.rda , c7_000 ptv.rda , c7_001.rda , c7_002.rda , c7_003.rda ,
c7_004.rda , c7_005.rda , envir = dta)
# Cubic Patch ----------------------------------------------------------
in_avg_s<-function(x, s){
#Calculates de average of the values in the cube
d1<-dim(x$dvf )[1]
d3<-dim(x$dvf )[3]
l<-seq(from = 1, to = d1, by = s)
w<-seq(from = 1, to = d3, by = s)
l2<-seq(from = 1, to = length(l), by = 1)
w2<-seq(from = 1, to = length(w), by = 1)
res <-data.frame(matrix(nrow = length(l)*length(l)*length(w),
ncol = 13))
colnames(res)<-c("patch_w", "patch_l", "patch_d", "patch_w2",
"patch_l2", "patch_d2", "patch", "avg", "min", "max",
"sd", "med", "riq")
res[,1]<-rep(l,times=length(l)*length(w))
res[,2]<-rep(sapply(l, function(x) rep(x,length(l))), length(w))
res[,3]<-unlist(lapply(w, function(x) rep(x,length(l)^2)))
res[,4]<-rep(l2 ,times=length(l)*length(w))
res[,5]<-rep(sapply(l2 , function(x) rep(x,length(l))), length(w))
res[,6]<-unlist(lapply(w2 , function(x) rep(x,length(l)^2)))
res[,7]<-paste(res[,4],res[,5], res[,6], sep="_" )









res[i,9] <-min(x$dvf[a:b,c:d,e:f], na.rm = TRUE)
res[i,10] <-max(x$dvf[a:b,c:d,e:f], na.rm = TRUE)
res[i,11] <-sd(x$dvf[a:b,c:d,e:f], na.rm=TRUE)
res[i,12] <-median(x$dvf[a:b,c:d,e:f], na.rm=TRUE)








matl <-array(NA ,c(d1 ,d1 ,d3))
matw <-array(NA ,c(d1 ,d1 ,d3))










mat <-data.frame(matrix(NA , nrow=d1*d1*d3 , ncol =4))








#this fuction is summarizing dose in the patch
#(max , min ...)
d1<-dim(x$dvf )[1]
d3<-dim(x$dvf )[3]
subx <-data.frame(matrix(NA , nrow=d1*d1*d3 , ncol =5))
colnames(subx)<-c("val", "patch_l", "patch_w", "patch_d", "patch")
subx[,1]<-as.vector(x$dvf [1:d1 ,1:d1 ,1:d3])















function(x) quantile(x,probs =0.75 , na.rm=TRUE)-
quantile(x,probs =0.25 , na.rm=TRUE))
res <-Reduce(function(x, y) merge(x, y, by="patch"),




#Build the cubic patch
d1<-dim(x$dvf )[1]
d3<-dim(x$dvf )[3]
dosel_111 <-data.frame(matrix(NA, nrow=d1*d1*d3, ncol =8))
colnames(dosel_111) <-c("dose", "patch_l", "patch_w", "patch_d",
"patch","row", "col", "layer")
dosel_111[ ,1] <-as.vector(x$dvf[1:d1 ,1:d1 ,1:d3])
dosel_111[ ,2:5] <-mat[ ,1:4]
dosel_111[ ,6] <-rep(1:d1, by=1, time=d1*d3)
dosel_111[ ,7] <-rep(1:d1, by=1, each=d1, time=d3)
dosel_111[ ,8] <-rep(1:d3, by=1, each=d1*d1)
return(dosel_111)
}
k<-8 #This is patch size , if want different size then change
mat <-numb(dta$c7_111.rda ,s=k)
dosel <-P_num(dta$c7_111.rda ,s=k)
Resumen <-eapply(dta , function(x)in_avg_s2(x,s=k), USE.NAMES = TRUE)
v <- in_avg_s2(dta$c7_011.rda ,s=k)
Resumen_l<-ldply(Resumen)
Resumen_l$Id<-sub("_.*", "", Resumen_l$.id)
Resumen_l$file <-substr(sub(".*_", "", Resumen_l$.id) ,1,2)
Resumen_l$date <-substr(sub(".*_", "", Resumen_l$.id) ,3,3)
Resumen_l<-Resumen_l[,c(".id", "Id", "file", "date", "patch", "n",
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"avg", "min", "max", "sd", "med", "riq")]
Resumen_w<-reshape(Resumen_l[,-1], idvar = c("Id", "date", "patch"),
timevar = "file", direction = "wide")
Resumen_w<-Resumen_w[,c("Id", "date", "patch", "n.01", "avg .01",
"avg.10","avg.11", "min.11", "max.11", "sd.11",
"med.11", "riq.11")]
colnames(Resumen_w)<-c("Id", "date", "patch", "n" , "Hazy", "Dense",
"Dose_avg", "Dose_min", "Dose_max", "Dose_sd",
"Dose_med", "Dose_riq")
Resumen_w$Com <-(1-( Resumen_w$Hazy+Resumen_w$Dense))
Resumen_w2<-reshape(Resumen_w, idvar = c("Id","patch"), timevar =
"date",direction = "wide")
Resumen_w2<-Resumen_w2[,c("Id", "patch", "n.1", "Dose_avg.1",
"Dose_min.1","Dose_max.1", "Dose_sd.1",
"Dose_med.1", "Dose_riq.1","Dense .1", "Hazy.1",
"Com.1", "Dense.2", "Hazy.2", "Com.2",
"Dense.3", "Hazy.3","Com.3", "Dense .4",




ifelse(Resumen_w$date ==4 ,18 ,24))))
#ZeroChange are patches that were always 100% normal




Resumen_w2$Com .5==1) , 2]
length(list_ZeroChange)
list_maxDoseZero <-Resumen_w[which(Resumen_w$Dose_max <=0) ,3]
Resumen_w$chageID <-ifelse(Resumen_w$patch %in% list_ZeroChange ,0, 1)
Resumen_w$someDose <-ifelse(Resumen_w$patch %in% list_maxDoseZero ,0, 1)
dosel$chageID <-ifelse(dosel$patch %in% list_ZeroChange ,0,1)
dosel$someDose <-ifelse(dosel$patch %in% list_maxDoseZero ,0, 1)
dosel <-dosel[!is.na(dosel$dose),]
rm(dta ,files , mat , matl , matd , matw)
rm(end , inicio , in_avg_s, in_avg_s2 , numb , P_num)
Resumen_w$keep <-ifelse(Resumen_w$chageID ==1,1,0)
Resumen_w$keep <-ifelse(Resumen_w$someDose ==1,1, Resumen_w$keep)
dataset <-Resumen_w[which(Resumen_w$keep ==1) ,]






dataset <-merge(dataset ,datadose ,by=c("patch"), all.x=T)
dataset_w<-Resumen_w2[Resumen_w2$patch %in% dataset$patch ,]
save.image(file = paste("cubic_patch", k,".RData", sep = ""))
# Spherical patch ------------------------------------------------------





matl <-array(NA ,c(d1 ,d1 ,d3))
matw <-array(NA ,c(d1 ,d1 ,d3))


























unwrap <-data.frame(matrix(NA , nrow=d1*d1*d3 , ncol =8))
colnames(unwrap)<-c(name , "patch_l", "patch_w", "patch_d",
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"patch", "row", "col", "layer")
unwrap [,1]<-as.vector(x$dvf [1:d1 ,1:d1 ,1:d3])
unwrap [,2:5] <-mat[,c(1:3 ,7)]
unwrap [,6]<-rep (1:d1 , by=1, time=d1*d3)
unwrap [,7]<-rep (1:d1 , by=1, each=d1 , time=d3)
unwrap [,8]<-rep (1:d3 , by=1, each=d1*d1)































unwrap <-data.frame(matrix(NA , nrow=d1*d1*d3 , ncol =5))
colnames(unwrap)<-c("value", "patch_l", "patch_w", "patch_d", "patch")
unwrap [,1]<-as.vector(x$dvf [1:d1 ,1:d1 ,1:d3])
unwrap [,2:5] <-mat[,c(1:3 ,7)]
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Resumen <-eapply(dta , function(x) DH_sum(x), USE.NAMES = TRUE)
Resumen_l<-ldply(Resumen)
Resumen_l<-separate(Resumen_l, .id , c("Id","file"), "_")
Resumen_l$date <-as.numeric(as.character(substr(Resumen_l$file , 3, 3)))




Resumen_w<-reshape(Resumen_l, idvar = c("Id","date", "patch"),
timevar = "file", direction = "wide")
Resumen_w<-Resumen_w[,c("Id","patch","date","count .01","count .10")]







Resumen_w2<-reshape(Resumen_w, idvar = c("Id","patch"),
timevar = "date", direction = "wide")




Resumen_w2$Com .24==1) , 1]
length(list_ZeroChange)
list_maxDoseZero <-Resumen_w[which(Resumen_w$Dose_max <=0) ,1]
Resumen_w$chageID <-ifelse(Resumen_w$patch %in% list_ZeroChange ,0, 1)
Resumen_w$someDose <-ifelse(Resumen_w$patch %in% list_maxDoseZero ,0, 1)
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dosel <-dosel.f$dose_raw
save.image(file = paste("spheric_patch.RData", sep = ""))
# Isodose patch --------------------------------------------------------
m<-ceiling(max(dta$c7_111. rda$dvf ,na.rm = T))
#Categorize dose for isodose lines
s1<-c(-Inf ,seq(0,m,by=1)) #0,
s2<-c(-Inf ,seq(0,m,by =0.5)) #0, ..
s3<-c(-Inf ,seq(0,m,by =0.2)) #0, .
s4<-c(-Inf ,seq(0,m,by =0.1)) #0, .
s5<-c(-Inf ,seq(0,m,by =0.05)) #0, .
d1<-dim(dta$c7_111. rda$dvf )[1]
d3<-dim(dta$c7_111. rda$dvf )[3]
dosel <-data.frame(matrix(NA , nrow=d1*d1*d3, ncol =4))
colnames(dosel)<-c("dose", "row", "col", "layer")
dosel[,1]<-as.vector(dta$c7_111. rda$dvf[1:d1 ,1:d1 ,1:d3])
dosel[,2]<-rep(1:d1 , by=1, time=d1*d3)
dosel[,3]<-rep(1:d1 , by=1, each=d1, time=d3)











max.val <-which(dta$c7_111. rda$dvf == max(dta$c7_111. rda$dvf , na.rm=T),
arr.ind = TRUE)
for (i in 1:5) {
nam <- paste("Resumen_s", i, sep = "")

















DH_sum <-function(x,dosel=dosel ,cat =1){
d1<-dim(x$dvf )[1]
d3<-dim(x$dvf )[3]
unwrap <-data.frame(matrix(NA , nrow=d1*d1*d3 , ncol =5))
colnames(unwrap)<-c("value", "patch_l", "patch_w", "patch_d", "patch")
unwrap [,1]<-as.vector(x$dvf [1:d1 ,1:d1 ,1:d3])
unwrap [,2:5] <-dosel[,c(2:4 ,4+ cat)]




Resumen_1<-eapply(dta , function(x) DH_sum(x,dosel=dosel ,cat=1),
USE.NAMES = TRUE)
Resumen_2<-eapply(dta , function(x) DH_sum(x,dosel=dosel ,cat=2),
USE.NAMES = TRUE)
Resumen_3<-eapply(dta , function(x) DH_sum(x,dosel=dosel ,cat=3),
USE.NAMES = TRUE)
Resumen_4<-eapply(dta , function(x) DH_sum(x,dosel=dosel ,cat=4),
USE.NAMES = TRUE)
Resumen_5<-eapply(dta , function(x) DH_sum(x,dosel=dosel ,cat=5),
USE.NAMES = TRUE)
# Code for isodose patch of 1Gy interval.
# Repeat this code for other sized changing Resumen_1
Resumen_l<-ldply(Resumen_1)
Resumen_l<-separate(Resumen_l, .id , c("Id","file"), "_")
Resumen_l$date <-as.numeric(as.character(substr(Resumen_l$file , 3, 3)))




Resumen_w<-reshape(Resumen_l, idvar = c("Id","date", "patch"),
timevar = "file", direction = "wide")
Resumen_w<-Resumen_w[,c("Id","patch","date","count .01","count .10")]










Resumen_w2<-reshape(Resumen_w, idvar = c("Id","patch"),
timevar = "date", direction = "wide")
list_ZeroChange <- Resumen_w2[ which(Resumen_w2$Com .3==1 &
Resumen_w2$Com .6==1 & Resumen_w2$Com .12==1 &
Resumen_w2$Com .18==1 & Resumen_w2$Com .24==1) , 1]
length(list_ZeroChange)
list_maxDoseZero <-Resumen_w[which(Resumen_w$Dose_max <=0) ,1]
Resumen_w$chageID <-ifelse(Resumen_w$patch %in% list_ZeroChange ,0, 1)
Resumen_w$someDose <-ifelse(Resumen_w$patch %in% list_maxDoseZero ,0, 1)
# After creating Resumen_1_w to Resumen_5_w then save data
save.image(file = paste("isodose_patch", k,".RData", sep = ""))
# Compositional data ---------------------------------------------------
# After creating the data sets , some adjustments to the composition
# were done (e.g. Fry zero transformation)
Resumen_w$keep <-ifelse(Resumen_w$chageID ==1,1,0)
Resumen_w$keep <-ifelse(Resumen_w$someDose ==1,1, Resumen_w$keep)
Resumen_w$ZeroHD <-ifelse(Resumen_w$Com==1,1,0) #Both hazy&dense are zero
dataset <-Resumen_w[which(Resumen_w$keep ==1) ,]










dataset$Dense .03 <-ifelse(dataset$Dense==0, dataset$ta ,ifelse(dataset$M==0,
dataset$Dense ,dataset$Dense -( dataset$Dense*dataset$ts)))
dataset$Hazy .03 <-ifelse(dataset$Hazy==0, dataset$ta ,ifelse(dataset$M==0,
dataset$Hazy ,dataset$Hazy -( dataset$Hazy*dataset$ts)))
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dataset$Com .03 <-ifelse(dataset$Com==0, dataset$ta ,ifelse(dataset$M==0,
















ifelse(dataset$date ==4 ,18 ,24))))
dataset$years <-dataset$date2/12
dataset$years2 <-as.numeric(as.character (( dataset$years )))**2











# Calinski -Harabasz (CH) index
library(nlme)
library(reghelper)
ctrl <- lmeControl(maxIter = 100, msMaxIter = 100, singular.ok=TRUE ,
returnObject=TRUE , opt=’optim’)
#For cubic
mod <- lme( dose~ 1, data=dosel , random = ~ 1|patch , control=ctrl)
#For spherical
mod <- lme( dose~ 1, data=dosel , random = ~ 1|patch , control=ctrl)
#For isodose










GeomSplitViolin <- ggproto("GeomSplitViolin", GeomViolin ,
draw_group = function(self , data , ...,
draw_quantiles = NULL) {
data <- transform(data , xminv = x -
violinwidth * (x - xmin), xmaxv = x +
violinwidth * (xmax - x))
grp <- data[1, "group"]
newdata <- plyr:: arrange(transform(data , x =
if (grp %% 2 == 1) xminv else xmaxv), if
(grp %% 2 == 1) y else -y)
newdata <- rbind(newdata[1, ], newdata ,
newdata[nrow(newdata), ], newdata[1, ])
newdata[c(1, nrow(newdata) - 1,
nrow(newdata)), "x"] <- round(newdata[1,
"x"])





gplot2 ::: create_quantile_segment_frame(data ,
draw_quantiles)
aesthetics <- data[rep(1, nrow(quantiles )),
setdiff(names(data), c("x", "y")), drop =
FALSE]
aesthetics$alpha <- rep(1, nrow(quantiles ))
both <- cbind(quantiles , aesthetics)












geom_split_violin <- function(mapping = NULL , data = NULL , stat =
"ydensity", position = "identity", ...,
draw_quantiles = NULL , trim = TRUE , scale =
"area", na.rm = FALSE ,
show.legend = NA , inherit.aes = TRUE) {
layer(data = data , mapping = mapping , stat = stat , geom =
GeomSplitViolin ,
position = position , show.legend = show.legend , inherit.aes =
inherit.aes ,
params = list(trim = trim , scale = scale , draw_quantiles =
draw_quantiles , na.rm = na.rm , ...))
}




ggplot(data=c, aes(x=factor(Months), y=P)) +
geom_bar(stat="identity",fill=alpha(c("#926 B8D") ,0.7)) +
xlab("Months after RT \n") +
ylab(paste("% of patches with RILD (N=",len ,")",sep = "")) +
scale_y_continuous(sec.axis = sec_axis(~ . * len/100,
name="Number of patches with RILD"),limits=c(0,1))
# Figure 2.13 (b) [2.17 , 2.23]
boxplot <-as.data.frame(dataset[dataset$date ==1 ,])
ggplot(data = boxplot , aes(x=factor(chageID), y=Dose_med)) +
geom_boxplot(aes(color=factor(chageID), fill = factor(chageID)),
alpha =0.7) +
xlab("Patch with RILD Presence") + ylab("Median Dose x Patch") +
geom_point(pch = 19, position = position_jitterdodge (),
alpha =0.3, size=1,aes(colour = factor(chageID )))+
scale_fill_manual(values = c("#B7B6BA", "#926 B8D")) +
scale_color_manual(values = c("#B7B6BA", "#926 B8D")) +
scale_x_discrete(labels=c("0"= "No", "1"="Yes")) +
scale_y_continuous(breaks=seq(0,max(boxplot$Dose_med),by=10))
# Figure 2.13 (c) [2.17 , 2.23]
my_dat2 <-dataset[,c("date2","Dense.lt","Hazy.lt")]
my_dat2 <- melt(my_dat2 , id.vars=c("date2"))





xlab("\nMonths after RT") +
ylab("alr transformation \n ln(Y/N)\n") +
scale_color_manual(name = "Type of RILD",
values=c("#926 B8D","#7 aadb1"),labels=c("Dense",
"Hazy")) +
scale_fill_manual(name = "Type of RILD",
values=alpha(c("#926 B8D","#7 aadb1"),0.7),
labels=c("Dense", "Hazy"))





k<-1 #Change k for different time points
ggtern(data=dataset[dataset$date2==a[[k]],c("Hazy","Dense","Com")],
aes(x=Dense , y=Hazy , z=Com)) + geom_point() +
theme_showarrows () + ggtitle(paste(a[[k]], " Months", sep = "")) +
theme(plot.title = element_text(face="bold", hjust = 0.5,vjust =8),
plot.margin = unit(c(0,0,0,0), "cm"))
#Figure 2.15 [2.19 , 2.25]
ggplot(dataset , aes(x=Dose_med , y=Dense.lt0)) +
geom_point(alpha =0.7,col="#926 b8d") +
xlab("Median dose") + ylab("alr(Dense)")+
theme(plot.title = element_text(hjust = 0.5), panel.grid.major =
element_blank(), panel.grid.minor = element_blank(),
panel.background = element_blank(), axis.line = element_line(colour =
"black"),text = element_text(size =16),
legend.position="bottom",legend.title = element_blank ())
ggplot(dataset , aes(x=Dose_med , y=Hazy.lt0)) +
geom_point(alpha =0.7,col="#926 b8d") +
xlab("Median dose") + ylab("alr(Hazy)")+
theme(plot.title = element_text(hjust = 0.5), panel.grid.major =
element_blank(), panel.grid.minor = element_blank(),
panel.background = element_blank(),axis.line = element_line(colour=
"black"),text = element_text(size =16),
legend.position="bottom",legend.title = element_blank ())
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B.2 Chapter 3: Two-part mixed-effects mixture model for zero-inflated longi-
tudinal compositional data
Also available at: https://github.com/vivifj03/TumorModel/blob/master/Code%20chapter3%
20-%20tpmemmzl.R
p.inf.l<-function(x){
#Some propi <-exp(eta)/(1+exp(eta)) can be inf , too small or large ,
#then we are truncating the values
x<-ifelse(is.finite(x),x ,0.999999)
x<-ifelse(x <0.000001 ,0.000001 ,x)
x<-ifelse(x >0.999999 ,0.999999 ,x)
}
p.inf <-function(x){
#Some propi <-exp(eta)/(1+exp(eta)) can be inf , too small or large ,





laplace2 <-function (logpost , mode , ...)
{
options(warn = -1)
fit = optim(mode , logpost , gr = NULL , ..., hessian = FALSE ,
control = list(fnscale = -1))
options(warn = 0)
mode = fit$par
stuff = list(mode = mode , converge = fit$convergence == 0)
return(stuff)
}










eta <- (X %*% Beta) + (Z %*% ram)
propi <-exp(eta)/(1+exp(eta))
propi <-apply(propi , 1, p.inf.l)
eta <- log(propi/(1-propi))
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lu<-sum((U * eta) + log(1-propi))
mat <-Psi_cc.i+D
mat.i<-solve(Psi_cc.i+D)




lklhd.em<-function(id ,datafile ,initial ,X.var=X.var ,Z.var=Z.var ,
X_a.var=X_a.var ,Z_a.var=Z_a.var ,U.var=U.var ,
V1=V1 ,V2=V2){
#Estimation of mixed model for random effects (m)
Beta=initial$Beta
Gamma=initial$Gamma










































H<-Psi_dd -(Psi_dc %*% Psi_cc.i %*% Psi_cd )
H.i<-ginv(H)
X_at<-diag (2) %x% as.matrix(X_a)






Psi_ddcci <-Psi_dc %*% solve(Psi_cc) #Check this in the future
#(when more random effects , if still a vector)
H.vech <-vech(H)
A_a<-matrix(V_a-X_at %*% Gamma)
tempcheck <-ifelse(sum(V_a==0)== length(V_a),0,1) #if sum is zero ,
#then all observations are zero
if(tempcheck ==1){











D<- t(Psi_dc %*% Psi_cc.i) %*% H.i %*% B.i %*% t(Z_at) %*%
Sigma.it %*% Z_at %*% Psi_dc %*% Psi_cc.i
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g_1.T<-E.T+(M_1.T %*% H.i %*% B.i %*% t(Z_at) %*% Sigma.it %*%
Z_at %*% Psi_dc %*% Psi_cc.i)
g_2.T<-E.T+(M_2.T %*% H.i %*% B.i %*% t(Z_at) %*% Sigma.it %*%
Z_at %*% Psi_dc %*% Psi_cc.i)
g.T <- E.T+(M.T %*% H.i %*% B.i %*% t(Z_at) %*% Sigma.it %*%
Z_at %*% Psi_dc %*% Psi_cc.i)
# Max part for m
other <-list(U=U, X=X, Z=Z, Beta=Beta , Psi_cc.i = Psi_cc.i, D=D,
g.To=g_1.T)
c_1t<- laplace2(lap.for.c,c,other)$mode
other <-list(U=U, X=X, Z=Z, Beta=Beta , Psi_cc.i = Psi_cc.i, D=D,
g.To=g_2.T)
c_2t<- laplace2(lap.for.c,c,other)$mode
eta.1<- (X %*% Beta) + (Z %*% c_1t)
propi .1<-exp(eta.1)/(1+exp(eta .1))
propi .1<-apply(propi.1, 1, p.inf)
eta.1<- log(propi.1/(1-propi .1))
W_t.1<- diag(c(propi .1),ncol=length(propi .1)) %*%
diag(c(1-propi .1),ncol=length(propi .1))
G.1<-(t(Z) %*% W_t.1 %*% Z ) + (Psi_cc.i+D)
G.1.i<-solve(G.1)
eta.2<- (X %*% Beta) + (Z %*% c_2t)
propi .2<-exp(eta.2)/(1+exp(eta .2))
propi .2<-apply(propi.2, 1, p.inf)
eta.2<- log(propi.2/(1-propi .2))
W_t.2<- diag(c(propi .2),ncol=length(propi .2)) %*%
diag(c(1-propi .2),ncol=length(propi .2))
G.2<-(t(Z) %*% W_t.2 %*% Z ) + (Psi_cc.i+D)
G.2.i<-solve(G.2)
lu<-sum((U * eta .1) + log(1-propi .1))
qua <- t(c_1t-( solve(Psi_cc.i+D)%*%t(g_1.T))) %*% (Psi_cc.i+D) %*%
(c_1t-( solve(Psi_cc.i+D)%*%t(g_1.T)))
f_1<-lu -((1/2)*qua)
lu<-sum((U * eta .2) + log(1-propi .2))
qua <-t(c_2t-( solve(Psi_cc.i+D)%*%t(g_2.T))) %*% (Psi_cc.i+D) %*%
(c_2t-( solve(Psi_cc.i+D)%*%t(g_2.T)))
f_2<-lu -((1/2)*qua)
m3_t.1<- diag(W_t.1) * (1-2*propi .1)
m4_t.1<- diag(W_t.1 %*% (diag(dim(W_t.1)[1]) -6*W_t.1))
m6_t.1<- m4_t.1*diag(diag(dim(W_t.1)[1]) -12*W_t.1) -(12*(m3_t.1^2))
P1.1<- (1/8)* m4_t.1 %*% diag(Z %*% G.1.i %*% t(Z))^2
P2.1<- (1/48)*t(m6_t.1) %*% diag(Z %*% G.1.i %*% t(Z))^3
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P3.1<- (15/72)* t(colSums(Z * m3_t.1 * diag(Z %*% G.1.i %*%
t(Z)))) %*% G.1.i %*% colSums(Z * m3_t.1 * diag(Z %*%
G.1.i %*% t(Z))) #Check that this runs well with more
# random efects
P.1<- 1 - P1.1 -P2.1 + P3.1
P.1<- ifelse(P.1>=1e-25,P.1 ,0.5)
lf1 <- -(n_a+(q/2))*log(2*pi) - (n_a/2)*log(det(Sigma)) -
(1/2)*log(det(H)) + (1/2)*log(det(B.i)) -
(1/2)*log(det(Psi_cc)) - ((1/2)* t(A_a) %*% (Sigma.it -
Sigma.it %*% Z_at %*% B.i %*% t(Z_at) %*% Sigma.it) %*% A_a) +
(t(A_a) %*% Sigma.it %*% Z_at %*% B.i %*% H.i %*% t(M_1.T)) -
((1/2)*m*t(mu_1) %*% H.i %*% B.i %*% t(Z_at) %*% Sigma.it %*%
Z_at %*% mu_1) + ((1/2)* g_1.T %*% solve(Psi_cc.i+D) %*%
t(g_1.T)) + f_1 + (1/2)*log(det(G.1)) + log(P.1)
f1<-exp(lf1)
m3_t.2<- diag(W_t.2) * (1-2*propi .2)
m4_t.2<- diag(W_t.2 %*% (diag(dim(W_t.2)[1]) -6*W_t.2))
m6_t.2<- m4_t.2*diag(diag(dim(W_t.2)[1]) -12*W_t.2) -(12*m3_t.2^2)
P1.2<- (1/8)* m4_t.2 %*% diag(Z %*% G.2.i %*% t(Z))^2
P2.2<- (1/48)*t(m6_t.2) %*% diag(Z %*% G.2.i %*% t(Z))^3
P3.2<- (15/72)* t(colSums(Z * m3_t.2 * diag(Z %*% G.2.i %*%
t(Z)))) %*% G.2.i %*% colSums(Z * m3_t.2 * diag(Z %*%
G.2.i %*% t(Z))) #Check that this runs well with more random
#efects
P.2<- 1 - P1.2 -P2.2 + P3.2
P.2<- ifelse(P.2>=1e-25,P.1 ,0.5)
lf2 <- -(n_a+(q/2))*log(2*pi) - (n_a/2)*log(det(Sigma)) -
(1/2)*log(det(H)) + (1/2)*log(det(B.i)) -
(1/2)*log(det(Psi_cc)) - ((1/2)* t(A_a) %*% (Sigma.it -
Sigma.it %*% Z_at %*% B.i %*% t(Z_at) %*% Sigma.it) %*% A_a) +
(t(A_a) %*% Sigma.it %*% Z_at %*% B.i %*% H.i %*% t(M_2.T)) -
((1/2)*(1-m)*t(mu_2) %*% H.i %*% B.i %*% t(Z_at) %*%
Sigma.it %*% Z_at %*% mu_2) + ((1/2)* g_2.T %*%







#max part for other par




eta <- (X %*% Beta) + (Z %*% c_t)
propi <-exp(eta)/(1+exp(eta))
propi <-apply(propi , 1, p.inf)
eta <- log(propi/(1-propi))
lu<-sum((U * eta) + log(1-propi))
qua <-t(c_t-( solve(Psi_cc.i+D)%*%t(g.T))) %*% (Psi_cc.i+D) %*%
(c_t-( solve(Psi_cc.i+D)%*%t(g.T)))
f_v2<-lu -((1/2)*qua)
W_t<- diag(c(propi),ncol=length(propi )) %*%
diag(c(1-propi),ncol=length(propi))
U_a<- (diag(1/diag(W_t)) %*% (U - propi )) + eta
G<-(t(Z) %*% W_t %*% Z ) + (Psi_cc.i+D)
G.i<-solve(G)
m3_t<-diag(W_t) * (1-2*propi)




P1<- (1/8)* m4_t %*% diag(Z %*% G.i %*% t(Z))^2
P2<- (1/48)*t(m6_t) %*% diag(Z %*% G.i %*% t(Z))^3
P3<- (15/72) * t(colSums(Z * m3_t * diag(Z %*% G.i %*% t(Z)))) %*%
G.i %*% colSums(Z * m3_t * diag(Z %*% G.i %*% t(Z))) #Check
# that this runs well with more random efects




for (k in 1:nrow(Z)) {
Ki.temp <-t(Z[k,]) %*% m3_t[k] %*% Z[k,] %*% G.i %*% t(Z[k,])
Ki=Ki+Ki.temp }
hi<-matrix(0,nrow=ncol(Z),ncol =ncol(Z) )
for (k in 1:nrow(Z)) {
h.temp <-m3_t[k] %*% G.i %*%t(Z[k,]) %*% (Z[k,] %*% G.i) %*%
(Z[k,] %*% G.i %*% Ki)
hi=hi+h.temp }
fi<-matrix(0,nrow=ncol(Z),ncol =ncol(Z) )
for (k in 1:nrow(Z)) {
fi.temp <-m6_t[k] %*% G.i %*%t(Z[k,]) %*% ((Z[k,] %*% G.i %*%
t(Z[k ,]))^2) %*% (Z[k,] %*% G.i)
fi=fi+fi.temp }
Fi<-matrix(0,nrow=ncol(Z),ncol =ncol(Z) )
for (k in 1:nrow(Z)) {
Fi.temp <-m4_t[k] %*% G.i %*% t(Z[k,]) %*% (Z[k,] %*% G.i %*%




for (k in 1:nrow(Z)) {
Rij[k,1] <- -((1/8)*m5_t[k] %*% (Z[k,] %*% G.i %*% t(Z[k ,]))^2) +
((1/4)* m3_t[k] %*% Z[k,] %*% Fi %*% t(Z[k,])) -
((1/48)*m7_t[k] %*% (Z[k,] %*% G.i %*% t(Z[k ,]))^3) +
((1/16)* m3_t[k] %*% Z[k,] %*% fi %*% t(Z[k,])) -
((15/72)*m3_t[k] %*% (Z[k,] %*% G.i %*% Ki)^2) +
((15/36)* m4_t[k] %*% (t(Ki) %*% G.i %*% t(Z[k,])) %*%
(Z[k,] %*% G.i %*% t(Z[k,]))) - ((15/36)*m3_t[k] %*%
Z[k,] %*% hi %*% t(Z[k,]))
}
Fij <-matrix(0,nrow=nrow(Z),ncol =1)
for (k in 1: nrow(Z)) {
Fij[k,1] <- ((1/4)*m4_t[k] %*% (Z[k,] %*% G.i %*% t(Z[k ,]))) +
((1/16)*m6_t[k] %*% (Z[k,] %*% G.i %*% t(Z[k ,]))^2) -
((15/36)*m3_t[k] %*% (Z[k,] %*% G.i %*% Ki)) }
Yi<- t(Z) %*% W_t %*% (U_a - (eta -(Z %*% c_t))) + t(E.T)
Hi<- t(Z_at) %*% Sigma.it %*% Z_at %*% B.i %*% H.i %*% Psi_dc %*%
Psi_cc.i
Eij.int <-matrix(0,nrow=nrow(Z),ncol =1)
for (k in 1:nrow(Z)) {
Eij.int[k,1] <- t(Z[k,]) %*% (((-1/2)*m3_t[k] %*% (Z[k,] %*% G.i %*%
t(Z[k ,]))) + (U[k] - propi[k]) + (Rij[k]/P) )}
Eij <- t(E.T)-(Psi_cc.i+D)%*%c_t +colSums(Eij.int)
Si<-((t(A_a) %*% Sigma.it %*% Z_at %*% B.i %*% H.i) %x% G.i)-(G.i
%x% t(Yi) %*% G.i %*% t(Hi))-(t(Yi) %*% G.i %x% G.i %*% t(Hi))
ti<- -G.i %*% t(Psi_dc %*% Psi_cc.i) %*% H.i %*% B.i %*% t(Z_at) %*%
Sigma.it %*% X_at
Di<- -(t(Yi) %*% G.i %x% G.i)
Mi<- -(t(Yi) %*% G.i %*% t(Psi_dc %*% Psi_cc.i) %*% t(Z_at) %*%
Sigma.it %*% Z_at %*% B.i %x% (G.i %*% t(Psi_dc %*% Psi_cc.i)))+
(t(A_a) %*% Sigma.it %*% Z_at %*% B.i %x% (G.i %*% t(Psi_dc %*%
Psi_cc.i)))- (t(A_a) %*% Sigma.it %*% Z_at %*% B.i %x% (G.i %*%
t(Psi_dc %*% Psi_cc.i) %*% H.i %*% B.i))+ (t(Yi) %*% G.i %*%
t(Psi_dc %*% Psi_cc.i) %*% t(Z_at) %*% Sigma.it %*% Z_at %*% B.i
%x% (G.i %*% t(Psi_dc %*% Psi_cc.i) %*% H.i %*% B.i))
Pi<- (t(Yi) %*% G.i %*% t(Psi_dc %*% Psi_cc.i) %*% t(Z_at) %*%
Sigma.it %*% Z_at %*% B.i %*% t(Z_at) %x% (G.i %*% t(Psi_dc %*%
Psi_cc.i) %*% H.i %*% B.i %*% t(Z_at)))-(t(Yi) %*% G.i %*%
t(Psi_dc %*% Psi_cc.i) %*% t(Z_at) %x% (G.i %*% t(Psi_dc %*%
Psi_cc.i) %*% H.i %*% B.i %*% t(Z_at)))-(t(A_a) %*% Sigma.it %*%
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Z_at %*% B.i %*% t(Z_at) %x% (G.i %*% t(Psi_dc %*% Psi_cc.i) %*%
H.i %*% B.i %*% t(Z_at)))+ (t(A_a) %x% (G.i %*% t(Psi_dc %*%
Psi_cc.i)%*% H.i %*% B.i %*% t(Z_at)))
#Score vectors
S_b.int1 <-matrix(0,nrow=nrow(Z),ncol=ncol(X))
for (k in 1:nrow(Z)) {
S_b.int1[k,]<-c(((-1/2)*m3_t[k] %*% (Z[k,] %*% G.i %*% t(Z[k ,])))) *




for (k in 1:nrow(Z)) {









S_g<-(t(X_at) %*% Sigma.it %*% V_a) - (t(X_at) %*% Sigma.it %*%
Z_at %*% B.i %*% t(Z_at) %*% Sigma.it %*% V_a) - (t(X_at) %*%
Sigma.it %*% X_at %*% Gamma) + (t(X_at) %*% Sigma.it %*%
Z_at %*% B.i %*% t(Z_at) %*% Sigma.it %*% X_at %*% Gamma) -
(t(X_at) %*% Sigma.it %*% Z_at %*% B.i %*% H.i %*% Psi_dc %*%
Psi_cc.i %*% c_t) + (t(ti) %*% Eij)
mu_1<-matrix(mu_1,ncol =1)
S_mu.int1 <- (H.i %*% B.i %*% t(Z_at) %*% Sigma.it %*% Z_at)
S_mu.int2 <- (t(Z_at) %*% Sigma.it %*% Z_at %*% B.i %*% H.i)
S_mu.int3 <- (S_mu.int1 + S_mu.int2) %*% mu_1
S_mu.int4 <- -(1/2)*(m+((m^2)/(1-m)))
S_mu<- c(S_mu.int4) * S_mu.int3
S_pcc.int1 <-ifelse(q==1,t((Psi_cc.i %x% Psi_cc.i)),t((Psi_cc.i %x%
Psi_cc.i) %*% duplication.matrix(n=q)))
S_pcc.int2 <-matrix(0,nrow=ncol(Z)*ncol(Z),ncol=ni)
for (k in 1:nrow(Z)) {
S_pcc.int2[,k]<- vec(G.i %*% t(Z[k,]) %*% Z[k,] %*% G.i) * Fij[k]}
S_pcc.int2 <-rowSums(S_pcc.int2)
S_pcc <- -S_pcc.int1 %*% ( (1/2)*vec(Psi_cc - G.i - c_t %*% t(c_t)) +
t(Di) %*% Eij + (1/P) %*% ( S_pcc.int2 - (15/72)*vec(G.i %*%
Ki %*% t(Ki) %*% G.i ) ) )
S_pcc <- as.matrix(apply(S_pcc , 1, function(x) {ifelse(abs(x)<1e-1 &
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x!=0, 0, x)}),ncol =1)
S_pdc.int1 <-matrix(0,nrow=ncol(Z_at)*ncol(Z),ncol=ni)
for (k in 1:nrow(Z)) {
S_pdc.int1[,k]<- vec(Hi %*% G.i %*% t(Z[k,]) %*% Z[k,] %*% G.i) *
Fij[k]}
S_pdc.int1 <-rowSums(S_pdc.int1)
S_pdc <- -(diag(x = 1, ncol(Z)) %x% Hi) %*% (vec(G.i) + vec(c_t %*%
t(c_t))) + vec(H.i %*% B.i %*% t(Z_at) %*% Sigma.it %*%
A_a %*% t(c_t)) + t(Si) %*% Eij + c(2/P) * (S_pdc.int1 -
(15/36) * vec(Hi %*% G.i %*% Ki %*% t(Ki) %*% G.i))
S_h.int1 <-matrix(0,nrow=ncol(Z_at)*2,ncol=ni)
for (k in 1:nrow(Z)) {
S_h.int1[,k]<- vec((diag(x = 1, ncol(Z_at)) - B.i %*% H.i) %*%
Psi_dc %*% Psi_cc.i %*% G.i %*% t(Z[k,]) %*%
Z[k,] %*% G.i %*% t(Psi_dc %*% Psi_cc.i) %*%
t(Z_at) %*% Sigma.it %*% Z_at %*% B.i) * Fij[k]}
S_h.int1 <-rowSums(S_h.int1)
S_h<-t((-H.i %x% H.i) %*% duplication.matrix(n=ncol(Z_at))) %*%
(-(1/2)*((B.i %*% t(Z_at) %*% Sigma.it %*% Z_at %*% Psi_dc %*%
Psi_cc.i %x% (Psi_dc %*% Psi_cc.i))-(B.i %*% H.i %*% Psi_dc %*%
Psi_cc.i %x%(B.i %*% t(Z_at) %*% Sigma.it %*% Z_at %*% Psi_dc %*%
Psi_cc.i))) %*% vec(G.i) + (1/2)*vec(H - B.i - B.i %*%
t(Z_at) %*% Sigma.it %*% A_a %*% t(A_a) %*% Sigma.it %*% Z_at %*%
B.i + c(m) * B.i %*% t(Z_at) %*% Sigma.it %*% Z_at %*% mu_1 %*%
t(mu_1) %*% H.i %*% B.i - c(m)*B.i %*% t(Z_at) %*% Sigma.it %*%
Z_at %*% mu_1 %*% t(mu_1)+(1 -c(m)) * B.i %*% t(Z_at) %*%
Sigma.it %*% Z_at %*% mu_2 %*% t(mu_2) %*% H.i %*% B.i -
(1-c(m))*B.i %*% t(Z_at) %*% Sigma.it %*% Z_at %*% mu_2%*%
t(mu_2)-Psi_dc %*% Psi_cc.i %*% c_t %*% t(c_t) %*% t(Psi_dc %*%
Psi_cc.i) %*% t(Z_at) %*% Sigma.it %*% Z_at %*% B.i + 2*B.i %*%
t(Z_at) %*% Sigma.it %*% A_a %*% t(c_t) %*% t(Psi_dc %*%
Psi_cc.i) + (B.i %*% H.i %*% Psi_dc %*% Psi_cc.i %*% c_t %*%
t(c_t) %*% t(Psi_dc %*% Psi_cc.i) %*% t(Z_at) %*% Sigma.it %*%
Z_at %*% B.i) - 2*B.i %*% t(Z_at) %*% Sigma.it %*% A_a %*%
t(c_t) %*% t(Psi_dc %*% Psi_cc.i) %*% H.i %*% B.i) + t(Mi)%*%
Eij + c(1/P)*(S_h.int1 - (15/72)*vec((diag(x = 1, ncol(Z_at))
-B.i %*% H.i) %*% Psi_dc %*% Psi_cc.i %*% G.i %*% Ki %*%
t(Ki) %*% G.i %*% t(Psi_dc %*% Psi_cc.i) %*% t(Z_at) %*%
Sigma.it %*% Z_at %*% B.i) ) )
S_sigma.int1 <-matrix(0,nrow=(dim(Sigma.it)[1]*dim(Sigma.it)[2]) ,
ncol=nrow(Z))
for (k in 1:nrow(Z)) {
S_sigma.int1[,k]<- vec(Z_at %*% B.i %*% H.i %*% (Psi_dc %*%
Psi_cc.i) %*% G.i %*% t(Z[k,]) %*% Z[k,] %*%
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G.i %*% t(Psi_dc %*% Psi_cc.i) %*%
(t(Z_at)-t(Z_at) %*% Sigma.it %*% Z_at %*%
B.i %*% t(Z_at))) * Fij[k]}
S_sigma.int1 <-rowSums(S_sigma.int1)
S_sigma.int2 <- ((1/2)*vec(- Z_at %*% B.i %*% t(Z_at) - A_a %*%
t(A_a) + (2*A_a %*% t(A_a) %*% Sigma.it %*% Z_at %*%
B.i %*% t(Z_at)) - Z_at %*% B.i %*% t(Z_at) %*%
Sigma.it %*% A_a %*% t(A_a) %*% Sigma.it %*% Z_at %*%
B.i %*% t(Z_at))- (c(m)/2)*vec(Z_at %*% B.i %*% H.i %*%
mu_1 %*% t(mu_1) %*% t(Z_at)- Z_at %*% B.i %*% H.i %*%
mu_1 %*% t(mu_1) %*% t(Z_at) %*% Sigma.it %*% Z_at %*%
B.i %*% t(Z_at))-((1-c(m))/2)*vec(Z_at %*% B.i %*%
H.i %*% mu_2 %*% t(mu_2) %*% t(Z_at)- Z_at %*% B.i %*%
H.i %*% mu_2 %*% t(mu_2) %*% t(Z_at) %*% Sigma.it %*%
Z_at %*% B.i %*% t(Z_at))+t(Pi) %*% Eij - (1/2)*
(((Z_at %*% B.i %*% H.i %*% Psi_dc %*% Psi_cc.i) %x%
(Z_at %*% Psi_dc %*% Psi_cc.i))-((Z_at %*% B.i %*%
H.i %*% Psi_dc %*% Psi_cc.i) %x% (Z_at %*% B.i %*%
t(Z_at) %*% Sigma.it %*% Z_at %*% Psi_dc %*%
Psi_cc.i))) %*% vec(G.i)+(1/2)*vec(-(Z_at %*% B.i %*%
H.i %*% Psi_dc %*% Psi_cc.i %*% c_t %*% t(c_t) %*%
t(Psi_dc %*% Psi_cc.i) %*% t(Z_at))+(Z_at %*% B.i %*%
H.i %*% Psi_dc %*% Psi_cc.i %*% c_t %*% t(c_t) %*%
t(Psi_dc %*% Psi_cc.i) %*% t(Z_at) %*% Sigma.it %*%
Z_at %*% B.i %*% t(Z_at))+2*(A_a %*% t(c_t) %*%
t(Psi_dc %*% Psi_cc.i) %*% H.i %*% B.i %*% t(Z_at))-
2*(Z_at %*% B.i %*% t(Z_at) %*% Sigma.it %*% A_a %*%
t(c_t) %*% t(Psi_dc %*% Psi_cc.i) %*% H.i %*% B.i %*%
t(Z_at )))+(1/c(P))*(S_sigma.int1 - (15/72)*vec(Z_at %*%
B.i %*% H.i %*% (Psi_dc %*% Psi_cc.i) %*% G.i %*%
Ki %*% t(Ki) %*% G.i %*% t(Psi_dc %*% Psi_cc.i) %*%
(t(Z_at)-t(Z_at) %*% Sigma.it %*% Z_at %*% B.i %*%
t(Z_at)))) )
Q_sigma <-(diag (2) %x% commutation.matrix(ni, 2) %x% diag(ni)) %*%
(diag (2) %x% diag (2) %x% vec(diag(ni)))
S_sigma.int3 <- t((-Sigma.i %x% Sigma.i) %*%
duplication.matrix(n=ncol(Z_at))) %*%
((n_a/2)*vec(Sigma) )
S_sigma <- S_sigma.int3 - t(duplication.matrix(n=2)) %*% t(Q_sigma) %*%
(t(Sigma.it) %x% Sigma.it) %*% S_sigma.int2
S<-as.matrix(c(S_b=S_b,S_g=S_g,S_mu=S_mu,S_sigma=S_sigma ,S_pcc=S_pcc ,
S_pdc=S_pdc ,S_h=S_h),nrow=23,ncol =1)













lklhd.dev <-function(id ,datafile ,initial ,X.var=X.var ,Z.var=Z.var ,
X_a.var=X_a.var ,Z_a.var=Z_a.var ,U.var=U.var ,V1=V1,V2=V2){
#This function calculates the Deviance
Beta=initial$Beta
Gamma=initial$Gamma










































H<-Psi_dd -(Psi_dc %*% Psi_cc.i %*% Psi_cd )
H.i<-ginv(H)
X_at<-diag (2) %x% as.matrix(X_a)






Psi_ddcci <-Psi_dc %*% solve(Psi_cc) #Check this in the future
#(when more random effects , if still a vector)
H.vech <-vech(H)
A_a<-matrix(V_a-X_at %*% Gamma)
tempcheck <-ifelse(sum(V_a==0)== length(V_a),0,1) #if sum is zero ,
# the all observations are zero
if(tempcheck ==1){











D<- t(Psi_dc %*% Psi_cc.i) %*% H.i %*% B.i %*% t(Z_at) %*%
Sigma.it %*% Z_at %*% Psi_dc %*% Psi_cc.i
g_1.T<-E.T+(M_1.T %*% H.i %*% B.i %*% t(Z_at) %*% Sigma.it %*%
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Z_at %*% Psi_dc %*% Psi_cc.i)
g_2.T<-E.T+(M_2.T %*% H.i %*% B.i %*% t(Z_at) %*% Sigma.it %*%
Z_at %*% Psi_dc %*% Psi_cc.i)
g.T <- E.T+(M.T %*% H.i %*% B.i %*% t(Z_at) %*% Sigma.it %*%
Z_at %*% Psi_dc %*% Psi_cc.i)
#max part for other par
other <-list(U=U, X=X, Z=Z, Beta=Beta , Psi_cc.i = Psi_cc.i, D=D,
g.To=E.T)
c_t<- laplace2(lap.for.c,c,other)$mode
eta <- (X %*% Beta) + (Z %*% c_t)
propi <-exp(eta)/(1+exp(eta))
propi <-apply(propi , 1, p.inf)
eta <- log(propi/(1-propi))
lu<-sum((U * eta) + log(1-propi))
qua <-t(c_t-( solve(Psi_cc.i+D)%*%t(g.T))) %*% (Psi_cc.i+D) %*%
(c_t-( solve(Psi_cc.i+D)%*%t(g.T)))
f_v2<-lu -((1/2)*qua)
W_t<- diag(c(propi),ncol=length(propi )) %*%
diag(c(1-propi),ncol=length(propi))
U_a<- (diag(1/diag(W_t)) %*% (U - propi )) + eta
G<-(t(Z) %*% W_t %*% Z ) + (Psi_cc.i+D)
G.i<-solve(G)
m3_t<-diag(W_t) * (1-2*propi)




P1<- (1/8)* m4_t %*% diag(Z %*% G.i %*% t(Z))^2
P2<- (1/48)*t(m6_t) %*% diag(Z %*% G.i %*% t(Z))^3
P3<- (15/72) * t(colSums(Z * m3_t * diag(Z %*% G.i %*% t(Z)))) %*%
G.i %*% colSums(Z * m3_t * diag(Z %*% G.i %*% t(Z))) #Check
#that this runs well with more random efects
P<- (1 - P1 - P2 + P3)
P<- ifelse(P>1e-25,P,0.5)
#loglike
lf<- -(n_a+(q/2))*log(2*pi) - (n_a/2)*log(det(Sigma)) -
(1/2)*log(det(H)) + (1/2)*log(det(B.i)) - (1/2)*log(det(Psi_cc)) -
((1/2)* t(A_a) %*% (Sigma.it - Sigma.it %*% Z_at %*% B.i %*%
t(Z_at) %*% Sigma.it) %*% A_a) + (t(A_a) %*% Sigma.it %*% Z_at %*%
B.i %*% H.i %*% t(M.T)) - ((1/2)*(m)*t(mu_1) %*% H.i %*% B.i %*%
t(Z_at) %*% Sigma.it %*% Z_at %*% mu_1) - ((1/2)*(1-m)*t(mu_2) %*%
H.i %*% B.i %*% t(Z_at) %*% Sigma.it %*% Z_at %*% mu_2) +
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lklhd.var <-function(id ,datafile ,est ,X.var=X.var ,Z.var=Z.var ,X_a.var=
X_a.var ,Z_a.var=Z_a.var ,U.var=U.var ,V1=V1,V2=V2){














































H<-Psi_dd -(Psi_dc %*% Psi_cc.i %*% Psi_cd )
H.i<-ginv(H)
X_at<-diag (2) %x% as.matrix(X_a)






Psi_ddcci <-Psi_dc %*% solve(Psi_cc) #Check this in the future (when
#more random effects , if still a vector)
H.vech <-vech(H)
A_a<-matrix(V_a-X_at %*% Gamma)
tempcheck <-ifelse(sum(V_a==0)== length(V_a),0,1) #if sum is zero , the
#all observations are zero
if(tempcheck ==1){











D<- t(Psi_dc %*% Psi_cc.i) %*% H.i %*% B.i %*% t(Z_at) %*%
Sigma.it %*% Z_at %*% Psi_dc %*% Psi_cc.i
g_1.T<-E.T+(M_1.T %*% H.i %*% B.i %*% t(Z_at) %*% Sigma.it %*%
Z_at %*% Psi_dc %*% Psi_cc.i)
g_2.T<-E.T+(M_2.T %*% H.i %*% B.i %*% t(Z_at) %*% Sigma.it %*%
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Z_at %*% Psi_dc %*% Psi_cc.i)
g.T <- E.T+(M.T %*% H.i %*% B.i %*% t(Z_at) %*% Sigma.it %*%
Z_at %*% Psi_dc %*% Psi_cc.i)
#max part for other par
other <-list(U=U, X=X, Z=Z, Beta=Beta , Psi_cc.i = Psi_cc.i, D=D,
g.To=E.T)
c_t<- laplace2(lap.for.c,c,other)$mode
eta <- (X %*% Beta) + (Z %*% c_t)
propi <-exp(eta)/(1+exp(eta))
propi <-apply(propi , 1, p.inf)
eta <- log(propi/(1-propi))
lu<-sum((U * eta) + log(1-propi))
qua <-t(c_t-( solve(Psi_cc.i+D)%*%t(g.T))) %*% (Psi_cc.i+D) %*%
(c_t-( solve(Psi_cc.i+D)%*%t(g.T)))
f_v2<-lu -((1/2)*qua)
W_t<- diag(c(propi),ncol=length(propi )) %*%
diag(c(1-propi),ncol=length(propi))
U_a<- (diag(1/diag(W_t)) %*% (U - propi )) + eta
G<-(t(Z) %*% W_t %*% Z ) + (Psi_cc.i+D)
G.i<-solve(G)
m3_t<-diag(W_t) * (1-2*propi)




P1<- (1/8)* m4_t %*% diag(Z %*% G.i %*% t(Z))^2
P2<- (1/48)*t(m6_t) %*% diag(Z %*% G.i %*% t(Z))^3
P3<- (15/72) * t(colSums(Z * m3_t * diag(Z %*% G.i %*% t(Z)))) %*%
G.i %*% colSums(Z * m3_t * diag(Z %*% G.i %*% t(Z))) #Check
#that this runs well with more random efects




for (k in 1:nrow(Z)) {
Ki.temp <-t(Z[k,]) %*% m3_t[k] %*% Z[k,] %*% G.i %*% t(Z[k,])
Ki=Ki+Ki.temp }
hi<-matrix(0,nrow=ncol(Z),ncol =ncol(Z) )
for (k in 1:nrow(Z)) {
h.temp <-m3_t[k] %*% G.i %*%t(Z[k,]) %*% (Z[k,] %*% G.i) %*%




for (k in 1:nrow(Z)) {
fi.temp <-m6_t[k] %*% G.i %*%t(Z[k,]) %*% ((Z[k,] %*% G.i %*%
t(Z[k ,]))^2) %*% (Z[k,] %*% G.i)
fi=fi+fi.temp }
Fi<-matrix(0,nrow=ncol(Z),ncol =ncol(Z) )
for (k in 1:nrow(Z)) {
Fi.temp <-m4_t[k] %*% G.i %*% t(Z[k,]) %*% (Z[k,] %*% G.i %*%
t(Z[k,])) %*% (Z[k,] %*% G.i)
Fi=Fi+Fi.temp }
Rij <-matrix(0,nrow=nrow(Z),ncol =1)
for (k in 1:nrow(Z)) {
Rij[k,1] <- -((1/8)*m5_t[k] %*% (Z[k,] %*% G.i %*% t(Z[k ,]))^2) +
((1/4)* m3_t[k] %*% Z[k,] %*% Fi %*% t(Z[k,])) -
((1/48)*m7_t[k] %*% (Z[k,] %*% G.i %*% t(Z[k ,]))^3) +
((1/16)* m3_t[k] %*% Z[k,] %*% fi %*% t(Z[k,])) -
((15/72)*m3_t[k] %*% (Z[k,] %*% G.i %*% Ki)^2) +
((15/36)* m4_t[k] %*% (t(Ki) %*% G.i %*% t(Z[k,])) %*%
(Z[k,] %*% G.i %*% t(Z[k,]))) -
((15/36)*m3_t[k] %*% Z[k,] %*% hi %*% t(Z[k,]))
}
Fij <-matrix(0,nrow=nrow(Z),ncol =1)
for (k in 1: nrow(Z)) {
Fij[k,1] <- ((1/4)*m4_t[k] %*% (Z[k,] %*% G.i %*% t(Z[k ,]))) +
((1/16)*m6_t[k] %*% (Z[k,] %*% G.i %*% t(Z[k ,]))^2) -
((15/36)*m3_t[k] %*% (Z[k,] %*% G.i %*% Ki)) }
Yi<- t(Z) %*% W_t %*% (U_a - (eta -(Z %*% c_t))) + t(E.T)
Hi<- t(Z_at) %*% Sigma.it %*% Z_at %*% B.i %*% H.i %*% Psi_dc %*%
Psi_cc.i
Eij.int <- matrix(0,nrow=nrow(Z),ncol =1)
for (k in 1:nrow(Z)) {
Eij.int[k,1] <- t(Z[k,]) %*% (((-1/2)*m3_t[k] %*% (Z[k,] %*% G.i %*%
t(Z[k ,]))) + (U[k] - propi[k]) + (Rij[k]/P) )}
Eij <- t(E.T)-(Psi_cc.i+D)%*%c_t +colSums(Eij.int)
Si<-((t(A_a) %*% Sigma.it %*% Z_at %*% B.i %*% H.i) %x% G.i)-(G.i %x%
t(Yi) %*% G.i %*% t(Hi))-(t(Yi) %*% G.i %x% G.i %*% t(Hi))
ti<- -G.i %*% t(Psi_dc %*% Psi_cc.i) %*% H.i %*% B.i %*% t(Z_at) %*%
Sigma.it %*% X_at
Di<- -(t(Yi) %*% G.i %x% G.i)
Mi<- -(t(Yi) %*% G.i %*% t(Psi_dc %*% Psi_cc.i) %*% t(Z_at) %*%
Sigma.it %*% Z_at %*% B.i %x% (G.i %*% t(Psi_dc %*% Psi_cc.i)))+
(t(A_a) %*% Sigma.it %*% Z_at %*% B.i %x% (G.i %*% t(Psi_dc %*%
Psi_cc.i)))-(t(A_a) %*% Sigma.it %*% Z_at %*% B.i %x% (G.i %*%
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t(Psi_dc %*% Psi_cc.i) %*% H.i %*% B.i))+(t(Yi) %*% G.i %*%
t(Psi_dc %*% Psi_cc.i) %*% t(Z_at) %*% Sigma.it %*% Z_at %*%
B.i %x% (G.i %*% t(Psi_dc %*% Psi_cc.i) %*% H.i %*% B.i))
Pi<- (t(Yi) %*% G.i %*% t(Psi_dc %*% Psi_cc.i) %*% t(Z_at) %*%
Sigma.it %*% Z_at %*% B.i %*% t(Z_at) %x% (G.i %*% t(Psi_dc %*%
Psi_cc.i) %*% H.i %*% B.i %*% t(Z_at)))-(t(Yi) %*% G.i %*%
t(Psi_dc %*% Psi_cc.i) %*% t(Z_at) %x% (G.i %*% t(Psi_dc %*%
Psi_cc.i) %*% H.i %*% B.i %*% t(Z_at)))-(t(A_a) %*% Sigma.it %*%
Z_at %*% B.i %*% t(Z_at) %x% (G.i %*% t(Psi_dc %*% Psi_cc.i) %*%
H.i %*% B.i %*% t(Z_at)))+(t(A_a) %x% (G.i %*% t(Psi_dc %*%
Psi_cc.i)%*% H.i %*% B.i %*% t(Z_at)))
#Score vectors
S_b.int1 <-matrix(0,nrow=nrow(Z),ncol=ncol(X))
for (k in 1:nrow(Z)) {
S_b.int1[k,]<-c(((-1/2)*m3_t[k] %*% (Z[k,] %*% G.i %*% t(Z[k ,])))) *




for (k in 1:nrow(Z)) {









S_g<-(t(X_at) %*% Sigma.it %*% V_a) - (t(X_at) %*% Sigma.it %*%
Z_at %*% B.i %*% t(Z_at) %*% Sigma.it %*% V_a) - (t(X_at) %*%
Sigma.it %*% X_at %*% Gamma) + (t(X_at) %*% Sigma.it %*%
Z_at %*% B.i %*% t(Z_at) %*% Sigma.it %*% X_at %*% Gamma) -
(t(X_at) %*% Sigma.it %*% Z_at %*% B.i %*% H.i %*% Psi_dc %*%
Psi_cc.i %*% c_t) + (t(ti) %*% Eij)
mu_1<-matrix(mu_1,ncol =1)
S_mu.int1 <- (H.i %*% B.i %*% t(Z_at) %*% Sigma.it %*% Z_at)
S_mu.int2 <- (t(Z_at) %*% Sigma.it %*% Z_at %*% B.i %*% H.i)
S_mu.int3 <- (S_mu.int1 + S_mu.int2) %*% mu_1
S_mu.int4 <- -(1/2)*(m+((m^2)/(1-m)))
S_mu<- c(S_mu.int4) * S_mu.int3




for (k in 1:nrow(Z)) {
S_pcc.int2[,k]<- vec(G.i %*% t(Z[k,]) %*% Z[k,] %*% G.i) * Fij[k]}
S_pcc.int2 <-rowSums(S_pcc.int2)
S_pcc <- -S_pcc.int1 %*% ( (1/2)*vec(Psi_cc - G.i - c_t %*% t(c_t)) +
t(Di) %*% Eij + (1/P) %*% ( S_pcc.int2 - (15/72)*vec(G.i %*%
Ki %*% t(Ki) %*% G.i ) ) )
S_pcc <- as.matrix(apply(S_pcc , 1, function(x) {ifelse(abs(x)<1e-1 &
x!=0, 0, x)}),ncol =1)
S_pdc.int1 <-matrix(0,nrow=ncol(Z_at)*ncol(Z),ncol=ni)
for (k in 1:nrow(Z)) {
S_pdc.int1[,k]<- vec(Hi %*% G.i %*% t(Z[k,]) %*% Z[k,] %*% G.i) *
Fij[k]}
S_pdc.int1 <-rowSums(S_pdc.int1)
S_pdc <- -(diag(x = 1, ncol(Z)) %x% Hi) %*% (vec(G.i) + vec(c_t %*%
t(c_t))) + vec(H.i %*% B.i %*% t(Z_at) %*% Sigma.it %*%
A_a %*% t(c_t)) + t(Si) %*% Eij + c(2/P) * (S_pdc.int1 -
(15/36) * vec(Hi %*% G.i %*% Ki %*% t(Ki) %*% G.i))
S_h.int1 <-matrix(0,nrow=ncol(Z_at)*2,ncol=ni)
for (k in 1:nrow(Z)) {
S_h.int1[,k]<- vec((diag(x = 1, ncol(Z_at)) - B.i %*% H.i) %*%
Psi_dc %*% Psi_cc.i %*% G.i %*% t(Z[k,]) %*%
Z[k,] %*% G.i %*% t(Psi_dc %*% Psi_cc.i) %*%
t(Z_at) %*% Sigma.it %*% Z_at %*% B.i) *
Fij[k]}
S_h.int1 <-rowSums(S_h.int1)
S_h<-t((-H.i %x% H.i) %*% duplication.matrix(n=ncol(Z_at))) %*%
( -(1/2)*((B.i %*% t(Z_at) %*% Sigma.it %*% Z_at %*% Psi_dc %*%
Psi_cc.i %x% (Psi_dc %*% Psi_cc.i))- (B.i %*% H.i %*% Psi_dc %*%
Psi_cc.i %x%(B.i %*% t(Z_at) %*% Sigma.it %*% Z_at %*% Psi_dc %*%
Psi_cc.i))) %*% vec(G.i) + (1/2)*vec(H - B.i - B.i %*%
t(Z_at) %*% Sigma.it %*% A_a %*% t(A_a) %*% Sigma.it %*% Z_at %*%
B.i + c(m) * B.i %*% t(Z_at) %*% Sigma.it %*% Z_at %*% mu_1 %*%
t(mu_1) %*% H.i %*% B.i - c(m)*B.i %*% t(Z_at) %*% Sigma.it %*%
Z_at %*% mu_1 %*% t(mu_1)+(1 -c(m)) * B.i %*% t(Z_at) %*%
Sigma.it %*% Z_at %*% mu_2 %*% t(mu_2) %*% H.i %*% B.i -
(1-c(m))*B.i %*% t(Z_at) %*% Sigma.it %*% Z_at %*% mu_2 %*%
t(mu_2)-Psi_dc %*% Psi_cc.i %*% c_t %*% t(c_t) %*% t(Psi_dc %*%
Psi_cc.i) %*% t(Z_at) %*% Sigma.it %*% Z_at %*% B.i + 2*B.i %*%
t(Z_at) %*% Sigma.it %*% A_a %*% t(c_t) %*% t(Psi_dc %*%
Psi_cc.i) + (B.i %*% H.i %*% Psi_dc %*% Psi_cc.i %*% c_t %*%
t(c_t) %*% t(Psi_dc %*% Psi_cc.i) %*% t(Z_at) %*% Sigma.it %*%
Z_at %*% B.i) - 2*B.i %*% t(Z_at) %*% Sigma.it %*% A_a %*%
t(c_t) %*% t(Psi_dc %*% Psi_cc.i) %*% H.i %*% B.i) + t(Mi)%*%
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Eij + c(1/P)*(S_h.int1 - (15/72)*vec((diag(x = 1, ncol(Z_at))-
B.i %*% H.i) %*% Psi_dc %*% Psi_cc.i %*% G.i %*% Ki %*% t(Ki) %*%
G.i %*% t(Psi_dc %*% Psi_cc.i) %*% t(Z_at) %*% Sigma.it %*%
Z_at %*% B.i) ) )
S_sigma.int1 <-matrix(0,nrow=(dim(Sigma.it)[1]*dim(Sigma.it)[2]) ,
ncol=nrow(Z))
for (k in 1:nrow(Z)) {
S_sigma.int1[,k]<- vec(Z_at %*% B.i %*% H.i %*% (Psi_dc %*%
Psi_cc.i) %*% G.i %*% t(Z[k,]) %*% Z[k,] %*%
G.i %*% t(Psi_dc %*% Psi_cc.i) %*%
(t(Z_at)-t(Z_at) %*% Sigma.it %*% Z_at %*%
B.i %*% t(Z_at))) * Fij[k]}
S_sigma.int1 <-rowSums(S_sigma.int1)
S_sigma.int2 <- ((1/2)*vec(- Z_at %*% B.i %*% t(Z_at) -A_a %*% t(A_a)+
(2*A_a %*% t(A_a) %*% Sigma.it %*% Z_at %*% B.i %*%
t(Z_at)) -Z_at %*% B.i %*% t(Z_at) %*% Sigma.it %*%
A_a %*% t(A_a) %*% Sigma.it %*% Z_at %*% B.i %*%
t(Z_at))-(c(m)/2)*vec(Z_at %*% B.i %*% H.i %*% mu_1 %*%
t(mu_1) %*% t(Z_at)- Z_at %*% B.i %*% H.i %*% mu_1 %*%
t(mu_1) %*% t(Z_at) %*% Sigma.it %*% Z_at %*% B.i %*%
t(Z_at))-((1-c(m))/2)*vec(Z_at %*% B.i %*% H.i %*%
mu_2 %*% t(mu_2) %*% t(Z_at)- Z_at %*% B.i %*% H.i %*%
mu_2 %*% t(mu_2) %*% t(Z_at) %*% Sigma.it %*% Z_at %*%
B.i %*% t(Z_at))+t(Pi) %*% Eij - (1/2)* (((Z_at %*%
B.i %*% H.i %*% Psi_dc %*% Psi_cc.i) %x% (Z_at %*%
Psi_dc %*% Psi_cc.i))-((Z_at %*% B.i %*% H.i %*%
Psi_dc %*% Psi_cc.i) %x% (Z_at %*% B.i %*% t(Z_at) %*%
Sigma.it %*% Z_at %*% Psi_dc %*% Psi_cc.i))) %*%
vec(G.i)+(1/2)*vec(-(Z_at %*% B.i %*% H.i %*% Psi_dc %*%
Psi_cc.i %*% c_t %*% t(c_t) %*% t(Psi_dc %*%
Psi_cc.i) %*% t(Z_at))+(Z_at %*% B.i %*% H.i %*%
Psi_dc %*% Psi_cc.i %*% c_t %*% t(c_t) %*% t(Psi_dc %*%
Psi_cc.i) %*% t(Z_at) %*% Sigma.it %*% Z_at %*% B.i %*%
t(Z_at))+2*(A_a %*% t(c_t) %*% t(Psi_dc %*% Psi_cc.i) %*%
H.i %*% B.i %*% t(Z_at))-2*(Z_at %*% B.i %*% t(Z_at) %*%
Sigma.it %*% A_a %*% t(c_t) %*% t(Psi_dc %*%
Psi_cc.i) %*% H.i %*% B.i %*%t(Z_at))) +(1/c(P))*
(S_sigma.int1 - (15/72)*vec(Z_at %*% B.i %*% H.i %*%
(Psi_dc %*% Psi_cc.i) %*% G.i %*% Ki %*% t(Ki) %*%
G.i %*% t(Psi_dc %*% Psi_cc.i) %*% (t(Z_at)-t(Z_at) %*%
Sigma.it %*% Z_at %*% B.i %*% t(Z_at)))) )
Q_sigma <-(diag (2) %x% commutation.matrix(ni, 2) %x% diag(ni)) %*%
(diag (2) %x% diag (2) %x% vec(diag(ni)))




S_sigma <- S_sigma.int3 - t(duplication.matrix(n=2)) %*% t(Q_sigma) %*%
(t(Sigma.it) %x% Sigma.it) %*% S_sigma.int2
for(l in 1: length(S_b)){
S_b[l]<-ifelse(is.na(S_b[l])==T,0,S_b[l])
}
for(l in 1: length(S_g)){
S_g[l]<-ifelse(is.na(S_g[l])==T,0,S_g[l])
}
for(l in 1: length(S_mu)){
S_mu[l]<-ifelse(is.na(S_mu[l])==T,0,S_mu[l])
}
S_0b <- S_b %*% t(S_b)
S_0g <- S_g %*% t(S_g)







lklhd.ram <-function(id ,datafile ,est ,X.var=X.var ,Z.var=Z.var ,
X_a.var=X_a.var ,Z_a.var=Z_a.var ,U.var=U.var ,V1=V1,V2=V2,
sim =10000){













































H<-Psi_dd-Psi_dc %*% Psi_cc.i %*% Psi_cd
H.i<-ginv(H)
X_at<-diag (2) %x% as.matrix(X_a)






Psi_ddcci <-Psi_dc %*% solve(Psi_cc) #Check this in the future (when
#more random effects , if still a vector)
H.vech <-vech(H)
A_a<-matrix(V_a-X_at %*% Gamma)
tempcheck <-ifelse(sum(V_a==0)== length(V_a),0,1) #if sum is zero ,
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#the all observations are zero
if(tempcheck ==1){






E.T<-t(A_a) %*% Sigma.it %*% Z_at %*% B.i %*% H.i %*% Psi_dc %*%
Psi_cc.i
D<- Psi_cc.i %*% Psi_cd %*% H.i %*% B.i %*% t(Z_at) %*% Sigma.it %*%
Z_at %*% Psi_dc %*% Psi_cc.i
g_1.T<-E.T+(t(mu_1) %*% H.i %*% B.i %*% t(Z_at) %*% Sigma.it %*%
Z_at %*% Psi_dc %*% Psi_cc.i)
g_2.T<-E.T+(t(mu_2) %*% H.i %*% B.i %*% t(Z_at) %*% Sigma.it %*%
Z_at %*% Psi_dc %*% Psi_cc.i)
c<-as.matrix(rep(0,length(Z.var)),ncol =1)
other <-list(U=U, X=X, Z=Z, Beta=Beta , Psi_cc.i = Psi_cc.i, D=D,
g.To=E.T)
c_t<- laplace2(lap.for.c,c,other)$mode
#Here I had to truncate c to get better predictions but I will have to
# check later
c_t <- ifelse(c_t>60,60,c_t)
eta <- (X %*% Beta) + (Z %*% c_t)
propi <-exp(eta)/(1+exp(eta))
propi <-apply(propi , 1, p.inf)
eta <- log(propi/(1-propi))
W_t<- diag(c(propi),ncol=length(propi )) %*%
diag(c(1-propi),ncol=length(propi))
G<-(t(Z) %*% W_t %*% Z ) + (Psi_cc.i+D)
G.i.ram <-solve(G)
random <-matrix(data=NA ,nrow=sim ,ncol =15)
colnames(random)<-c("c","cc^t","g","q","w","cw","cc^tw","d1.1","d1.2",
"d2.1","d2.2","d1.1w","d1.2w","d2.1w","d2.2w")
#random [,1]<-rmvt(sim , sigma = G.i.ram , df = 4, delta = c_t,type =
c("shifted")) #With more RE in c, the multivariate f
#unction must be used
random [,1]<-rep(101,sim)
for(e in 1:sim){
while (random[e,1] >100) {
random[e,1] <-rt(1, df=4, ncp=c_t)
}
#random[e,1] <-rt(1, df=4, ncp=c_t)
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random[e,2] <-random[e,1]*random[e,1]
random[e,8:9] <- (mu_1 + (Psi_dc %*% Psi_cc.i * random[e ,1])) +
(B.i %*% ((t(Z_at) %*% Sigma.it %*% A_a) -
(t(Z_at) %*% Sigma.it %*% Z_at %*% Psi_dc %*%
Psi_cc.i * random[e,1]) ))
random[e ,10:11] <- (mu_2 + (Psi_dc %*% Psi_cc.i * random[e ,1])) +
(B.i %*% ((t(Z_at) %*% Sigma.it %*% A_a) -
(t(Z_at) %*% Sigma.it %*% Z_at %*% Psi_dc %*%
Psi_cc.i * random[e,1]) ))
}
for(e in 1:sim){
#random[e,3] <-dmvt(random[e,1],sigma = G.i.ram , df = 4, delta = c_t,
#type = c(" shifted ")) #With more RE in c, the
#multivariate function must be used
random[e,3] <-dt(random[e,1], df=4, ncp=c_t)
random[e,4] <-dmvnorm(random[e,1], mean = rep(0, q), sigma = Psi_cc ,
log = FALSE)
eta <- (X %*% Beta) + (Z %*% random[e,1])
propi <-exp(eta)/(1+exp(eta))
propi <-apply(propi , 1, p.inf)
eta <- log(propi/(1-propi))
lu<-sum((U * eta) + log(1-propi))
lf1 <- m*exp( (t(A_a) %*% Sigma.it %*% Z_at %*% B.i %*% H.i %*%
mu_1) - (1/2)*(t(mu_1) %*% H.i %*% B.i %*% t(Z_at) %*%
Sigma.it %*% Z_at %*% mu_1))* exp((E.T %*% random[e,1]) -
(t(mu_1) %*% H.i %*% B.i %*% t(Z_at) %*% Sigma.it %*% Z_at %*%
Psi_dc %*% Psi_cc.i %*% random[e,1]) - (1/2)*
(t(random[e,1]) %*% D %*% random[e,1]) )
lf2 <- (1-m)*exp( (t(A_a) %*% Sigma.it %*% Z_at %*% B.i %*% H.i %*%
mu_2) - (1/2)*(t(mu_2) %*% H.i %*% B.i %*% t(Z_at) %*%
Sigma.it %*% Z_at %*% mu_2))*exp((E.T %*% random[e,1]) -
(t(mu_2) %*% H.i %*% B.i %*% t(Z_at) %*% Sigma.it %*% Z_at %*%
Psi_dc %*% Psi_cc.i %*% random[e,1]) - (1/2)*
(t(random[e,1])%*% D %*% random[e,1]) )
lf<- -(n_a+(q/2))*log(2*pi) - (n_a/2)*log(det(Sigma)) -(1/2)*
log(det(H)) + (1/2)*log(det(B.i)) - ((1/2)* t(A_a) %*%
(Sigma.it - Sigma.it %*% Z_at %*% B.i %*% t(Z_at) %*%
Sigma.it) %*% A_a) + log(lf1 + lf2)
qu<- exp(lu) * exp(lf)
random[e,4] <- random[e,4]*qu
random[e,4] <-ifelse(is.finite(random[e,4]), random[e,4] ,0)
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random[v,4] <-dmvnorm(random[v,1], mean = rep(0, q), sigma =








random [,5]<-random [,4]/random [,3]
sumsum <-ifelse(is.infinite(sum(random [,5]*random [,5])) &
sum(random [,5]*random [,5])<0 ,0,1)
while (sumsum <1e-10) {
random [,4]<-random [,4]*(1e+10)
random [,5]<-random [,4]/random [,3]
sumsum <-ifelse(is.infinite(sum(random [,5]*random [,5])) &
sum(random [,5]*random [,5])<0 ,0,1)
}
sumsum <-ifelse(is.infinite(sum(random [,5]*random [,5])) &
sum(random [,5]*random [,5])>0 ,0,1)
while (sumsum <1e-10) {
random [,4]<-random [,4]/(1e+10)
random [,5]<-random [,4]/random [,3]
sumsum <-ifelse(is.infinite(sum(random [,5]*random [,5])) &





#### estimates without adjustments on weights
random [,6]<-random [,1]*random [,5]
random [,7]<-random [,2]*random [,5]
random [,12] <-random [,8]*random [,5]
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random [,13] <-random [,9]*random [,5]
random [,14] <-random [,10]*random [,5]
random [,15] <-random [,11]*random [,5]
random <- random[complete.cases(random), ]
c.est <- mean(random [,6])/ mean(random [,5])
#c.est <- ifelse(c.est < -100,-100,c.est)
#c.est <- ifelse(c.est > 100,100,c.est)
cc.t.est <- mean(random [,7])/ mean(random [,5])
d1.est <- (m*mean(random [,12])/ mean(random [,5])) +
((1-m)*mean(random [,14])/ mean(random [,5]))
d2.est <- (m*mean(random [,13])/ mean(random [,5])) +
((1-m)*mean(random [,15])/ mean(random [,5]))
mean.w<-mean(random [,5])
ess1 <-(( random [,5]/mean.w)-1)^2
ess1 <-sum(ess1)
ess1 <- sqrt(ess1/nrow(random ))
ess2 <-(sum(random [ ,5])^2)/sum(random [,5]*random [,5])
ram.est <-list(c_t=c_t,c.est=c.est ,cc.t.est=cc.t.est ,d1.est=d1.est ,






























random.t <- random.t[complete.cases(random.t), ]
c.est.t <- mean(random.t[,6])/ mean(random.t[,5])
cc.t.est.t <- mean(random.t[,7])/ mean(random.t[,5])
d1.est.t <- (m*mean(random.t[,12])/ mean(random.t[,5])) +
((1-m)*mean(random.t[,14])/ mean(random.t[,5]))











r_eff <- relative_eff(random.p[,5], chain_id = rep(1,sim))
psis_result <- psis(log_ratios , r_eff = r_eff)
random.p[,5]<-weights(psis_result , log=FALSE , normalize = FALSE)
sumsum <-ifelse(is.infinite(sum(random.p[,5]*random.p[,5])) &
sum(random.p[,5]*random.p[,5])<0 ,0,1)






















random.p <- random.p[complete.cases(random.p), ]
c.est.p <- mean(random.p[,6])/ mean(random.p[,5])
cc.t.est.p <- mean(random.p[,7])/ mean(random.p[,5])
d1.est.p <- (m*mean(random.p[,12])/ mean(random.p[,5])) +
((1-m)*mean(random.p[,14])/ mean(random.p[,5]))













B.3 Chapter 4: Simulation assessing model performance




## Simulation base on spherical data
set.seed (124)
for (n in c(300 ,500 ,1000)) {
for (ni in c(3,4,5)) {
for (rp in 1:1000) {
# Dose




Dose <- rep(Dose ,times=ni)
id <- rep (1:n,times=ni)
t <- c(3,6,12,18,24)/12
t <- t[1:ni]
time <- rep(t, each=n)
data <- as.data.frame(cbind(id ,Dose ,time))
data$time2 <- (data$time )^2
data$int <- 1
data <- data[,c("id","int","Dose","time","time2")]




mu_1 <- c( -0.1 ,0.1)
mu_2 <- -(m/(1-m))*mu_1
Psi_diag <-diag(sqrt(c(1 ,0.5 ,1)))
R <- matrix(c(1 ,0.1 ,0.2 ,0.1 ,1 ,0.1 ,0.2 ,0.1 ,1) , nrow = 3)
Psi <-Psi_diag %*% R %*% Psi_diag
Psi_cc <- as.matrix(Psi[1,1])
Psi_dd <- as.matrix(Psi [2:3 ,2:3])





mu1 <- matrix(c(0,mu_1),ncol = 1)





Var.V2),nrow = 2,ncol = 2)
Beta <- as.matrix(c(-10,1.5,-2,-3),ncol =1)
Gamma <- as.matrix(c(-7,1,0.5,-1,
-3,2,0.5,-1),ncol =1)
b <- (m*mvrnorm(n = n, mu1 , Psi ))+((1 -m)*mvrnorm(n = n, mu2 ,
Psi))
d <- data.frame(b[,2:3],i=rep(1:ni,ea=n))





X <- as.matrix(dataU [,-1])
Z <- as.matrix(dataU[,c("int")])
Zc <- (Z * c)
logit_U <- X %*% Beta + Zc
pU <- exp(logit_U)/(1+ exp(logit_U))
U <-rbinom(length(pU),1,pU)
ps<-prop.table(table(U))[2]
Zd1 <- Z * d[,1]
Zd2 <- Z * d[,2]
X <- as.matrix(data[,-1])
Z <- as.matrix(data[,c("int")])
V1 <- X %*% Gamma [1:4 ,] + Zd1 + e[,1]
V2 <- X %*% Gamma [5:8 ,] + Zd2 + e[,2]




sim.val <-c(Beta=Beta ,Gamma=Gamma , Psi_cc=Psi_cc ,Psi_dd=Psi_dd ,
































n<- NUMBER #300, 500, 1000
rp<-REP #1-1000





###### Mixed effects logistic regression - gets initial values
#This models is using time in years
data <-dataset
inicio.naive <-Sys.time()
md1 <- glmer(nonZeroHD ~ Dose + time + time2 + (1 | patch),
data = data , family = binomial ,





temp$V1u <- ifelse(temp$V1u==0,NA ,temp$V1u)
temp$V2u <- ifelse(temp$V2u==0,NA ,temp$V2u)
temp <- temp[is.na(temp$V1u )==F | is.na(temp$V1u )==F,]
md2d2 <- lmer(V1u ~ Dose + time + time2 + (1| patch),
data = temp , control = lmerControl(optCtrl=
list(maxfun =2e10 )))
md2d2.r<-ranef(md2d2)
md2h2 <- lmer(V2u ~ Dose + time + time2 + (1| patch),
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data = temp , control = lmerControl(optCtrl=
list(maxfun =2e10 )))
md2h2.r<-ranef(md2h2)
# Predictions in naive model =====================================
coefp <- md1@beta
temp2 <-unlist(unique(temp$patch ))
temp2 <-cbind(temp2 ,md2d2.r$patch [,1])











data <-merge(data ,temp2 ,by="patch", all.x = T)
coefd <- md2d2@beta
coefh <- md2h2@beta
data$naive.p1 <- predict(md1 , type = "response")
data$naive.d<- coefd [1] + coefd [2]*data$Dose + coefd [3]*data$time +
coefd [4]*data$time2 + data$d1
data$naive.h<- coefh [1] + coefh [2]*data$Dose + coefh [3]*data$time +
coefh [4]*data$time2 + data$d2
data$naive.dr<- data$V1u - data$naive.d
data$naive.hr<- data$V2u - data$naive.h
data$V1u.e<-ifelse(data$V1u==0,0,exp(data$V1u))
data$V2u.e<-ifelse(data$V2u==0,0,exp(data$V2u))
data$naive.de<- data$naive.p1 * exp(data$naive.d) *
mean(exp(md2d2@resp$wtres))
data$naive.he<- data$naive.p1 * exp(data$naive.h) *
mean(exp(md2h2@resp$wtres))
data$naive.res.de<- data$V1u.e - data$naive.de

































# Likelihood (tpmemmzl) ===========================================
#Initial values
#Ocurrence variable
Beta <- as.matrix(md1@beta ,ncol =1)
if ((( md1@theta )^2) <0.1) {
#In case the initial value of Psi_cc was zero then put a small value













nrow = length(md2d2@theta )+ length(md2h2@theta),
ncol = length(md2d2@theta )+ length(md2h2@theta ))





#random efects between models
m<-0.55 #set probability for normal mixture distribution for
#random effects
mu_1<-c( -0.05 ,0.05) #Set mean first normal dristribution for
#random effects
par.l<-list(Beta=Beta ,Gamma=Gamma , Psi_cc=Psi_cc ,Psi_dd=Psi_dd ,
Var.V1=Var.V1 ,Var.V2=Var.V2 ,corr=corr ,
Psi_dc=Psi_dc ,m=m,mu_1=mu_1)
par <-c(Beta=Beta ,Gamma=Gamma , Psi_cc=Psi_cc ,Psi_dd=Psi_dd ,










source("tpmemmzl.R") #code in Chapter 3
# Deviance with the sim values
sim <-par.l
sim$Beta <-as.matrix(sim.val[1:4] , ncol =1)
sim$Gamma <-as.matrix(sim.val [5:12] , ncol =1)
sim$Psi_cc<-as.matrix(sim.val[13], ncol =1)





sim$Psi_dc<-matrix(c(sim.val [21:22]) , nrow=2,ncol =1)
sim$m<-sim.val [23]
sim$mu_1<-matrix(c(sim.val [24:25]) , nrow=2,ncol =1)





t.dev <-matrix(0,nrow=length(in.dev), ncol = 1)




### Estimation of fixed effects ####################################
inicio.coef <-Sys.time()
maxit =1000 #For empirical bayes estimates
step=1
criterion =0
estimate <- vector("list", maxit +1)
estimate [[1]] <-par.l
dif.theta <- vector("list", maxit)
rel.dif.theta <- vector("list", maxit)
dev <-vector("numeric", maxit)
reldev <-vector("numeric", maxit)










solve(par.l$Psi_cc) %*% t(par.l$Psi_dc)) ))





t.dev <-matrix(0,nrow=length(in.dev), ncol = 1)




dev [[1]] <- -2*colSums(t.dev)
print(dev [[1]])













solve(par.l$Psi_cc) %*% t(par.l$Psi_dc)) ))
theta0 <-theta






subm <-matrix(0,nrow=length(t), ncol = 1)
for (i in 1: length(t)) {
subm[i,1] <-t[[i]]$m
}
score <-matrix(0,nrow=length(t), ncol = length(t[[1]]$scorei ))




for (i in trunk) {
cuts <-0+3*sd(score[,i])




score <-colSums(score ,na.rm = T)
theta <-theta+score
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#Check values of Sigma , Psi_cc














corr.test <-theta [16]/(sqrt(theta [15])*sqrt(theta [17]))
while (corr.test <= ( -0.95)) {
corr.test0 <- theta0 [16]/(sqrt(theta0 [15])*sqrt(theta0 [17]))
#corr.test1 <- theta [16]/(sqrt(theta [15])*sqrt(theta [17]))
corr.test1 <- -0.90
corr.new <- (corr.test0+corr.test1)/2
theta [16] <-corr.new*sqrt(theta [15])*sqrt(theta [17])
corr.test <-theta [16]/(sqrt(theta [15])*sqrt(theta [17]))
}
while (corr.test >= 0.95) {
corr.test0 <- theta0 [16]/(sqrt(theta0 [15])*sqrt(theta0 [17]))
#corr.test1 <- theta [16]/(sqrt(theta [15])*sqrt(theta [17]))
corr.test1 <- 0.90
corr.new <- (corr.test0+corr.test1)/2
theta [16] <-corr.new*sqrt(theta [15])*sqrt(theta [17])
corr.test <-theta [16]/(sqrt(theta [15])*sqrt(theta [17]))
}
















Beta=matrix(theta [1:4], ncol =1)
Gamma=matrix(theta [5:12] , ncol =1)
mu_1= matrix(theta [13:14] , ncol =1)
Var.V1=theta [15]
Var.V2=theta [17]
corr=theta [16]/(sqrt(theta [15])*sqrt(theta [17]))
Psi_cc=matrix(theta [18], ncol =1)
Psi_dc.i=matrix(theta [19:20] , ncol =1)
Psi_dc=Psi_dc.i%*%Psi_cc
Psi_cd=t(Psi_dc)
H<-matrix(c(theta [21],rep(theta [22],2), theta [23]) , ncol =2)
# Check H is positive define
while (det(H) <= 0 )
{
theta [21] <- (theta0 [21]+ theta [21])/2
theta [22] <- (theta0 [22]+ theta [22])/2
theta [23] <- (theta0 [23]+ theta [23])/2
H<-matrix(c(theta [21],rep(theta [22],2), theta [23]) , ncol =2)
}












H<-matrix(c(theta [21], theta [22], theta [22], theta [23]) , ncol =2)
while (det(H) <= 0 )
{
theta [21] <- (theta0 [21]+ theta [21])/2
theta [22] <- (theta0 [22]+ theta [22])/2
theta [23] <- (theta0 [23]+ theta [23])/2




par.l<-list(Beta=Beta ,Gamma=Gamma , Psi_cc=Psi_cc ,Psi_dd=Psi_dd ,









t.dev <-matrix(0,nrow=length(in.dev), ncol = 1)




print( paste("new deviance",dev[[step ]]))
#Step -halving in case deviance is larger than previous iteration
reldev [[step]]<-((dev[[step]] - dev[[step -1]])/(0.1 +
abs(dev[[step ]])) )
loop3 <-0
if (reldev [[step ]]>=1e-8){
ii<-1
while (reldev [[step]] >-1e-8) {



















t.dev <-matrix(0,nrow=length(in.dev), ncol = 1)




reldev [[step]]<-((dev[[step]] - dev[[step -1]])/(0.1 +
abs(dev[[step ]])) )















solve(par.l$Psi_cc) %*% t(par.l$Psi_dc)) ))
estimate [[step]]<-par.l
eu.dis[step] <-(dist(rbind(theta0 ,theta), method =
"euclidean")^2)/length(theta)
dif.theta[[step]] <- (theta0 -theta)
rel.dif.theta[[step]] <- (theta -theta0)/theta
absdev <-ifelse(step==2,1,abs(dev[[step]] - dev[[step -1]]))
criterion.step <-ifelse(step <=maxit ,0,1)
criterion.distance <-ifelse(max(abs(dif.theta [[step ]]))>1e-8,0,1)




















### Standard errors ###############################################





S_0b.total <-matrix(0,nrow=4, ncol = 4)
S_0g.total <-matrix(0,nrow=8, ncol = 8)
S_0mu.total <-matrix(0,nrow=2, ncol = 2)









bias <-par.final -sim.val #Bias
rel.bias <-bias*100/sim.val #Relative Bias
sqrt(diag(S_0b.total.i)) #SE for occurence model
sqrt(diag(S_0g.total.i)) #SE for intensity model
se.final1 <-c(sqrt(diag(S_0b.total.i)),sqrt(diag(S_0g.total.i)))
lci1 <-par.final [1:12] -(1.96*se.final1)
uci1 <-par.final [1:12]+(1.96*se.final1)
coverage1 <-rep(0 ,12)





### Random effects #################################################
try(if(criterion.step ==1) stop("estimation did not converge"))
iniciop <-Sys.time()







### Predicted values ################################################
#Predicted using basic EB RE
ran.est <- as.data.frame(matrix(NA ,length(patch ),7))
ran.est[,1] <- patch











dataset <-dataset [ ,1:11]
dataset$V1u.e<-ifelse(dataset$nonZeroHD ==0,0,exp(dataset$V1))
dataset$V2u.e<-ifelse(dataset$nonZeroHD ==0,0,exp(dataset$V2))
dataset <-merge(dataset ,ran.est ,by="patch",all.x = T)
dataset$logp.1 <- par.l$Beta [1] + par.l$Beta [2] * dataset$Dose +
par.l$Beta [3] * dataset$time + par.l$Beta [4] * dataset$time2 +
dataset$c.est
dataset$odds.1 <- exp(dataset$logp .1)
dataset$p.1 <- dataset$odds.1 / (1 + dataset$odds .1)
dataset$subpred1 <- par.l$Gamma [1] + par.l$Gamma [2] * dataset$Dose +
par.l$Gamma [3] * dataset$time + par.l$Gamma [4] * dataset$time2 +
dataset$d1.est
dataset$subpred2 <- par.l$Gamma [5] + par.l$Gamma [6] * dataset$Dose +
par.l$Gamma [7] * dataset$time + par.l$Gamma [8] * dataset$time2 +
dataset$d2.est
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dataset$subres1 <- dataset$V1u -dataset$subpred1
dataset$subres2 <- dataset$V2u -dataset$subpred2
duan1 <- mean(exp(dataset[dataset$nonZeroHD ==1,"subres1"]))



































#Best possible score is 1.0
#Predicted using truncated EB RE
dataset.t<-dataset [ ,1:13]
ran.est <- as.data.frame(matrix(NA ,length(patch ),7))
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ran.est[,1] <- patch











dataset.t<-merge(dataset.t,ran.est ,by="patch",all.x = T)
dataset.t$logp.1 <- par.l$Beta [1] +par.l$Beta [2] * dataset.t$Dose +
par.l$Beta [3] * dataset.t$time + par.l$Beta [4] * dataset.t$time2 +
dataset.t$c.est
dataset.t$odds.1 <- exp(dataset.t$logp .1)
dataset.t$p.1 <- dataset.t$odds.1 / (1 + dataset.t$odds .1)
dataset.t$subpred1 <- par.l$Gamma [1]+ par.l$Gamma [2]*dataset.t$Dose +
par.l$Gamma [3] * dataset.t$time + par.l$Gamma [4]*dataset.t$time2 +
dataset.t$d1.est
dataset.t$subpred2 <- par.l$Gamma [5] +par.l$Gamma [6]*dataset.t$Dose +
par.l$Gamma [7] * dataset.t$time + par.l$Gamma [8] * dataset.t$time2 +
dataset.t$d2.est
dataset.t$subres1 <- dataset.t$V1u -dataset.t$subpred1
dataset.t$subres2 <- dataset.t$V2u -dataset.t$subpred2
duan1 <- mean(exp(dataset.t[dataset.t$nonZeroHD ==1,"subres1"]))

































#Predicted using pareto EB RE
dataset.p<-dataset [ ,1:13]
ran.est <- as.data.frame(matrix(NA ,length(patch ),7))
ran.est[,1] <- patch











dataset.p<-merge(dataset.p,ran.est ,by="patch",all.x = T)
dataset.p$logp.1 <- par.l$Beta [1]+ par.l$Beta [2]*dataset.p$Dose +
par.l$Beta [3] * dataset.p$time + par.l$Beta [4]*dataset.p$time2 +
dataset.p$c.est
dataset.p$odds.1 <- exp(dataset.p$logp .1)
dataset.p$p.1 <- dataset.p$odds.1 / (1 + dataset.p$odds .1)
dataset.p$subpred1 <- par.l$Gamma [1]+ par.l$Gamma [2]*dataset.p$Dose +
par.l$Gamma [3] * dataset.p$time + par.l$Gamma [4]*dataset.p$time2 +
dataset.p$d1.est
dataset.p$subpred2 <- par.l$Gamma [5]+ par.l$Gamma [6]*dataset.p$Dose +
par.l$Gamma [7] * dataset.p$time + par.l$Gamma [8] * dataset.p$time2 +
180
dataset.p$d2.est
dataset.p$subres1 <- dataset.p$V1u -dataset.p$subpred1
dataset.p$subres2 <- dataset.p$V2u -dataset.p$subpred2
duan1 <- mean(exp(dataset.p[dataset.p$nonZeroHD ==1,"subres1"]))





































# Combine Simulation Results =======================================
files1 <-list.files(path = "s1/300/3/pred/",pattern = "*.RData")
files2 <-list.files(path = "s1/300/4/pred/",pattern = "*.RData")
files3 <-list.files(path = "s1/300/5/pred/",pattern = "*.RData")
files4 <-list.files(path = "s1/500/3/pred/",pattern = "*.RData")
files5 <-list.files(path = "s1/500/4/pred/",pattern = "*.RData")
files6 <-list.files(path = "s1/500/5/pred/",pattern = "*.RData")
files7 <-list.files(path = "s1/1000/3/pred/",pattern = "*.RData")
files8 <-list.files(path = "s1/1000/4/pred/",pattern = "*.RData")
files9 <-list.files(path = "s1/1000/5/pred/",pattern = "*.RData")




NN<- c(300 ,500 ,1000)
prop <- c(3,4,5)
tot <-length(rp)*length(NN)*length(prop)
results <-as.data.frame(matrix(0,nrow =tot ,ncol = 280))
line <-1
for (i in 1:3) {
for (k in 1:1000) {
for (g in 1:3) {
results[line ,1] <- NN[i]
results[line ,2] <- prop[g]

















naive <- as.data.frame(matrix(0,nrow =tot2 ,ncol = 57))
naive [ ,1:5] <- results [ ,1:5]
V1 <- as.data.frame(matrix(0,nrow =tot2 ,ncol = 19))







for (l in 1:tot2) {
load(file = results[l,4])
naive[l,6:9] <- coefp
naive[l ,10:13] <- coefd
naive[l ,14:17] <- coefh
naive[l ,18:21] <- sqrt(diag(vcov(md1)))
naive[l ,22:25] <- sqrt(diag(vcov(md2d2 )))






































results[l ,129:153] <- initial.val
results[l ,154:178] <-par.final -initial.val
results[l ,179:203] <-(par.final -initial.val)*100/initial.val
coverage3 <-rep(0 ,12)













results[l ,224] <-end.coef -inicio.coef
results[l ,225] <-ps
results[l ,226] <-max(abs(dif.theta[[step ]]))
results[l ,227] <-max(abs(rel.dif.theta[[step ]]))
results[l ,228] <-absdev





results[l ,278] <- dev[[step]]
results[l ,279] <- dev0



















































































































































































# This code uses the compile simulation
# (scenario|sample size|RILD proportion)




#First , delete objects we do not need
rm(list=setdiff(ls(), c("results", "resultsold", "naive", "V1", "V2",
"V1.m", "V2.m", "V1_t", "V2_t", "V1.m_t",
"V2.m_t", "V1_p", "V2_p", "V1.m_p", "V2.m_p")))
# We need to trimm the outliers.
# We did 1% (0.5% at each end)
# Next lines , find the cutoff for trimming
resultsorig <-results
results.p05 <-aggregate(results[,c(1:2 ,6:30)] ,
by = list(results$N,results$ni),
function(x) quantile(x, c(.005) , na.rm=T))
results.p995 <-aggregate(results[,c(1:2 ,6:30)] ,
by = list(results$N,results$ni),
function(x) quantile(x, c(.995) , na.rm=T))
# Next lines are very inefficient and take long time but they






























beta1a <-results.p05[results.p05$N==N & results.p05$ni==ni ,"beta1"]
beta2a <-results.p05[results.p05$N==N & results.p05$ni==ni ,"beta2"]
beta3a <-results.p05[results.p05$N==N & results.p05$ni==ni ,"beta3"]
beta4a <-results.p05[results.p05$N==N & results.p05$ni==ni ,"beta4"]
gamma1a <-results.p05[results.p05$N==N & results.p05$ni==ni ,"gamma1"]
gamma2a <-results.p05[results.p05$N==N & results.p05$ni==ni ,"gamma2"]
gamma3a <-results.p05[results.p05$N==N & results.p05$ni==ni ,"gamma3"]
gamma4a <-results.p05[results.p05$N==N & results.p05$ni==ni ,"gamma4"]
gamma5a <-results.p05[results.p05$N==N & results.p05$ni==ni ,"gamma5"]
gamma6a <-results.p05[results.p05$N==N & results.p05$ni==ni ,"gamma6"]
gamma7a <-results.p05[results.p05$N==N & results.p05$ni==ni ,"gamma7"]
gamma8a <-results.p05[results.p05$N==N & results.p05$ni==ni ,"gamma8"]
Psi_cca <-results.p05[results.p05$N==N & results.p05$ni==ni ,"Psi_cc"]
Psi_dd1a <-results.p05[results.p05$N==N & results.p05$ni==ni ,"Psi_dd1"]
Psi_dd2a <-results.p05[results.p05$N==N & results.p05$ni==ni ,"Psi_dd2"]
Psi_dd3a <-results.p05[results.p05$N==N & results.p05$ni==ni ,"Psi_dd3"]
Psi_dd4a <-results.p05[results.p05$N==N & results.p05$ni==ni ,"Psi_dd4"]
Var.V1a <-results.p05[results.p05$N==N & results.p05$ni==ni ,"Var.V1"]
Var.V2a <-results.p05[results.p05$N==N & results.p05$ni==ni ,"Var.V2"]
corra <-results.p05[results.p05$N==N & results.p05$ni==ni,"corr"]
Psi_dc1a <-results.p05[results.p05$N==N & results.p05$ni==ni ,"Psi_dc1"]
Psi_dc2a <-results.p05[results.p05$N==N & results.p05$ni==ni ,"Psi_dc2"]
ma<-results.p05[results.p05$N==N & results.p05$ni==ni ,"m"]
mu_1_1a<-results.p05[results.p05$N==N & results.p05$ni==ni ,"mu_1_1"]
mu_1_2a<-results.p05[results.p05$N==N & results.p05$ni==ni ,"mu_1_2"]
beta1b <-results.p995[results.p995$N==N & results.p995$ni==ni ,"beta1"]
beta2b <-results.p995[results.p995$N==N & results.p995$ni==ni ,"beta2"]
beta3b <-results.p995[results.p995$N==N & results.p995$ni==ni ,"beta3"]
beta4b <-results.p995[results.p995$N==N & results.p995$ni==ni ,"beta4"]
gamma1b <-results.p995[results.p995$N==N & results.p995$ni==ni ,"gamma1"]
gamma2b <-results.p995[results.p995$N==N & results.p995$ni==ni ,"gamma2"]
gamma3b <-results.p995[results.p995$N==N & results.p995$ni==ni ,"gamma3"]
gamma4b <-results.p995[results.p995$N==N & results.p995$ni==ni ,"gamma4"]
gamma5b <-results.p995[results.p995$N==N & results.p995$ni==ni ,"gamma5"]
gamma6b <-results.p995[results.p995$N==N & results.p995$ni==ni ,"gamma6"]
gamma7b <-results.p995[results.p995$N==N & results.p995$ni==ni ,"gamma7"]
gamma8b <-results.p995[results.p995$N==N & results.p995$ni==ni ,"gamma8"]
Psi_ccb <-results.p995[results.p995$N==N & results.p995$ni==ni ,"Psi_cc"]
Psi_dd1b <-results.p995[results.p995$N==N & results.p995$ni==ni ,"Psi_dd1"]
Psi_dd2b <-results.p995[results.p995$N==N & results.p995$ni==ni ,"Psi_dd2"]
Psi_dd3b <-results.p995[results.p995$N==N & results.p995$ni==ni ,"Psi_dd3"]
Psi_dd4b <-results.p995[results.p995$N==N & results.p995$ni==ni ,"Psi_dd4"]
Var.V1b <-results.p995[results.p995$N==N & results.p995$ni==ni ,"Var.V1"]
Var.V2b <-results.p995[results.p995$N==N & results.p995$ni==ni ,"Var.V2"]
corrb <-results.p995[results.p995$N==N & results.p995$ni==ni,"corr"]
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Psi_dc1b <-results.p995[results.p995$N==N & results.p995$ni==ni ,"Psi_dc1"]
Psi_dc2b <-results.p995[results.p995$N==N & results.p995$ni==ni ,"Psi_dc2"]
mb<-results.p995[results.p995$N==N & results.p995$ni==ni ,"m"]
mu_1_1b<-results.p995[results.p995$N==N & results.p995$ni==ni ,"mu_1_1"]
mu_1_2b<-results.p995[results.p995$N==N & results.p995$ni==ni ,"mu_1_2"]
results[j,]$beta1trim <-ifelse(results[j,]$beta1 <beta1a |
results[j,]$beta1 >beta1b ,1,0)
results[j,]$beta2trim <-ifelse(results[j,]$beta2 <beta2a |
results[j,]$beta2 >beta2b ,1,0)
results[j,]$beta3trim <-ifelse(results[j,]$beta3 <beta3a |
results[j,]$beta3 >beta3b ,1,0)
results[j,]$beta4trim <-ifelse(results[j,]$beta4 <beta4a |
results[j,]$beta4 >beta4b ,1,0)
results[j,]$gamma1trim <-ifelse(results[j,]$gamma1 <gamma1a |
results[j,]$gamma1 >gamma1b ,1,0)
results[j,]$gamma2trim <-ifelse(results[j,]$gamma2 <gamma2a |
results[j,]$gamma2 >gamma2b ,1,0)
results[j,]$gamma3trim <-ifelse(results[j,]$gamma3 <gamma3a |
results[j,]$gamma3 >gamma3b ,1,0)
results[j,]$gamma4trim <-ifelse(results[j,]$gamma4 <gamma4a |
results[j,]$gamma4 >gamma4b ,1,0)
results[j,]$gamma5trim <-ifelse(results[j,]$gamma5 <gamma5a |
results[j,]$gamma5 >gamma5b ,1,0)
results[j,]$gamma6trim <-ifelse(results[j,]$gamma6 <gamma6a |
results[j,]$gamma6 >gamma6b ,1,0)
results[j,]$gamma7trim <-ifelse(results[j,]$gamma7 <gamma7a |
results[j,]$gamma7 >gamma7b ,1,0)
results[j,]$gamma8trim <-ifelse(results[j,]$gamma8 <gamma8a |
results[j,]$gamma8 >gamma8b ,1,0)
results[j,]$Psi_cctrim <-ifelse(results[j,]$Psi_cc <Psi_cca |
results[j,]$Psi_cc >Psi_ccb ,1,0)
results[j,]$Psi_dd1trim <-ifelse(results[j,]$Psi_dd1 <Psi_dd1a |
results[j,]$Psi_dd1 >Psi_dd1b ,1,0)
results[j,]$Psi_dd2trim <-ifelse(results[j,]$Psi_dd2 <Psi_dd2a |
results[j,]$Psi_dd2 >Psi_dd2b ,1,0)
results[j,]$Psi_dd3trim <-ifelse(results[j,]$Psi_dd3 <Psi_dd3a |
results[j,]$Psi_dd3 >Psi_dd3b ,1,0)
results[j,]$Psi_dd4trim <-ifelse(results[j,]$Psi_dd4 <Psi_dd4a |
results[j,]$Psi_dd4 >Psi_dd4b ,1,0)
results[j,]$Var.V1trim <-ifelse(results[j,]$Var.V1 <Var.V1a |
results[j,]$Var.V1 >Var.V1b ,1,0)
results[j,]$Var.V2trim <-ifelse(results[j,]$Var.V2 <Var.V2a |
results[j,]$Var.V2 >Var.V2b ,1,0)
results[j,]$corrtrim <-ifelse(results[j,]$corr <corra |
results[j,]$corr >corrb ,1,0)
results[j,]$Psi_dc1trim <-ifelse(results[j,]$Psi_dc1 <Psi_dc1a |
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results[j,]$Psi_dc1 >Psi_dc1b ,1,0)
results[j,]$Psi_dc2trim <-ifelse(results[j,]$Psi_dc2 <Psi_dc2a |
results[j,]$Psi_dc2 >Psi_dc2b ,1,0)






results$trim <-ifelse(results$beta1trim ==1 & results$beta2trim ==1 &
results$beta3trim ==1 & results$beta4trim ==1,1,0)
resultstrim <-results[results$trim ==0,] #this data set deletes the
#simulations where the betas are outliers (all of them)
#summary
#Predictions - Estimates convergence
conv.summary <-aggregate(resultstrim$criterion.step ,
by = list(resultstrim$N,resultstrim$ni), length)
ps.summary <-aggregate(resultstrim$ps ,
by = list(resultstrim$N,resultstrim$ni), mean)
#Next line creates time for estimation of the coef in min
resultstrim$time.coef <-(resultstrim$end.coef -
resultstrim$inicio.coef)/60
#Next line creates time for estimation of the RE in min
resultstrim$time.RE<-(resultstrim$endp -resultstrim$iniciop)/60
time.summary <-aggregate(resultstrim$time.coef ,
by = list(resultstrim$N,resultstrim$ni), mean)
timep.summary <-aggregate(resultstrim$time.RE,
by = list(resultstrim$N,resultstrim$ni), mean)
step.summary <-aggregate(resultstrim$step ,
by = list(resultstrim$N,resultstrim$ni), mean)
mean_result <-aggregate(resultstrim , by = list(resultstrim$N,
resultstrim$ni), function(x) mean(x, na.rm=TRUE))
write.csv(mean_result , "mean_result.csv")
sd_result <-aggregate(resultstrim , by = list(resultstrim$N,
resultstrim$ni), function(x) sd(x, na.rm=TRUE))
write.csv(sd_result , "sd_result.csv")
#Subset other datasets based on resultstrim
resultstrim$reps <-paste(resultstrim$N,"_",resultstrim$ni,"_",
resultstrim$rep ,sep = "")
V1$reps <-paste(V1$N,"_",V1$ni ,"_",V1$rep ,sep = "")
V1.trim <-subset(V1 , reps %in% resultstrim$reps)
V1_p$reps <-paste(V1_p$N,"_",V1_p$ni ,"_",V1_p$rep ,sep = "")
V1_p.trim <-subset(V1_p, reps %in% resultstrim$reps)
V1_t$reps <-paste(V1_t$N,"_",V1_t$ni ,"_",V1_t$rep ,sep = "")
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V1_t.trim <-subset(V1_t, reps %in% resultstrim$reps)
V2$reps <-paste(V2$N,"_",V2$ni ,"_",V2$rep ,sep = "")
V2.trim <-subset(V2 , reps %in% resultstrim$reps)
V2_p$reps <-paste(V2_p$N,"_",V2_p$ni ,"_",V2_p$rep ,sep = "")
V2_p.trim <-subset(V2_p, reps %in% resultstrim$reps)
V2_t$reps <-paste(V2_t$N,"_",V2_t$ni ,"_",V2_t$rep ,sep = "")
V2_t.trim <-subset(V2_t, reps %in% resultstrim$reps)
t.V1<-aggregate(V1.trim , by = list(V1.trim$N,V1.trim$ni),
function(x) mean(x, na.rm=TRUE))
t.V1_p<-aggregate(V1_p.trim , by = list(V1_p.trim$N,V1_p.trim$ni),
function(x) mean(x, na.rm=TRUE))
t.V1_t<-aggregate(V1_t.trim , by = list(V1_t.trim$N,V1_t.trim$ni),
function(x) mean(x, na.rm=TRUE))
t.V2<-aggregate(V2.trim , by = list(V2.trim$N,V2.trim$ni),
function(x) mean(x, na.rm=TRUE))
t.V2_p<-aggregate(V2_p.trim , by = list(V2_p.trim$N,V2_p.trim$ni),
function(x) mean(x, na.rm=TRUE))
t.V2_t<-aggregate(V2_t.trim , by = list(V2_t.trim$N,V2_t.trim$ni),
function(x) mean(x, na.rm=TRUE))
s.V1<-aggregate(V1.trim , by = list(V1.trim$N,V1.trim$ni),
function(x) sd(x, na.rm=TRUE))
s.V1_p<-aggregate(V1_p.trim , by = list(V1_p.trim$N,V1_p.trim$ni),
function(x) sd(x, na.rm=TRUE))
s.V1_t<-aggregate(V1_t.trim , by = list(V1_t.trim$N,V1_t.trim$ni),
function(x) sd(x, na.rm=TRUE))
s.V2<-aggregate(V2.trim , by = list(V2.trim$N,V2.trim$ni),
function(x) sd(x, na.rm=TRUE))
s.V2_p<-aggregate(V2_p.trim , by = list(V2_p.trim$N,V2_p.trim$ni),
function(x) sd(x, na.rm=TRUE))
s.V2_t<-aggregate(V2_t.trim , by = list(V2_t.trim$N,V2_t.trim$ni),
function(x) sd(x, na.rm=TRUE))
#Subset other datasets based on resultstrim
naive$reps <-paste(naive$N,"_",naive$ni,"_",naive$rep ,sep = "")
naive.trim <-subset(naive , reps %in% resultstrim$reps)
t.naive <-aggregate(naive.trim , by = list(naive.trim$N,naive.trim$ni),
function(x) mean(x, na.rm=TRUE))





# File Simulations 2020 05 10. xlsx has the organized results
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# of the simulations
pred <-read.xlsx("Simulations 2020 05 10. xlsx", sheetIndex =2, header=TRUE)
coef <-read.xlsx("Simulations 2020 05 10. xlsx", sheetIndex =6, header=TRUE)
bias <-read.xlsx("Simulations 2020 05 10. xlsx", sheetIndex =7, header=TRUE)
se_sim <-read.xlsx("Simulations 2020 05 10. xlsx", sheetIndex =8, header=TRUE)
sd_sim <-read.xlsx("Simulations 2020 05 10. xlsx", sheetIndex =9, header=TRUE)














ggplot(data=pred ,aes(x = ni ,y = Estimates .. Convergence ,
col=factor(Patches ))) +
geom_jitter(width = 0.005, aes(shape=factor(Patches)),size = 2) +
scale_shape_manual(name="Number of\nPatches",values=c(16, 3, 17)) +
scale_color_manual(name="Number of\nPatches",
values=c("#926 b8d","#7 aadb1","#E8CA47")) +
scale_x_continuous(name="Time points", breaks=c(3,4,5)) +
scale_y_continuous(name="Convergence (%)",
breaks=seq (98 ,100 ,0.5) , limits = c(98 ,100)) +
ggplot(data=pred ,aes(x = ni ,y = Average ..time.RE..m.,
col=factor(Patches ))) +
geom_jitter(width = 0.005, aes(shape=factor(Patches)),size = 2) +
scale_shape_manual(name="Number of\nPatches",values=c(16, 3, 17)) +
scale_color_manual(name="Number of\nPatches",
values=c("#926 b8d","#7 aadb1","#E8CA47")) +
scale_x_continuous(name="Time points", breaks=c(3,4,5)) +
scale_y_continuous(name="Average Time RE (min)") +
ggplot(data=pred ,aes(x = ni ,y = Average ..time.coef..m.,
col=factor(Patches ))) +
geom_jitter(width = 0.005, aes(shape=factor(Patches)),size = 2) +
scale_shape_manual(name="Number of\nPatches",values=c(16, 3, 17)) +
scale_color_manual(name="Number of\nPatches",
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values=c("#926 b8d","#7 aadb1","#E8CA47")) +
scale_x_continuous(name="Time points", breaks=c(3,4,5)) +
scale_y_continuous(name="Average Time Coefficients (min)") +
ggplot(data=pred ,aes(x = ni ,y = Average ..steps ,col=factor(Patches )))+
geom_jitter(width = 0.005, aes(shape=factor(Patches)),size = 2) +
scale_shape_manual(name="Number of\nPatches",values=c(16, 3, 17)) +
scale_color_manual(name="Number of\nPatches",
values=c("#926 b8d","#7 aadb1","#E8CA47")) +
scale_x_continuous(name="Time points", breaks=c(3,4,5)) +
scale_y_continuous(name="Average iterations before convergence",


















#plot with no bars
ggplot(data=coeff ,aes(x = ni ,y = Beta1 ,col=factor(Patches ))) +
geom_jitter(width = 0.1,aes(shape=factor(Patches)),size = 2) +
geom_hline(yintercept =-10,color="#B7B6BA",linetype="dashed")+
scale_shape_manual(name="Number of\nPatches",values=c(16, 3, 17))+
scale_color_manual(name="Number of\nPatches",
values=c("#926 b8d","#7 aadb1","#E8CA47")) +
scale_x_continuous(name="Time points", breaks=c(3,4,5)) +
scale_y_continuous(name="Intercept") +
#plot with sd of the estimates
ggplot(coeff , aes(x=ni , y=Beta1 ,color=factor(Patches ))) +
geom_point(position=position_dodge (0.5), aes(shape=factor(Patches)),
size = 2)+
geom_errorbar(aes(ymin=Beta1 -(2*Beta1.s), ymax=Beta1 +(2*Beta1.s)),
width =.2, position=position_dodge (0.5))+
geom_hline(yintercept =-10,color="#B7B6BA",linetype="dashed")+
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scale_shape_manual(name="Number of\nPatches",values=c(16, 3, 17)) +
scale_color_manual(name="Number of\nPatches",
values=c("#926 b8d","#7 aadb1","#E8CA47")) +
scale_x_continuous(name="Time points", breaks=c(3,4,5)) +
scale_y_continuous(name="Intercept") +
#plot with average se







scale_shape_manual(name="Number of\nPatches",values=c(16, 3, 17)) +
scale_color_manual(name="Number of\nPatches",
values=c("#926 b8d","#7 aadb1","#E8CA47")) +
scale_x_continuous(name="Time points", breaks=c(3,4,5)) +
scale_y_continuous(name="Intercept") +
# Same plots for Beta2 , Beta3 , Beta4 , Gamma1 , Gamma2 , Gamma3 , Gamma4 ,
# Gamma5 , Gamma6 , Gamma7 , Gamma8
### Bias #############################################
ggplot(data=bias ,aes(x = ni ,y = Beta1 ,col=factor(Patches ))) +
geom_jitter(width = 0.1,aes(shape=factor(Patches)),size = 2) +
scale_shape_manual(name="Number of\nPatches",values=c(16, 3, 17)) +
scale_color_manual(name="Number of\nPatches",
values=c("#926 b8d","#7 aadb1","#E8CA47")) +
scale_x_continuous(name="Time points", breaks=c(3,4,5)) +
scale_y_continuous(name="Bias in Intercept") +
# Same plots for Beta2 , Beta3 , Beta4 , Gamma1 , Gamma2 , Gamma3 , Gamma4 ,
# Gamma5 , Gamma6 , Gamma7 , Gamma8
### Plots predictions #############################################
t.V1<- merge(t.V1,s.V1,by=c("Group .1","Group .2"),all=T)
t.V1_p<-merge(t.V1_p,s.V1_p,by=c("Group .1","Group .2"),all=T)
t.V1_t<-merge(t.V1_t,s.V1_t,by=c("Group .1","Group .2"),all=T)
t.V2<- merge(t.V2,s.V2,by=c("Group .1","Group .2"),all=T)
t.V2_p<-merge(t.V2_p,s.V2_p,by=c("Group .1","Group .2"),all=T)
t.V2_t<-merge(t.V2_t,s.V2_t,by=c("Group .1","Group .2"),all=T)

























scale_shape_manual(name="Number of\nPatches",values=c(16, 3, 17)) +
scale_color_manual(name="Number of\nPatches",
values=c("#926 b8d","#7 aadb1","#E8CA47")) +
scale_x_continuous(name="Time points", breaks=c(3,4,5)) +
scale_y_continuous(name=expression(paste("Corr"^2,
"observed vs. predicted")),limits = c(-1,1)) +
ggplot(t.V1_p, aes(x=ni , y=mase ,color=factor(N))) +
geom_point(position=position_dodge (0.5), aes(shape=factor(N)),
size = 2)+
geom_errorbar(aes(ymin=mase -(1.96*mase.s), ymax=mase +1.96*mase.s),
width =.2, position=position_dodge (0.5))+
geom_hline(yintercept =1,color="#B7B6BA",linetype="dashed")+
scale_shape_manual(name="Number of\nPatches",values=c(16, 3, 17)) +
scale_color_manual(name="Number of\nPatches",
values=c("#926 b8d","#7 aadb1","#E8CA47")) +
scale_x_continuous(name="Time points", breaks=c(3,4,5)) +
scale_y_continuous(name="MASE observed vs. predicted",
limits = c(0 ,1.6)) +
# Same plots for t.V2_p
### Plots predictions with naive ###################################
t.naive <- merge(t.naive ,s.naive ,by=c("Group .1","Group .2"),all=T)
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t.naive <-t.naive[order(t.naive$N.x,t.naive$ni.x),]







scale_shape_manual(name="Number of\nPatches",values=c(16, 3, 17)) +
scale_color_manual(name="Number of\nPatches",
values=c("#926 b8d","#7 aadb1","#E8CA47")) +
scale_x_continuous(name="Time points", breaks=c(3,4,5)) +
scale_y_continuous(name=expression(paste("Corr"^2,
"observed vs. predicted")),limits = c(-1,1)) +





width =.2, position=position_dodge (0.5))+
geom_hline(yintercept =1,color="#B7B6BA",linetype="dashed")+
scale_shape_manual(name="Number of\nPatches",values=c(16, 3, 17)) +
scale_color_manual(name="Number of\nPatches",
values=c("#926 b8d","#7 aadb1","#E8CA47")) +
scale_x_continuous(name="Time points", breaks=c(3,4,5)) +
scale_y_continuous(name="MASE observed vs. predicted",
limits = c(0 ,1.6)) +
# Same plots for naive.corr2.V2, naive.mase.V1.x
#######################################################################
# Previous code was repeated for Type I error simulations using the
# following data set
# Data with zero dose effect ##########################################
# Dose coefficients were set to zero. Also , the intercept was changed to
# get higher probabilities to get 0s and 1s
set.seed (124)
for (n in c(300 ,500 ,1000)) {
for (ni in c(3,4,5)) {
for (rp in 1:1000) {
# Dose




Dose <- rep(Dose ,times=ni)
id <- rep (1:n,times=ni)
t <- c(3,6,12,18,24)/12
t <- t[1:ni]
time <- rep(t, each=n)
data <- as.data.frame(cbind(id ,Dose ,time))
data$time2 <- (data$time )^2
data$int <- 1
data <- data[,c("id","int","Dose","time","time2")]




mu_1 <- c( -0.1 ,0.1)
mu_2 <- -(m/(1-m))*mu_1
Psi_diag <-diag(sqrt(c(1 ,0.5 ,1)))
R <- matrix(c(1 ,0.1 ,0.2 ,0.1 ,1 ,0.1 ,0.2 ,0.1 ,1) , nrow = 3)
Psi <-Psi_diag %*% R %*% Psi_diag
Psi_cc <- as.matrix(Psi[1,1])
Psi_dd <- as.matrix(Psi [2:3 ,2:3])





mu1 <- matrix(c(0,mu_1),ncol = 1)





Var.V2),nrow = 2,ncol = 2)
Beta <- as.matrix(c(1,0,-2,-3),ncol =1)
Gamma <- as.matrix(c(-5,0,0.5,-1,
-2,0,0.5,-1),ncol =1)
b <- (m*mvrnorm(n = n, mu1 , Psi ))+((1 -m)*mvrnorm(n = n, mu2 , Psi))
d <- data.frame(b[,2:3],i=rep(1:ni,ea=n))




X <- as.matrix(dataU [,-1])
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Z <- as.matrix(dataU[,c("int")])
Zc <- (Z * c)
logit_U <- X %*% Beta + Zc
pU <- exp(logit_U)/(1+ exp(logit_U))
U <-rbinom(length(pU),1,pU)
ps<-prop.table(table(U))[2]
Zd1 <- Z * d[,1]
Zd2 <- Z * d[,2]
X <- as.matrix(data[,-1])
Z <- as.matrix(data[,c("int")])
V1 <- X %*% Gamma [1:4 ,] + Zd1 + e[,1]
V2 <- X %*% Gamma [5:8 ,] + Zd2 + e[,2]




sim.val <-c(Beta=Beta ,Gamma=Gamma , Psi_cc=Psi_cc ,Psi_dd=Psi_dd ,


















# Data with zero time effect #########################################
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set.seed (124)
for (n in c(300 ,500 ,1000)) {
for (ni in c(3,4,5)) {
for (rp in 1:1000) {
# Dose
Dose <-rlnorm(n, meanlog = 0, sdlog =1)
Dose <-Dose*(60/max(Dose))
#plot(density(Dose))
Dose <- rep(Dose ,times=ni)
id <- rep (1:n,times=ni)
t <- c(3,6,12,18,24)/12
t <- t[1:ni]
time <- rep(t, each=n)
data <- as.data.frame(cbind(id ,Dose ,time))
data$time2 <- (data$time )^2
data$int <- 1
data <- data[,c("id","int","Dose","time","time2")]




mu_1 <- c( -0.1 ,0.1)
mu_2 <- -(m/(1-m))*mu_1
Psi_diag <-diag(sqrt(c(1 ,0.5 ,1)))
R <- matrix(c(1 ,0.1 ,0.2 ,0.1 ,1 ,0.1 ,0.2 ,0.1 ,1) , nrow = 3)
Psi <-Psi_diag %*% R %*% Psi_diag
Psi_cc <- as.matrix(Psi[1,1])
Psi_dd <- as.matrix(Psi [2:3 ,2:3])





mu1 <- matrix(c(0,mu_1),ncol = 1)





Var.V2),nrow = 2,ncol = 2)




b <- (m*mvrnorm(n = n, mu1 , Psi ))+((1 -m)*mvrnorm(n = n, mu2 , Psi))
d <- data.frame(b[,2:3],i=rep(1:ni,ea=n))




X <- as.matrix(dataU [,-1])
Z <- as.matrix(dataU[,c("int")])
Zc <- (Z * c)
logit_U <- X %*% Beta + Zc
pU <- exp(logit_U)/(1+ exp(logit_U))
U <-rbinom(length(pU),1,pU)
ps<-prop.table(table(U))[2]
Zd1 <- Z * d[,1]
Zd2 <- Z * d[,2]
X <- as.matrix(data[,-1])
Z <- as.matrix(data[,c("int")])
V1 <- X %*% Gamma [1:4 ,] + Zd1 + e[,1]
V2 <- X %*% Gamma [5:8 ,] + Zd2 + e[,2]




sim.val <-c(Beta=Beta ,Gamma=Gamma , Psi_cc=Psi_cc ,Psi_dd=Psi_dd ,



















# Data with zero time^2 effect #######################################
set.seed (124)
for (n in c(300 ,500 ,1000)) {
for (ni in c(3,4,5)) {
for (rp in 1:1000) {
# Dose
Dose <-rlnorm(n, meanlog = 0, sdlog =1)
Dose <-Dose*(60/max(Dose))
#plot(density(Dose))
Dose <- rep(Dose ,times=ni)
id <- rep (1:n,times=ni)
t <- c(3,6,12,18,24)/12
t <- t[1:ni]
time <- rep(t, each=n)
data <- as.data.frame(cbind(id ,Dose ,time))
data$time2 <- (data$time )^2
data$int <- 1
data <- data[,c("id","int","Dose","time","time2")]




mu_1 <- c( -0.1 ,0.1)
mu_2 <- -(m/(1-m))*mu_1
Psi_diag <-diag(sqrt(c(1 ,0.5 ,1)))
R <- matrix(c(1 ,0.1 ,0.2 ,0.1 ,1 ,0.1 ,0.2 ,0.1 ,1) , nrow = 3)
Psi <-Psi_diag %*% R %*% Psi_diag
Psi_cc <- as.matrix(Psi[1,1])
Psi_dd <- as.matrix(Psi [2:3 ,2:3])





mu1 <- matrix(c(0,mu_1),ncol = 1)






Var.V2),nrow = 2,ncol = 2)
Beta <- as.matrix(c(-10,1.5,-2,0),ncol =1)
Gamma <- as.matrix(c(-7,1,0.5,0,
-3,2,0.5,0),ncol =1)
b <- (m*mvrnorm(n = n, mu1 , Psi ))+((1 -m)*mvrnorm(n = n, mu2 , Psi))
d <- data.frame(b[,2:3],i=rep(1:ni,ea=n))




X <- as.matrix(dataU [,-1])
Z <- as.matrix(dataU[,c("int")])
Zc <- (Z * c)
logit_U <- X %*% Beta + Zc
pU <- exp(logit_U)/(1+ exp(logit_U))
U <-rbinom(length(pU),1,pU)
ps<-prop.table(table(U))[2]
Zd1 <- Z * d[,1]
Zd2 <- Z * d[,2]
X <- as.matrix(data[,-1])
Z <- as.matrix(data[,c("int")])
V1 <- X %*% Gamma [1:4 ,] + Zd1 + e[,1]
V2 <- X %*% Gamma [5:8 ,] + Zd2 + e[,2]




sim.val <-c(Beta=Beta ,Gamma=Gamma , Psi_cc=Psi_cc ,Psi_dd=Psi_dd ,




















B.4 Chapter 5: Application on reference patienter data
Also available at: https://github.com/vivifj03/TumorModel/blob/master/Code%20chapter5%
20-%20ref%20patient.R






















###### Mixed effects logistic regression - gets initial values
#This models is using time in years
inicio.naive <-Sys.time()
md1 <- glmer(nonZeroHD ~ Dose_med + years + years2 + (1 | patch),
data = dataset , family = binomial)
temp <-dataset[is.na(dataset$Dense.lt)==F | is.na(dataset$Hazy.lt)==F,]
### Dense
md2d <- lme(Dense.lt ~ Dose_med + years + years2 , random = ~ 1| patch ,
data = temp)
md2d2 <- lmer(Dense.lt ~ Dose_med + years + years2 + (1| patch),





md2h <- lme(Hazy.lt ~ Dose_med + years + years2 , random= ~ 1| patch ,
data = temp)
md2h2 <- lmer(Hazy.lt ~ Dose_med + years + years2 + (1| patch),





Beta <- as.matrix(md1@beta ,ncol =1)
if ((( md1@theta )^2) <0.1) {












nrow = length(md2d2@theta )+ length(md2h2@theta),
ncol = length(md2d2@theta )+ length(md2h2@theta ))
corr <-cor(temp$Dense.lt , temp$Hazy.lt)
Var.V1<-attr(VarCorr(md2d2), "sc")^2
Var.V2<-attr(VarCorr(md2h2), "sc")^2




m<-0.55 #set probability for normal mixture distribution for
#random effects
mu_1<-c( -0.05 ,0.05) #Set mean first normal dristribution for
#random effects
par.l<-list(Beta=Beta ,Gamma=Gamma , Psi_cc=Psi_cc ,Psi_dd=Psi_dd ,
Var.V1=Var.V1 ,Var.V2=Var.V2 ,corr=corr ,
Psi_dc=Psi_dc ,m=m,mu_1=mu_1)
par <-c(Beta=Beta ,Gamma=Gamma , Psi_cc=Psi_cc ,Psi_dd=Psi_dd ,













# Likelihood - Model ------------------------------------------------
source("tpmemmzl.R")





estimate <- vector("list", maxit +1)
estimate [[1]] <-par.l
dif.theta <- vector("list", maxit)
rel.dif.theta <- vector("list", maxit)
dev <-vector("numeric", maxit)
reldev <-vector("numeric", maxit)











ginv(par.l$Psi_cc) %*% t(par.l$Psi_dc)) ))





t.dev <-matrix(0,nrow=length(in.dev), ncol = 1)
for (i in 1: length(in.dev)) {
t.dev[i,1] <-in.dev[[i]]
}
dev [[1]] <- -2*colSums(t.dev)
print(dev [[1]])













ginv(par.l$Psi_cc) %*% t(par.l$Psi_dc)) ))
theta0 <-theta







subm <-matrix(0,nrow=length(t), ncol = 1)
for (i in 1: length(t)) {
subm[i,1] <-t[[i]]$m
}
score <-matrix(0,nrow=length(t), ncol = length(t[[1]]$scorei ))




for (i in trunk) {
cuts <-0+3*sd(score[,i])




score <-colSums(score ,na.rm = T)
theta <-theta+score
#Check values of Sigma , Psi_cc














corr.test <-theta [16]/(sqrt(theta [15])*sqrt(theta [17]))
while (corr.test <= ( -0.95)) {
corr.test0 <- theta0 [16]/(sqrt(theta0 [15])*sqrt(theta0 [17]))
#corr.test1 <- theta [16]/(sqrt(theta [15])*sqrt(theta [17]))
corr.test1 <- -0.90
corr.new <- (corr.test0+corr.test1)/2
theta [16] <-corr.new*sqrt(theta [15])*sqrt(theta [17])
corr.test <-theta [16]/(sqrt(theta [15])*sqrt(theta [17]))
}
while (corr.test >= 0.95) {
corr.test0 <- theta0 [16]/(sqrt(theta0 [15])*sqrt(theta0 [17]))
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#corr.test1 <- theta [16]/(sqrt(theta [15])*sqrt(theta [17]))
corr.test1 <- 0.90
corr.new <- (corr.test0+corr.test1)/2
theta [16] <-corr.new*sqrt(theta [15])*sqrt(theta [17])
corr.test <-theta [16]/(sqrt(theta [15])*sqrt(theta [17]))
}















Beta=matrix(theta [1:4], ncol =1)
Gamma=matrix(theta [5:12] , ncol =1)
mu_1= matrix(theta [13:14] , ncol =1)
Var.V1=theta [15]
Var.V2=theta [17]
corr=theta [16]/(sqrt(theta [15])*sqrt(theta [17]))
Psi_cc=matrix(theta [18], ncol =1)
Psi_dc.i=matrix(theta [19:20] , ncol =1)
Psi_dc=Psi_dc.i%*%Psi_cc
Psi_cd=t(Psi_dc)
H<-matrix(c(theta [21],rep(theta [22],2), theta [23]) , ncol =2)
while (det(H) <= 0 )
{
theta [21] <- (theta0 [21]+ theta [21])/2
theta [22] <- (theta0 [22]+ theta [22])/2
theta [23] <- (theta0 [23]+ theta [23])/2
H<-matrix(c(theta [21],rep(theta [22],2), theta [23]) , ncol =2)
}













H<-matrix(c(theta [21], theta [22], theta [22], theta [23]) , ncol =2)
while (det(H) <= 0 )
{
theta [21] <- (theta0 [21]+ theta [21])/2
theta [22] <- (theta0 [22]+ theta [22])/2
theta [23] <- (theta0 [23]+ theta [23])/2
H<-matrix(c(theta [21],rep(theta [22],2), theta [23]) , ncol =2)
}
Psi_dd=H+(Psi_dc.i %*% Psi_cd)
par.l<-list(Beta=Beta ,Gamma=Gamma , Psi_cc=Psi_cc ,Psi_dd=Psi_dd ,









t.dev <-matrix(0,nrow=length(in.dev), ncol = 1)




print( paste("new deviance",dev[[step ]]))
#Step -halving in case deviance is larger than previous iteration
reldev [[step]]<-((dev[[step]] - dev[[step -1]])/(0.1 +
abs(dev[[step ]])) )
loop3 <-0
if (reldev [[step ]]>=1e-8){
ii<-1
while (reldev [[step]] > -1e-8) {
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t.dev <-matrix(0,nrow=length(in.dev), ncol = 1)




reldev [[step]]<-((dev[[step]] - dev[[step -1]])/(0.1 +
abs(dev[[step ]])) )















solve(par.l$Psi_cc) %*% t(par.l$Psi_dc)) ))
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estimate [[step]]<-par.l
eu.dis[step] <-(dist(rbind(theta0 ,theta), method = "euclidean")^2)/
length(theta)
dif.theta[[step]] <- (theta0 -theta)
rel.dif.theta[[step]] <- (theta -theta0)/theta
absdev <-ifelse(step==2,1,abs(dev[[step]] - dev[[step -1]]))
criterion.step <-ifelse(step <=maxit ,0,1)
criterion.distance <-ifelse(max(abs(dif.theta [[step ]]))>1e-8,0,1)



















# For figures of coefficientes at each iteration






































### Standard errors ###############################################





S_0b.total <-matrix(0,nrow=4, ncol = 4)
S_0g.total <-matrix(0,nrow=8, ncol = 8)
S_0mu.total <-matrix(0,nrow=2, ncol = 2)













lci1 <-par.final [1:12] -(1.96*se.final1)
uci1 <-par.final [1:12]+(1.96*se.final1)
save.image(filestimates)
### Random effects ################################################
try(if(criterion.step ==1) stop("estimation did not converge"))
iniciop <-Sys.time()











### Predicted values ################################################
ran.est <- as.data.frame(matrix(NA ,length(patch ),7))
ran.est[,1] <- patch











dataset <-dataset [ ,1:38]
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dataset <-merge(dataset ,ran.est ,by="patch",all.x = T)
dataset$logp.1 <- par.l$Beta [1] + par.l$Beta [2]*dataset$Dose_med +
par.l$Beta [3] * dataset$years + par.l$Beta [4] * dataset$years2 +
dataset$c.est
dataset$odds.1 <- exp(dataset$logp .1)
dataset$p.1 <- dataset$odds.1 / (1 + dataset$odds .1)
dataset$subpred1 <- par.l$Gamma [1] + par.l$Gamma [2]*dataset$Dose_med +
par.l$Gamma [3] * dataset$years + par.l$Gamma [4] * dataset$years2 +
dataset$d1.est
dataset$subpred2 <- par.l$Gamma [5]+ par.l$Gamma [6]*dataset$Dose_med +
par.l$Gamma [7] * dataset$years + par.l$Gamma [8] * dataset$years2 +
dataset$d2.est
dataset$subres1 <- dataset$Dense.lt0 -dataset$subpred1







duan1 <- mean(exp(dataset[dataset$nonZeroHD ==1,"subres1"]))



































ran.est <- as.data.frame(matrix(NA ,length(patch ),7))
ran.est[,1] <- patch











dataset.t<-merge(dataset.t,ran.est ,by="patch",all.x = T)
dataset.t$logp.1 <- par.l$Beta [1]+ par.l$Beta [2]*dataset.t$Dose_med +
par.l$Beta [3] * dataset.t$years + par.l$Beta [4] * dataset.t$years2 +
dataset.t$c.est
dataset.t$odds.1 <- exp(dataset.t$logp .1)
dataset.t$p.1 <- dataset.t$odds.1 / (1 + dataset.t$odds .1)
dataset.t$subpred1 <- par.l$Gamma [1]+ par.l$Gamma [2]*dataset.t$Dose_med +
par.l$Gamma [3] * dataset.t$years + par.l$Gamma [4] * dataset.t$years2 +
dataset.t$d1.est
dataset.t$subpred2 <- par.l$Gamma [5]+ par.l$Gamma [6]*dataset.t$Dose_med +
par.l$Gamma [7] * dataset.t$years + par.l$Gamma [8] * dataset.t$years2 +
dataset.t$d2.est
dataset.t$subres1 <- dataset.t$Dense.lt0 -dataset.t$subpred1








duan1 <- mean(exp(dataset.t[dataset.t$nonZeroHD ==1,"subres1"]))







































ran.est <- as.data.frame(matrix(NA ,length(patch ),7))
ran.est[,1] <- patch












dataset.p<-merge(dataset.p,ran.est ,by="patch",all.x = T)
dataset.p$logp.1 <- par.l$Beta [1]+ par.l$Beta [2]*dataset.p$Dose_med +
par.l$Beta [3] * dataset.p$years + par.l$Beta [4] * dataset.p$years2 +
dataset.p$c.est
dataset.p$odds.1 <- exp(dataset.p$logp .1)
dataset.p$p.1 <- dataset.p$odds.1 / (1 + dataset.p$odds .1)
dataset.p$subpred1 <- par.l$Gamma [1]+ par.l$Gamma [2]*dataset.p$Dose_med +
par.l$Gamma [3] * dataset.p$years + par.l$Gamma [4] * dataset.p$years2 +
dataset.p$d1.est
dataset.p$subpred2 <- par.l$Gamma [5]+ par.l$Gamma [6]*dataset.p$Dose_med +
par.l$Gamma [7] * dataset.p$years + par.l$Gamma [8] * dataset.p$years2 +
dataset.p$d2.est
dataset.p$subres1 <- dataset.p$Dense.lt0 -dataset.p$subpred1







duan1 <- mean(exp(dataset.p[dataset.p$nonZeroHD ==1,"subres1"]))































































### Scaled residuals for v for those with at least one nonzero #####
agg3 <-agg2[agg2$nonZeroHD!=0,]
agg3$scaled.v1.res <-(agg3$Dense.lt0 - agg3$subpred1)/
sqrt(agg3$nonZeroHD*par.l$Var.V1)











v <- dataset.p[order(dataset.p$patch , dataset.p$date),]
v <- v[!duplicated(v$patch),]
test <-qqnorm(v$c.est , pch = 1, frame = FALSE ,col = "#926 b8d")
x <- c(quantile(test$x,0.25) , quantile(test$x ,0.75))









plot(test$x,log(test$y+(abs(min(test$y))+1)) , col = "#926 b8d",
xlab="Theoretical Quantiles", ylab="Sample Quantiles", yaxt="n",
main="Normal Q-Q Plot")
abline(intercept , slope , col="#B7B6BA", lwd = 2)
axis(2,at=la ,labels=la2)
x <- c(quantile(test$x,0.25) , quantile(test$x ,0.75))





plot(test$x,sqrt(test$y+(abs(min(test$y)))),col = "#926 b8d",






plot(test$x,sqrt(test$y+(abs(min(test$y)))),col = "#926 b8d",
xlab="Theoretical Quantiles", ylab="Sample Quantiles", yaxt="n",
main="Normal Q-Q Plot")
abline(intercept , slope , col="#B7B6BA", lwd = 2)
axis(2,at=la ,labels=la2)
x <- c(quantile(test$x,0.25) , quantile(test$x ,0.75))




plot(test$x,sign(test$y)*(abs(test$y)^(1/3)),col = "#926 b8d",






plot(test$x,sign(test$y)*(abs(test$y)^(1/3)),col = "#926 b8d",
xlab="Theoretical Quantiles", ylab="Sample Quantiles", yaxt="n",
main="Normal Q-Q Plot")
abline(intercept , slope , col="#B7B6BA", lwd = 2)
axis(2,at=la ,labels=la2)
x <- c(quantile(test$x,0.25) , quantile(test$x ,0.75))




plot(test$x,sign(test$y)*(abs(test$y)^(1/5)),col = "#926 b8d",






plot(test$x,sign(test$y)*(abs(test$y)^(1/5)),col = "#926 b8d",
222
xlab="Theoretical Quantiles", ylab="Sample Quantiles", yaxt="n",
main="Normal Q-Q Plot")
abline(intercept , slope , col="#B7B6BA", lwd = 2)
axis(2,at=la ,labels=la2)
qqnorm(v[v$Com!=1,]$c.est , pch = 1, frame = FALSE ,col = "#926 b8d")
qqline(v[v$Com!=1,]$c.est , col ="#B7B6BA", lwd = 2)
qqnorm(v[v$Com==1,]$c.est , pch = 1, frame = FALSE ,col = "#926 b8d")
qqline(v[v$Com==1,]$c.est , col ="#B7B6BA", lwd = 2)
boxplot(c.est~nonZeroHD , data=v)
qqnorm(dataset.t$subres1 , pch = 1, frame = FALSE)
qqline(dataset.t$subres1 , col = "steelblue", lwd = 2)
qqnorm(dataset.t$subres2 , pch = 1, frame = FALSE)
qqline(dataset.t$subres2 , col = "steelblue", lwd = 2)
qqnorm(dataset.t$residuals1 , pch = 1, frame = FALSE)
qqline(dataset.t$residuals1 , col = "steelblue", lwd = 2)
qqnorm(dataset.t$residuals2 , pch = 1, frame = FALSE)







### Additive logistic transform ###################################
alrInv(c(par.l$Gamma [[1]], par.l$Gamma [[5]]))
ef.dose <-c(par.l$Gamma [[2]], par.l$Gamma [[6]])
alrInv(ef.dose)
sqrt(ef.dose %*% solve(diag (2) + c(1,1) %*% t(c(1 ,1))) %*% (ef.dose))
ef.time <-c(par.l$Gamma [[3]], par.l$Gamma [[7]])
alrInv(ef.time)
sqrt(ef.time %*% solve(diag (2) + c(1,1) %*% t(c(1 ,1))) %*% (ef.time))
ef.time2 <-c(par.l$Gamma [[4]], par.l$Gamma [[8]])
alrInv(ef.time2)
sqrt(ef.time2 %*% solve(diag (2) + c(1,1) %*% t(c(1 ,1))) %*% (ef.time2))


















sum(v2$dense.res.f^2 ) + sum(v2$hazy.res.f^2 ) +
sum(v2$com.res.f^2 )








sum(v2$dense.res.p1^2 ) + sum(v2$hazy.res.p1^2 ) +
sum(v2$com.res.p1^2 )








sum(v2$dense.res.p2^2 ) + sum(v2$hazy.res.p2^2 ) +
sum(v2$com.res.p2^2 )
sqrt(sum(v2$dense.res.p2^2 ) + sum(v2$hazy.res.p2^2 ) +
sum(v2$com.res.p2^2 ))
# Figures ===========================================================








ggplot(dataset.p, aes(x=Dose_med , y=subres1.st)) +
geom_point(alpha =0.7,col="#926 b8d") +
xlab("Median Dose") + ylab("Standardized residual - alr(Dense)")+
theme(plot.title = element_text(hjust = 0.5), panel.grid.major =
element_blank(), panel.grid.minor = element_blank(),
panel.background = element_blank(), axis.line =
element_line(colour = "black"),text = element_text(size =16),
legend.position="bottom",legend.title = element_blank ())
ggplot(dataset.p, aes(x=Dose_med , y=residuals1.st)) +
geom_point(alpha =0.7,col="#926 b8d") +
xlab("Median Dose") + ylab("Standardized residual - alr(Dense)")+
theme(plot.title = element_text(hjust = 0.5), panel.grid.major =
element_blank(), panel.grid.minor = element_blank(),
panel.background = element_blank(), axis.line =
element_line(colour = "black"),text = element_text(size =16),
legend.position="bottom",legend.title = element_blank ())
ggplot(dataset.p, aes(x=Dose_med , y=subres2.st)) +
geom_point(alpha =0.7,col="#926 b8d") +
xlab("Median Dose") + ylab("Standardized residual - alr(Hazy)")+
theme(plot.title = element_text(hjust = 0.5), panel.grid.major =
element_blank(), panel.grid.minor = element_blank(),
panel.background = element_blank(), axis.line =
element_line(colour = "black"),text = element_text(size =16),
legend.position="bottom",legend.title = element_blank ())
ggplot(dataset.p, aes(x=Dose_med , y=residuals2.st)) +
geom_point(alpha =0.7,col="#926 b8d") +
xlab("Median Dose") + ylab("Standardized residual - alr(Hazy)")+
theme(plot.title = element_text(hjust = 0.5), panel.grid.major =
element_blank(), panel.grid.minor = element_blank(),
panel.background = element_blank(), axis.line =
element_line(colour = "black"),text = element_text(size =16),
legend.position="bottom",legend.title = element_blank ())
ggplot(dataset.p, aes(x=factor(date2), y=subres1.st)) +
geom_point(alpha =0.7,col="#926 b8d") +
xlab("Months after RT") + ylab("Standardized residual - alr(Dense)")+
theme(plot.title = element_text(hjust = 0.5), panel.grid.major =
element_blank(), panel.grid.minor = element_blank(),
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panel.background = element_blank(), axis.line =
element_line(colour = "black"),text = element_text(size =16),
legend.position="bottom",legend.title = element_blank ())
ggplot(dataset.p, aes(x=factor(date2), y=residuals1.st)) +
geom_point(alpha =0.7,col="#926 b8d") +
xlab("Months after RT") + ylab("Standardized residual - alr(Dense)")+
theme(plot.title = element_text(hjust = 0.5), panel.grid.major =
element_blank(), panel.grid.minor = element_blank(),
panel.background = element_blank(), axis.line =
element_line(colour = "black"),text = element_text(size =16),
legend.position="bottom",legend.title = element_blank ())
ggplot(dataset.p, aes(x=factor(date2), y=subres2.st)) +
geom_point(alpha =0.7,col="#926 b8d") +
xlab("Months after RT") + ylab("Standardized residual - alr(Hazy)")+
theme(plot.title = element_text(hjust = 0.5), panel.grid.major =
element_blank(), panel.grid.minor = element_blank(),
panel.background = element_blank(), axis.line =
element_line(colour = "black"),text = element_text(size =16),
legend.position="bottom",legend.title = element_blank ())
ggplot(dataset.p, aes(x=factor(date2), y=residuals2.st)) +
geom_point(alpha =0.7,col="#926 b8d") +
xlab("Months after RT") + ylab("Standardized residual - alr(Hazy)")+
theme(plot.title = element_text(hjust = 0.5), panel.grid.major =
element_blank(), panel.grid.minor = element_blank(),
panel.background = element_blank(), axis.line =
element_line(colour = "black"),text = element_text(size =16),
legend.position="bottom",legend.title = element_blank ())
#Figure 5.5
ggplot(dataset.p, aes(x=logp.1, y=subpred1 )) +
geom_point(alpha =0.7,col="#926 b8d") +
xlab("Logit -probability of RILD") + ylab("Mean alr(Dense)")+
theme(plot.title = element_text(hjust = 0.5), panel.grid.major =
element_blank(), panel.grid.minor = element_blank(),
panel.background = element_blank(), axis.line =
element_line(colour = "black"),text = element_text(size =16),
legend.position="bottom",legend.title = element_blank ())
ggplot(dataset.p, aes(x=logp.1, y=subpred2 )) +
geom_point(alpha =0.7,col="#926 b8d") +
xlab("Logit -probability of RILD") + ylab("Mean alr(Hazy)")+
theme(plot.title = element_text(hjust = 0.5), panel.grid.major =
element_blank(), panel.grid.minor = element_blank(),
panel.background = element_blank(), axis.line =
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element_line(colour = "black"),text = element_text(size =16),
legend.position="bottom",legend.title = element_blank ())
#Figure 5.6
ggplot(agg2 , aes(x=nonZeroHD , y=p.1)) +
geom_point(pch = 19, position = position_jitter(),alpha =0.3,
size=1,col="#B7B6BA") +
geom_point(alpha =0.7,col="#926 b8d") +
xlab("Observed") + ylab("Predicted")+
scale_x_continuous(breaks=c(0,1,2,3,4,5), labels=c(0,1,2,3,4,5)) +
theme(plot.title = element_text(hjust = 0.5), panel.grid.major =
element_blank(), panel.grid.minor = element_blank(),
panel.background = element_blank(), axis.line =
element_line(colour = "black"),text = element_text(size =16),
legend.position="bottom",legend.title = element_blank ())
#Figure 5.7
ggplot(dataset.p, aes(x=Dense.lt0 , y=subpred1 )) +
geom_point(alpha =0.7,col="#926 b8d") +
geom_abline(slope=1, intercept=0,col="#B7B6BA") +
xlab("Observed alr(Dense)") + ylab("Sub -predicted alr(Dense)")+
theme(plot.title = element_text(hjust = 0.5), panel.grid.major =
element_blank(), panel.grid.minor = element_blank(),
panel.background = element_blank(), axis.line =
element_line(colour = "black"),text = element_text(size =16),
legend.position="bottom",legend.title = element_blank ())
ggplot(dataset.p, aes(x=Hazy.lt0 , y=subpred2 )) +
geom_point(alpha =0.7,col="#926 b8d") +
geom_abline(slope=1, intercept=0,col="#B7B6BA") +
xlab("Observed alr(Hazy)") + ylab("Sub -predicted alr(Hazy)")+
theme(plot.title = element_text(hjust = 0.5), panel.grid.major =
element_blank(), panel.grid.minor = element_blank(),
panel.background = element_blank(), axis.line =
element_line(colour = "black"),text = element_text(size =16),
legend.position="bottom",legend.title = element_blank ())
ggplot(dataset.p, aes(x=Dense.lt0 , y=pred1)) +
geom_point(alpha =0.7,col="#926 b8d") +
geom_abline(slope=1, intercept=0,col="#B7B6BA") +
xlab("Observed alr(Dense)") + ylab("Predicted alr(Dense)")+
theme(plot.title = element_text(hjust = 0.5), panel.grid.major =
element_blank(), panel.grid.minor = element_blank(),
panel.background = element_blank(), axis.line =
element_line(colour = "black"),text = element_text(size =16),
legend.position="bottom",legend.title = element_blank ())
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ggplot(dataset.p, aes(x=Hazy.lt0 , y=pred2)) +
geom_point(alpha =0.7,col="#926 b8d") +
geom_abline(slope=1, intercept=0,col="#B7B6BA") +
xlab("Observed alr(Hazy)") + ylab("Predicted alr(Hazy)")+
theme(plot.title = element_text(hjust = 0.5), panel.grid.major =
element_blank(), panel.grid.minor = element_blank(),
panel.background = element_blank(), axis.line =
element_line(colour = "black"),text = element_text(size =16),















aes(x=dense.pred.f, y=hazy.pred.f, z=com.pred.f)) +
geom_point() +
geom_point(aes(x=xm[1], y=xm[2], z=xm[3], colour="Mean")) +
scale_colour_manual(name = element_blank(), labels =
"Mean \ncomposition",values=c("#7aadb1"))+
xlab("Dense") + ylab("Hazy") + zlab("Normal") +
theme_showarrows () + ggtitle(paste(k, " Months", sep = "")) +
theme(plot.title = element_text(face="bold", hjust = 0.5,vjust =8),
plot.margin = unit(c(0,0,0,0), "cm"))
#Figure 5.9
ef.dose.data <-as.data.frame(rep (1:60 ,5))
colnames(ef.dose.data)<-c("Dose")
ef.dose.data$lDose <-log(ef.dose.data$Dose)
ef.dose.data$month <-rep(c(3,6,12,18,24), each =60)
ef.dose.data$time <-ef.dose.data$month/12
ef.dose.data$log <-par.l$Beta [[1]] + (ef.dose.data$lDose *
par.l$Beta [[2]]) + (ef.dose.data$time * par.l$Beta [[3]]) +
((ef.dose.data$time ^2) * par.l$Beta [[4]])
ef.dose.data$p.1<-exp(ef.dose.data$log)/(1+ exp(ef.dose.data$log))
ef.dose.data$subpred1 <-par.l$Gamma [[1]] + (ef.dose.data$lDose *
par.l$Gamma [[2]]) + (ef.dose.data$time * par.l$Gamma [[3]])+
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((ef.dose.data$time ^2) * par.l$Gamma [[4]])
ef.dose.data$subpred2 <-par.l$Gamma [[5]] + (ef.dose.data$lDose *
par.l$Gamma [[6]]) + (ef.dose.data$time * par.l$Gamma [[7]]) +


















aes(x=dense.pred.f, y=hazy.pred.f, z=com.pred.f, color=Dose)) +
geom_point ()+
geom_point(aes(x=b[1], y=b[2], z=b[3]), colour = "#7 aadb1") +
scale_color_gradient(breaks= c(10,20,30,40,50,60), labels=
c(10,20,30,40,50,60), limits=c(0,60),
low = "#926 b8d" , high = "#E8CA47") +
labs(fill = "Median dose") + xlab("Dense") + ylab("Hazy") +
zlab("Normal") +
theme_showarrows () + ggtitle(paste(k, " Months", sep = "")) +
theme(plot.title = element_text(face="bold", hjust = 0.5,vjust =8),
plot.margin = unit(c(0,0,0,0), "cm"))
B.5 Chapter 6: Cluster analysis on reference patienter data












load(".RData") #Data set with prediction (v2 in code Chapter 5)






























d3<-dist(df_list$ ‘3‘[,5:7], method = "euclidean")
d6<-dist(df_list$ ‘6‘[,5:7], method = "euclidean")
d12 <-dist(df_list$ ‘12‘[,5:7], method = "euclidean")
d18 <-dist(df_list$ ‘18‘[,5:7], method = "euclidean")






































#Peter J. Rousseeuw (1987). "Silhouettes: a Graphical Aid to the
#Interpretation and Validation of Cluster Analysis ". Computational
#and Applied Mathematics. 20: 53 -65. doi :10.1016/0377 -0427(87)90125 -7.
x<-c(2,3,4,5,6,7)
y<-c(0.75 ,0.58 ,0.52 ,0.57 ,0.52 ,0.51)
dxy <-as.data.frame(cbind(x,y))
ggplot(dxy ,aes(x = x,y = y)) +
geom_line(col="#926 b8d") + geom_point(col="#926 b8d")+
xlab("Number of clusters") + ylab("Average Silhouette Score")+
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#Figure 6.2
#replace c2 for c3 -c7
ggplot(data = patch_c, aes(x=factor(c2), y=Dose)) +
geom_boxplot(alpha =0.7) +
geom_point(pch = 19, position = position_jitterdodge (),
alpha =0.7, size=1,aes(colour = factor(changeID )))+
xlab("Cluster") + ylab("Median Dose") +
scale_color_manual(values = c("#B7B6BA", "#926 B8D"),
labels = c("No RILD", "RILD"), name="")
#Figure 6.3
# for Figure 6.4 replace dense.pred.f, hazy.pred.f, com.pred.f, for
# Dense , Hazy , Com
cluster.labs <- c("Cluster 1","Cluster 2")
names(cluster.labs) <- c("1", "2")
ggplot(dcluster , aes(x=factor(date), y=dense.pred.f)) +
geom_boxplot(alpha =0.7, color="#926 B8D")+
facet_wrap(~c2,labeller = labeller(c2 = cluster.labs)) +
xlab("Months after RT") + ylab("Predicted Dense %") + ylim (0,1)
ggplot(dcluster , aes(x=factor(date), y=hazy.pred.f)) +
geom_boxplot(alpha =0.7, color="#7 aadb1")+
facet_wrap(~c2,labeller = labeller(c2 = cluster.labs)) +
xlab("Months after RT") + ylab("Predicted Hazy %") + ylim (0,1)
ggplot(dcluster , aes(x=factor(date), y=com.pred.f)) +
geom_boxplot(alpha =0.7, color="#B7B6BA")+
facet_wrap(~c2,labeller = labeller(c2 = cluster.labs)) +
xlab("Months after RT") + ylab("Predicted Normal %") + ylim (0,1)
cluster.labs <- c("Cluster 1","Cluster 2","Cluster 3")
names(cluster.labs) <- c("1", "2", "3")
ggplot(dcluster , aes(x=factor(date), y=dense.pred.f)) +
geom_boxplot(alpha =0.7, color="#926 B8D")+
facet_wrap(~c3,labeller = labeller(c3 = cluster.labs)) +
xlab("Months after RT") + ylab("Predicted Dense %") + ylim (0,1)
ggplot(dcluster , aes(x=factor(date), y=hazy.pred.f)) +
geom_boxplot(alpha =0.7, color="#7 aadb1")+
facet_wrap(~c3,labeller = labeller(c3 = cluster.labs)) +
xlab("Months after RT") + ylab("Predicted Hazy %") + ylim (0,1)
ggplot(dcluster , aes(x=factor(date), y=com.pred.f)) +
geom_boxplot(alpha =0.7, color="#B7B6BA")+
facet_wrap(~c3,labeller = labeller(c3 = cluster.labs)) +
xlab("Months after RT") + ylab("Predicted Normal %") + ylim (0,1)
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cluster.labs <- c("Cluster 1","Cluster 2","Cluster 3","Cluster 4")
names(cluster.labs) <- c("1", "2", "3","4")
ggplot(dcluster , aes(x=factor(date), y=dense.pred.f)) +
geom_boxplot(alpha =0.7, color="#926 B8D")+
facet_wrap(~c4,labeller = labeller(c4 = cluster.labs),nrow = 1) +
xlab("Months after RT") + ylab("Predicted Dense %") + ylim (0,1)
ggplot(dcluster , aes(x=factor(date), y=hazy.pred.f)) +
geom_boxplot(alpha =0.7, color="#7 aadb1")+
facet_wrap(~c4,labeller = labeller(c4 = cluster.labs),nrow = 1) +
xlab("Months after RT") + ylab("Predicted Hazy %") + ylim (0,1)
ggplot(dcluster , aes(x=factor(date), y=com.pred.f)) +
geom_boxplot(alpha =0.7, color="#B7B6BA")+
facet_wrap(~c4,labeller = labeller(c4 = cluster.labs),nrow = 1)+
xlab("Months after RT") + ylab("Predicted Normal %") + ylim (0,1)
cluster.labs <- c("Cluster 1","Cluster 2","Cluster 3","Cluster 4",
"Cluster 5")
names(cluster.labs) <- c("1", "2", "3","4","5")
ggplot(dcluster , aes(x=factor(date), y=dense.pred.f)) +
geom_boxplot(alpha =0.7, color="#926 B8D")+
facet_wrap(~c5,labeller = labeller(c5 = cluster.labs),nrow = 1) +
xlab("Months after RT") + ylab("Predicted Dense %") + ylim (0,1)
ggplot(dcluster , aes(x=factor(date), y=hazy.pred.f)) +
geom_boxplot(alpha =0.7, color="#7 aadb1")+
facet_wrap(~c5,labeller = labeller(c5 = cluster.labs),nrow = 1) +
xlab("Months after RT") + ylab("Predicted Hazy %") + ylim (0,1)
ggplot(dcluster , aes(x=factor(date), y=com.pred.f)) +
geom_boxplot(alpha =0.7, color="#B7B6BA")+
facet_wrap(~c5,labeller = labeller(c5 = cluster.labs),nrow = 1)+
xlab("Months after RT") + ylab("Predicted Normal %") + ylim (0,1)
B.6 Chapter 7: Association of tissue change with radiation pneumonitis in
NSCLS patients











# 1. Run model with data set of each patient , save model ’s coefficients
# and transform them back to compositional data.
# 2. Use the predictions for each patient and cluster them using the
# medoids of the reference patient.
coef <-read.xlsx("File with coefficients for each patient ’s model")
coef_com <-read.xlsx("File with coefficients in compositional form for
                     each patient ’s model")
cluster <-read.xlsx("File with distribution (in percentage) of patches in
                     each clustering configuration for each patient")
# Figures =============================================================
# Figure 7.1
# replace beta2 for beta3 -beta4 , gamma2 -gamma8
ggplot(data=coef , aes(x = beta2)) +
geom_histogram(aes(color = factor(rp), fill = factor(rp)),
position = "identity", bins = 30, alpha = 0.4) +
xlab("Coefficient for dose") + ylab("Count") +
scale_color_manual(name="RP",values = c("#926 b8d","#E8CA47"),
labels = c("No", "Yes")) +
scale_fill_manual(name="RP",values = c("#926 b8d","#E8CA47"),
labels = c("No", "Yes"))
### Regression ###########################################################
cluster$rpf <-ifelse(cluster$rp==0,"No","Yes")
X = acomp( cluster [ ,13:17] )
X = zeroreplace(X ,0.001)
mylogit <- glm(rp ~ ilr(X), data = cluster , family = "binomial")
(a = coef(mylogit )[1])
(b = ilrInv(coef(mylogit )[-1],orig=X))
summary(mylogit)
predict(mylogit)
predpr <-predict(mylogit , type = "response")
mylogit_pred = ifelse(predict(mylogit , type = "link") > 0, "Yes", "No")
calc_class_err = function(actual , predicted) {
mean(actual != predicted)
}
calc_class_err(actual = cluster$rpf , predicted = mylogit_pred)
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train_tab = table(predicted = mylogit_pred , actual = cluster$rpf)
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